NITRIC OXIDE RELEASING STEROIDS

Abstract

The invention relates to nitrooxyderivative of corticosteroids of general formula (I) and pharmaceutically acceptable salts or stereoisomers thereof

Description

FIELD OF THE INVENTION

The present invention relates to steroidal compounds having an improved pharmacological activity and lower side effects, to a process for their preparation and to pharmaceutical formulation containing them.

The compounds of the present invention may be used, as drugs w having antiinflammatory activity at peripheral level, for the therapy of respiratory diseases such as asthma and COPD, in ocular disease therapies such as ocular hypertension, age-related macular degeneration, diabetic macular edema, diabetic retinopathy, hypertensive retinopathy and retinal vasculopathies, or in dermatological disease therapies such asdermatosis, atopic dermatitis, inflammation, eczema, erythema, papulation, scaling, erosion, oozing, crusting, pruritis, psoriasis, epidermalysis bullosa, erythema, hidradenitis suppurative, warts, diaper rash, jock itch. In particular the compounds of the present invention are useful in ocular disease therapies.

BACKGROUND OF THE INVENTION

In the prior art nitrooxy derivatives of steroids, which are usable also as cardiovascular agents for the coronary insufficiency or angina pectoris therapy, are described.

For example, German patent DE 2,222,491 describes the preparation of pregnane derivatives having in position 21 the —CH₂—O—NO₂ group. In said patent it is stated that said N derivatives have a cardiotropic activity. This activity represents a drawback for said compounds, since they modify the cardiac frequency.

U.S. Pat. No. 3,494,941 describes steroid derivatives from 3-hydroxy-extrane or from extr-4 en-3 one, used as vasodilators in the treatment of cardiac affections such as coronary insufficiency and angina pectoris. In the structure of said compounds a ONO₂ group is at the free end of the alkylene chain which is linked by an ether bond to the steroid in position 17. According to said patent it is possible to have nitrate groups also in the positions 3 and 16 of the steroidal structure. The same drawbacks mentioned above as regards the effects on the cardiac frequency can be repeated for the compounds of this patent.

U.S. Pat. No. 3,183,252 describes derivatives of 16-nitrate-alkylpregnanes wherein the alkyl group is linked to the pregnane structure by a carbon-carbon bond. The compounds according to said patent can be used as vasodilators. The same drawbacks reported for the above prior art can be repeated.

WO 98/15568 and WO 03/064443 in the name of the Applicant is describe nitrate esters of steroidal compounds, wherein between the steroidal structure and the nitrooxy group a bivalent linking group is inserted. Said compounds show a good efficacy and/or good tolerability with respect to the corresponding precursors.

Patent application WO 00/61604 in the name of the Applicant describes nitrooxy derivatives of steroidal compounds with various linking groups having at one end a nitrooxy group, and covalently linked with the other end to a steroidal compound. In said application the uses concern the compounds usable in the treatment of patients in oxidative stress. Said compounds contain in the molecule also a bivalent linking group which must be capable to prevent the free radicals production and is selected on the basis of the tests reported therein.

SUMMARY OF THE INVENTION

The Applicant has surprisingly and unexpectedly found a class of nitric oxide releasing compounds with a better bioavailability and/or a prolonged release of NO in comparison with the compounds known in prior art. In general the compounds of the present invention have a better drugability in comparison to the corresponding compounds of the prior art.

DETAILED DESCRIPTION OF THE INVENTION

Object of the present invention are compounds of general formula (I) and pharmaceutically acceptable salts or stereoisomers thereof.

R-(Z)_a-R_x  (I)

wherein R is a corticosteroid residue of formula (II):

wherein:R₁ is OH, R₂—CH₃, or R₁ and R₂ are taken together to form a group of formula (III)

• • R₃ is Cl or F;
  • R₄ is H or F;wherein R₁, R₂, R₃ and R₄ can be linked to the correspondent carbon atoms of the steroidal structure in position α or β; with the proviso that:when R₁ and R₂ are the group of formula (III) then R₃ is F and R₉ is H or F;when R₁ is OH and R₂—CH₃ then R₄ is H and R₃ is Cl or F; preferred corticosteroid radicals are R of formula (II) wherein:R₁ is OH in position α, R₂—CH₃ in position 1, R₃ is Cl in position α and R₄ is H; orR₁ is OH in position α, R₂—CH₃ in position R₃ is F in position α and R₄ is H; orR₁ and R₂ are taken together to form a group of formula (III)

R₃ is F and R₄ is H, R₁, R₂ and R₃ are in position α; orR₁ and R₂ are taken together to form a group of formula (III)

R₃ and R₄ are F, R₁, R₂, R₃ and R₄ are in position α;a in formula (I) is equal to 0 or 1;Z is a group capable of binding R_x and is selected from —C(O)—, or —CH(R′)—O— wherein R′ is selected from H or a straight or branched C₁-C₄ alkyl, preferably R′ is H or —CH₃;R_x is a radical and is selected from the following meanings:

A)

(a1) —HN—CH(R¹)—C(O)-(T-Y—ONO₂)

(a2) —C(O)—CH(R¹)—NH-(T′-Y—ONO₂)

(a3) —HN—CH(R^1a-T″-Y—ONO₂)—COOR^3a

(a4) —C(O)—OH(R^1a-T″-Y′—ONO₂)

(a5) —R^1b—CH(NHR^4a)—C(O)-(T-Y—ONO₂)

(a6) —R^1b—CH(COOR^3a)NH-(T′-Y—ONO₂)

(a7) —HN—CH(R^1a-T″-Y′—ONO₂)—C(O)-(T-Y—ONO₂)

(a8) —C(O)—CH(R^1a-T″-Y′—ONO₂)—NH-(T′-Y—ONO₂)

(a9) —R^1b—CH(NH-T′-Y′—ONO₂)—C(O)-(T-Y—ONO₂)

(a10) —R^1b—CH(C(O)-T-Y—ONO₂)—NH-(T′-Y—ONO₂)

wherein:

R¹ is selected from:

• • A1) H, —CH₃, isopropyl, isobutyl, sec-butyl, tert-butyl, methylthio-(CH₂)₂—, phenyl, benzyl, C₆H₅—CH₂—CH₂—, 2-monosubstituted benzyl, or 3-monosubstituted benzyl or 4-monosubstituted benzyl wherein the substituent of the benzyl is selected from —F, —Cl, I, —NO₂, —CF₃, —CH₃, CN, C₆H₅CO—;

2,4-dichlorobenzyl, 3,4-dichlorobenzyl, 3,4-difluorobenzyl, 2-pyrrolidyl, 3-triptophanyl-CH₂—, 3-benzothienyl-CH₂—, 4-imidazolyl-CH₂—, 9-anthranyl-CH₂—, cyclohexyl, cyclohexyl-CH₂-cyclohexyl-(CH₂)₂—, cyclopentyl-CH₂—, (C₆H₅)₂CH—, 4-B(OH)₂— benzyl, 4-quinolyl-CH₂—, 3-quinolyl-CH₂—, 2-quinolyl-CH₂—, 2-quinoxalyl-CH₂—, 2-furyl-CH₂—, 1-naphtyl-CH₂—, 2-naphtyl-CH₂—, 2-pyridyl-CH₂—, 3-pyridyl-CH₂—, 4-pyridyl-CH₂—, 2-thienyl-CH₂—, 3-thienyl-CH₂—, C₆H₄—CH═CH—CH₂—, CH₂═CH—CH₂—, CH≡CH—CH₂—, NH₂—CO—CH₂—, NH₂CH—CO—(CH₂)₂—, NH₂(═NH)NH—(CH₂)₃—, P(═O)(OCH₃)₂, I—CH₂—, preferably R¹ is H, —CH₃, isopropyl, benzyl;

• • A2) —CH₂—SH, —CH₂—OH, —CH(CH₃)—OH, —CH₂—[(C₆H₄)-(4-OH)], —CH₂—[(C₆H₂)-(3,5-diiodo)-(4-OH)], —CH₂—[(C₆H₃)-(3-nitro)-(4-CH)], preferably R¹ is —CH₂—OH or —CH₂—[(C₆H₄)-(4-OH)];
  • A3) —CH₂—NHR″, —(CH₂)₂—NHR″, —(CH₂)₃—NHR″, —(CH₂)₄—NHR″, wherein R″ is H, —C(O)CH₃ or

wherein R^3a is H or a linear or branched C₁-C₁₀ alkyl chain, preferably R^5a is H or a linear (C₁-C₅) alkyl, preferably R¹ is —(CH₂)₄—NHR″, wherein R″ is as above defined;

• • A4) —CH₂—C(O)R″—(CH₂)₂—C(O)R″—(CH₂)₄—C(O)R″ wherein R″ is —OR^5a or

wherein R^5a is as above defined, preferably R¹ is —CH₂—C(O)R′″,

wherein R″ is as above defined;

R^1a is selected from,

• • A5) —CH₂—S—, —CH₂—O—, —CH(CH₃)—O—, —CH₂[(C₆H₄)—(4-O)—], —CH₂-[(3,5-diiodo)-(C₆H₂)—(4-O)—], —CH₂-[(3-nitro)-(C₆H₃)—(4-O)—], preferably R^1a is —CH₂—O—;
  • A6) —CH₂—NH—, —(CH₂)₂—NH—, —(CH₂)₃—NH—, —(CH₂)₄—NH—, preferably R^1a is —(CH₂)₄—NH— or —CH₂—NH—;
  • A7) —CH₂—C(O)—(CH₂)₂—C(O)—(CH₂)₄—C(O)—, preferably R^1a is —CH₂—C(O)—;

R^3a is selected from H, —R^5a or

• • wherein R^5a is as above defined;

R^4a is selected from H or —C(O)CH₃ or

wherein R^5a is as above defined;

R^1b is selected from

• • A8) —S—CH₂—, —O—CH(CH₃)—, —O—CH₂—, [-(4-O)—(C₆H₄)]—CH₂—, [—(4-O)-(3,5-diiodo)-(C₆H₂)]—CH₂—, [—(4-O)-(3-nitro)-(C₆H₃)]—CH₂—, preferably R^1b is —O—CH₂— or [—(4-O)—(C₆H₄)]—CH₂—;
  • A9) —HN—CH₂—, —HN—(CH₂)₂—, —HN—(CH₂)₃—, —HN—(CH₂)₄—, preferably R^1b is —HN—(CH₂)₄— or —HN—CH₂—;
  • A10) —C(O)—CH₂—, —C(O)—(CH₂)₂—, —C(O)—(CH₂)₄—, preferably R^1b is —C(O)—CH₂—;T is selected from —O—, —S—, —NR′—, —O—CH(R′)—O—C(O)— or —O—CH(R′)—O—C(O)O— wherein R′ is as above defined;T′ is —C(O)—C(O)—X″— wherein X″ is —O— or —S—, or T′ is —C(O)—NR′— wherein R′ is as above defined;T″ is independently selected from —O(O)—, —C(O)—X″—, —C(O)—NR′—O—, —S—, —NR′—O—CH(R′)—O—O(O)—, —O—CH(R′)—O—C(O)O—, wherein X″ and R′ are as above defined, with the proviso that T″ is —O(O)—, —O(O)—X″— or —C(O)—NR′— when T″ is linked to —NH—, —O—, or —S—; orT″ is —O—, —S—, —NR′—O—CH(R′)—O—O(O)—, —O—CH(R′)—O—O(O)O— when T″ is linked to —O(O)—;Y and Y′ are as below defined;

B)

(b1) —HN—CH(R²)—CH₂C(O)-(T-Y—ONO₂)

(b2) —O(O)—CH₂—CH(R²)—NH-(T′-Y—ONO₂)

(b3) —HN—CH(R^2a-T″-Y′—NO₂)—CH₂COOR^3a

(b4) —C(O)—CH₂—CH(R^1a-T″-Y′—ONO₂)—NHR^4a

(b5) —R^2b—CH(NHR^4a)—CH₂C(O)-(T-Y—ONO₂)

(b6) —R^2b—CH(CH₂COOR^3a)NH-(T′-Y—ONO₂)

(b7) —HN—CH(R^2a-T″-Y′—ONO₂)—CH₂—C(O)-(T-Y—ONO₂)

(b8) —C(O)—CH₂—CH(R^2a-T″-Y—ONO₂)—NH-(T-Y—ONO₂)

(b9) —R^2b—CH(NH-T′-Y′—ONO₂)—CH₂O(O)-(T′-Y—ONO₂)

(b10) —R^2b—CH(CH₂C(O)-T-Y′—ONO₂)—NH-(T′-Y′—ONO₂)

wherein

R² is selected from

B1) H, —CH₃, CF₃, isopropyl, isobutyl, sec-butyl, methylthio-(CH₂)₂—, phenyl, benzyl, 3-triptophanyl-CH₂—, NH₂—C(O)—CH₂—, NH₂—C(O)—(CH₂)₂—, NH₂ (═NH)NH—(CH₂)₃—, tBuO—CH(CH₃)—, benzyl-O—CH₂—, 4-terbutoxy-benzyl, 4-phenylbenzyl, preferably R² is H, —CH₃, isopropyl, benzyl;

• • B2) —CH₂—SH, —CH₂—OH, —CH(CH₃)—OH, —CH₂—[(C₆H₄)-(4-OH)], —CH₂—[(C₆H₂)-(3,5-diiodo)-(4-OH)], —(CH₂)—[(C₆H₃)—(3-nitro)-(4OH)];
  • B3) -CH₂—NHR″, —(CH₂)₂—NHR″—(CH₂)₃—NHR″, —(CH₂)₄—NHR″, wherein R′″ is as above defined, preferably R² is —(CH₂)₄—NHR″;
  • B4) —CH₂—C(O)—R″, (CH₂)₂—C(O)—R′″, —(CH₂)₄—C(O)—R″ wherein R′″ is as above defined, preferably R² is —CH₂—C(O)—R′″;

R^2a is selected from

• • B5) —CH₂—S—, —CH₂—O—, —CH(CH₃)—O— or —CH₂[(C₆H₄)—(4-O)—], —CH₂-[(3,5-diiodo)-(C₆H₂)—(4-O)—], —CH₂-[(3-nitro)-(C₆H₃)—(4-O)—], preferably R^2a is —CH₂—O—;
  • B6) —CH₂—NH—, —(CH₂)₂—NH—, —(CH₂)₃—NH—, —(CH₂)₄—NH—, preferably R^2a is —(CH₂)₄—NH— or —CH₂NH—;
  • B7) —CH₂—C(O)—, —(CH₂)₂—O(O)—(CH₂)₄—O(O)—, preferably R^2a is —CH₂—C(O)—;

R^2b is selected from

• • B8) —S—CH₂—, —O—CH(CH₃)—, —O—CH₂—, [-(4-O)—(C₆H₄)]—CH₂—, [-(4-O)-(3,5-diiodo) (C₆H₂)]—CH₂—, [-(4-O)-(3-nitro)-(C₆H₃)]—CH₂—, preferably R^2b is —O—CH₂— or [-(4-O)—(C₆H₄)]—CH₂—;
  • B9) —HN—CH₂—, —HN—(CH₂)₂—, —HN—(CH₂)₃—, —HN—(CH₂)₄—, preferably R^2b is —HN—(CH₂)₄— or —HN—CH₂—;
  • B10) —C(O)—CH₂—, —C(O)—(CH₂)₂—, —C(O)—(CH₂)₄—, preferably R^2b is —C(O)—CH₂—;R^3a and R^4a are as above defined;T, T′ and T″ are as above defined and Y and Y′ are as below defined;

C)

(c1) —HN—(CH₂)_b—C(O)-(T-Y—ONO₂)

(c2) —C(O)—(CH₂)_b—NH-(T′-Y—ONO₂);

wherein b is an integer from 3 to 6,T and T′ are as above defined and Y and Y′ are as below defined;

D)

(d1) —HN—CH(R¹²)—CH₂—O-(T′″-Y—ONO₂)

(d2) —O—CH₂—CH(R¹²)—NH-(T′-Y—ONO₂)

(d3) —HN—CH(R^12a-T″-Y′—ONO₂)—CH₂OH

(d4) —O—CH₂—CH(R^12a-T″-Y′—ONO₂)—NHR^4a

(d5) —R^12b—CH(NHR^4a)—CH₂—O-(T′″-Y—ONO₂)

(d6) —R^12b—CH(CH₂OH)—NH-(T′″-Y—ONO₂)

(d7) —HN—CH(R^12a-T″-Y′—ONO₂)—CH₂—O-(T″-Y—ONO₂)

(d8) —O—CH₂—CH(R^12a-T″-Y′—ONO₂)—NH-(T′-Y—ONO₂)

(d9) —R^12b—CH(NH-T′-Y′—ONO₂)—CH₂—O-(T′″-Y—ONO₂)

(d10) —R^12b—CH(CH₂—O-T′″-Y′—ONO₂)—NH-(T′-Y—ONO₂)

whereinT′″ is independently selected from —C(O)—, —C(O)X″— wherein X″ is —O— or —S—, or —C(O)—NR′— wherein R′ is as above defined;T′ and T″ are as above defined;Y and Y′ are as below defined;R¹² is selected from:

• • D1) H, —CH₃, isopropyl, isobutyl, sec-butyl, methylthio-(CH₂)₂—, benzyl, 3-triptophanyl-CH₂—, 4-imidazolyl-CH₂—, NH₂—CO—CH₂—, NH₂—CO—(CH₂)₂—, NH₂ (═NH)NH—(CH₂)₃—, preferably R¹² is H;
  • D2) —CH₂—OH, —CH(CH₃)—OH, —CH₂—[(C₆H₄)-(4-OH)], —CH₂—[(C₆H₃)-(3,5-diiodo)-(4-OH)], —CH₂—[(C₆H₃)-(3-nitro)-(4-OH)], preferably R¹² is —CH₂—OH or —CH₂—[(C₆H₄)—(4-OH)];
  • D3) —CH₂—NHR″, —(CH₂)₂—NHR″, —(CH₂)₃—NHR″, —(CH₂)₄—NHR″, wherein R″ is as above defined, preferably R¹² is —(CH₂)₄—NHR″;
  • D4) —CH₂—C(O)R″, —(CH₂)₂—C(O)R′″, (CH₂)₄—C(O)R′″ wherein R′″ is as above defined, preferably R¹² is —CH₂—C(O)R′″;

R^12a is selected from

• • D5) —CH₂—O—, —CH(CH₃)—O— or —CH₂—[(C₆H₄)-(4-O)—], —CH₂-[3,5-diiodo-(C₆H₂)—(4-O)—], —CH₂—[3-nitro-(C₆H₃)-4-O—], preferably R^12a is CH₂—O— or —CH₂[(C₆H₄)—(4-O)—];
  • D6) —CH₂—NH—, —(CH₂)₂—NH—, —(CH₂)₃—NH—, —(CH₂)₄—NH—, preferably R^12a is —(CH₂)₄—NH— or —CH₂—NH—;
  • D7) —CH₂—C(O)—(CH₂)₂—C(O) (CH₂)₄—C(O)—, preferably R^12a is —CH₂—C(O)—;

R^12b is selected from

• • D8) —O—CH₂—, —O—CH(CH₃)—, [—(4-O)—(C₆H₄)]—CH₂, [—(4-O)-(3,5-diiodo)-(C₆H₂)]—CH₂, [-(4-O)-(3-nitro)-(C₆H₃)]—CH₂—, preferably R^12b is —O—CH₂— or [-(4-O)—(C₆H₄)]—CH₂—;
  • D9) —HN—CH₂—, —HN—(CH₂)₂—, —HN—(CH₂)₃—, —HN—(CH₂)₄—, preferably to R^12b is —HN—(CH₂)₄— or —HN—CH₂—;
  • D10) —C(O)—CH₂—, —C(O)—(CH₂)₂—, is —C(O)—CH₂—;R^4a is as above defined;

E)

wherein c is equal to 0 or 1, d is an integer from 0 to 3 with the proviso that c is 0 or 1 when d is 0 and c is 0 when d is 1, 2 or 3, T and T′ are as above defined and Y is as below defined;

F)

wherein e and f are equal to 0 or 1, with the proviso that f is 0 when e is 0 and f is 0 or 1 when e is 1, T and T′ are as above defined and Y is as below reported;

G)

wherein R³ is H, CH₃, propyl, (C₆H₅)₂CH—, 1-naphtyl-CH₂—, benzyl, allyl, 2-bromobenzyl, 2-chlorobenzyl, 3-chlorobenzyl, fluorobenzyl, 4-bromobenzyl, 4-methylbenzyl, preferably R³ is H, T and T′ are as above defined and Y is as below defined;

H)

wherein R⁴ is H, benzyl, 4-bromobenzyl, 2-bromobenzyl, T and T′ are as above defined and Y is as below defined;

I)

wherein R⁵ is H, R⁶ is H, or R⁵ and R⁶ when taken together are a double bond, T and T′ are as above defined and Y is as below reported;

L)

wherein T and T′ are as above defined and Y is as below reported;

M)

wherein T and T′ are as above defined and Y is as below reported;

N)

wherein c is as above defined, d is equal to 0 or 1, T and T′ are as above defined and Y is as below reported;

O)

wherein R⁷ is H, R⁸ is H, or R⁷ and R⁸ when taken together are a double bond, c is as above defined, T and T′ are as above defined and Y is as below reported;

P)

wherein T and T′ are as above defined and Y is as below reported;

Q)

wherein T and T′ are as above defined and Y is as below reported;

R)

wherein T and T′ are as above defined and Y is as below reported;

S)

wherein T and T′ are as above defined and Y is as below reported;

T)

wherein T and T′ are as above defined and Y is as below reported;

U)

wherein R⁹ and R″ are H, CH₃, R¹¹ is CH₃ or 4-piperidinyl with the proviso that R⁹ and R¹⁰ are H when R¹¹ is 4-piperidinyl and R⁹ and R¹⁰ are CH₃ when R¹¹ is CH₃, T and T′ are as above defined and Y is as below reported;

V)

wherein T and T′ are as above defined and Y is as below reported;with the proviso that in the formula (I):a is 0 or a is 1 and Z is —CH(R′)—O— wherein R′ is as above defined, when R_x is:

(a2), (a4) or (a8);

(a5), (a6), (a9) or (a10) and R^1b is selected from the group A10);

(b2), (b4) or (b8);

(b5), (b6), (b9) or (b10) and R^2b is selected from the group B10);

(c2);

(d5), (d6), (d9) or (d10) and R^12b is selected from the group D10);

(e2), (f1), (g2), (h1), (i1), (l2), (m2), (n2), (o2), (p2), (q2), (r2), (s2), (t1) or (u2);

a is 1 and Z is —C(O)—, when R_x is:

(a1), (a3) or (a7);

(a5), (a6), (a9) or (a10) and R^1b is selected from the groups A8) and A9);

(b1), (b3) or (b7);

(b5), (b6), (b9) or (b10) and R^2b is selected from the groups B8) or B9);

(c1);

(d1), (d2), (d3), (d4), (d7) or (d8);

(d5), (d6), (d9) or (d10) and R^12b is selected from the groups D8) or D9);

(e1), (f2), (g1), (h2), (i2), (l1), (m1), (n1), (o1), (p1), (g1), (r1), (s1), (t2) or (u1).

Y and Y′ are bivalent radicals each independently selected from the following meanings:a)

straight or branched C₁-C₂₀ alkylene, preferably a straight or branched C₁-C₁₀ alkylene,

straight or branched C₁-C₂₀ alkylene substituted with one or more of the substituents selected from the group consisting of: halogen atoms, hydroxy, —ONO₂ or T₂, wherein T₂ is —OC(O) (C₁-C₁₀ alkyl)-ONO₂ or —O(C₁-C₁₀ alkyl)-ONO₂, preferably Y or Y′ is a straight or branched C₁-C₁₀ alkylene substituted with a —ONO₂ group;

cycloalkylene with 5 to 7 carbon atoms into cycloalkylene ring, the ring being optionally substituted with one or more straight or branched C₁-C₁₀ alkyl chains, preferably the ring being optionally substituted with CH₃;

whereinn⁰ is an integer from 0 to 20, preferably is 0 or 1;n¹ is 0 or 1, preferably n¹ is 1;U is a linear or branched C₁-C₂₀ alkylene optionally substituted with a —ONO₂ group, preferably U is a linear C₁-C₁₀ alkylene or U is a linear or branched C₁-C₁₀ alkylene substituted with a —ONO₂ group;

whereinn⁰ is an integer from 0 to 20, preferably n⁰ is 0 or 1;n is 0 or 1, preferably n¹ is 1;U is a linear or branched C₁-C₂₀ alkylene optionally substituted with a —ONO₂ group, preferably U is a linear C₁-C₁₀ alkylene or U is a linear or branched C₁-C₁₀ alkylene substituted with a —ONO₂ group;

wherein:n² is an integer from 0 to 2, R¹³ is H or CH₃, T₁ is —O—C(O)— or —C(O)O—;n¹ and U are as above defined;

n² is an integer from 0 to 2, preferably n² is 1;R¹³ is H or CH₃, preferably R¹³ is CH₃;Y is —CH₂—CH₂— or —CH═CH—(CH₂)_n^2′—, wherein n^2′ is 0 or 1, preferably Y¹ is —CH═CH—(CH₂)_n^2′— and n^2′ is 0;T₁═—O—C(O)— or —C(O)O—, preferably T₁ is —C(O)O—;n¹ is 0 or 1, preferably n¹ is 1;U is a linear or branched C₁-C₂₀ alkylene optionally substituted with a —ONO₂ group, preferably U is a linear C₁-C₁₀ alkylene or U is a linear or branched C₁-C₁₀ alkylene substituted with a —ONO₂ group;more preferably n² is 1, R¹³ is CH₃, Y¹ is —CH═CH—(CH₂)_n^2′ and n^2′ is 0, T₁ is —C(O)O— and U is a linear C₁-C₁₀ alkylene;

wherein:n² is an integer from 0 to 2, preferably n² is 1;R¹³ is H or CH₃, preferably R¹³ is CH₃;Y¹ is —CH₂—CH₂— or —(CH₂)_n^2′—CH═CH—, wherein n is 0 or 1,preferably Y¹ is —(CH₂)_n^2′—CH═CH— and n^2′ is 0;

(T₁)′=—O—C(O)—;

n¹ is 0 or 1, preferably n is 1;U is a linear or branched C₁-C₂₀ alkylene optionally substituted with a —ONO₂ group, preferably U is a linear C₁-C₁₀ alkylene or U is a linear or branched C₁-C₁₀ alkylene substituted with a —ONO₂ group;more preferably n² is 1, R¹³ is CH₃, Y¹ is —CH═CH—(CH₂)_n^2′— and n^2′ is 0, T₁ is —OC(O)— and U is a linear C₁-C₁₀ alkylene; when Y and Y′ are selected from b), c), d), e) or e′), the —ONO₂ group of -(T-Y—ONO₂), -(T′-Y—ONO₂), -(T″-Y′—ONO₂), -(T′Y′—ONO₂), -(T′″-Y—ONO₂) and -(T′″-Y′—ONO₂) is linked to the —(CH₂)— group;

wherein T₂ is —O— or —S—, —NH—, preferably T₂ is —O—, n³ is an integer from 1 to 6, preferably n³ is 1;

wherein:n⁴ is an integer from 0 to 10, preferably n is 0 or 1;n⁵ is an integer from 1 to 10, preferably n⁵ is 1;

R¹⁴, R¹⁵, R¹⁶, R¹⁷ are the same or different, and are H or straight or branched C₁-C₄ alkyl, preferably R¹⁴, R¹⁵, R¹⁶ and R¹⁷ are H;

wherein the —ONO₂ group is linked to

wherein n⁵ is as defined above;

Y² is an heterocyclic saturated, unsaturated or aromatic 5 or 6 members ring, containing one or more heteroatoms selected from nitrogen, oxygen, sulphur, and is selected from the group consisting of:

The term “C₁-C₁₀ alkyl” as used herein refers to branched or straight alkyl groups including methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, t-butyl, pentyl, hexyl, octyl and the like.

The term “cycloalkylene” as used herein refers to ring having from 5 to 7 carbon atoms including, but not limited to, cyclopentylene, cyclohexylene optionally substituted with side chains such as straight or branched (C₁-C₁₀)-alkyl, preferably CH₃.

The term “heterocyclic” as used herein refers to saturated, unsaturated or aromatic 5 or 6 members ring, containing one or more heteroatoms selected from nitrogen, oxygen, sulphur, such as for example pyridine, pyrazine, pyrimidine, pyrrolidine, morpholine, imidazole and the like.

Preferred compounds of formula (I) for the treatment of ocular diseases, in particular ocular hypertension, age-related macular degeneration, diabetic macular edema, diabetic retinopathy, hypertensive retinopathy and retinal vasculopathies, are those wherein the corticosteroid residue R is selected from the group consisting of betamethasone, fluocinolone acetonide, triamcinolone acetonide.

Another embodiment of the invention relates to compounds of formula (I) wherein in the corticosteroid R of formula (II) R₁, R₂, R₃ and R₄ have the following meanings:R₁ is OH in position α, R₂ —CH₃ in position p, R₃ is Cl in is position α and R₄ is H; orR₁ is OH in position α, R₂ —CH₃ in position p, R₃ is F in position α and R₄ is H; orR₁ and R₂ are taken together to form a group of formula (III)

R₃ is F and R₄ is H, R₁, R₂ and R₃ are in position α; orR₁ and R₂ are taken together to form a group of formula (III)

R₃ and R₄ are F, R₁, R₂, R₃ and R₄ are in position α;in formula (I)a is 0 andR_x is selected from:

—C(O)—CH(R¹)—NH-(T′-Y—ONO₂)  (a2)

whereinR¹ of the group A1) is selected from H, isobutyl, benzyl, C₆H₅—CH₂—CH₂—, 2-monosubstituted benzyl, or 3-monosubstituted benzyl or 4-monosubstituted benzyl wherein the substituent of the benzyl is selected from —F, —Cl, I, —NO₂, —CF₃, —CH₃, CN, C₆H₅CO—;R¹ of the group A2) is selected from —CH₂—OH, —CH(CH₃) OH— or —CH₂[(C₆H₄)—(4-OH)], orR¹ of the group A3) is selected from —CH₂—NHR″, —(CH₂)₂—NHR″, —(CH₂)₃—NHR″, —(CH₂)₄—NHR″, wherein R″ is H, or —C(O)CH₃;R¹ of the group A4) is selected from —CH₂—C(O)R″, (CH₂)₂— C(O)R″, —(CH₂)₄—C(O)R′″ wherein R″ is OR^5a wherein R^5a is H or a linear (C₁-C₅) alkyl;T′ is —C(O)—C(O)—X″ wherein X″ is —S— or —O—, preferably T′ is —C(O)—;Y is as below defined;

or R_x is

—C(O)—CH(R^1a-T″-Y′—ONO₂)—NHR^4a  (a4)

wherein R^1a of the group A5) is selected from —CH₂—O—, —CH(CH₃) O— or —CH₂[(C₆H₄)-(4-O)—], orR^1a of the group A6) is selected from —CH₂—NH—, —(CH₂)₂—NH—, (CH₂)₃—NH—, —(CH₂)₄—NH—, orR^1a of the group A7) is selected from —CH₂—C(O)—(CH₂)₂—C(O) —(CH₂)₄—C(O)—;

R^4a is H or —O(O)CH₃;

T″ is —C(O)— or —C(O)—X″ wherein X″ is —S— or —O—, when R^1a is selected from the group A5) or A6), preferably T″ is —C(O)—;T″ is —O—, —S—, —NR′— or —O—CH(R′)—O—C(O)— wherein R′ is H or —CH₃, when R^1a is selected from the group A7);Y′ is as below defined;or R_x is selected from

(a5) —R^1b—CH(NHR^4a)—C(O)-(T-Y—ONO₂)

(a6) —R^1b—CH(COOR^3a)—NH-(T′Y—ONO₂)

(a9) —R^1b—CH(NH-T′Y′-ONO₂)—C(O)-(T-Y—ONO₂) or

(a10) —R^1b—CH(C(O)-T-Y′—ONO₂)—NH-(T′Y—ONO₂)

whereinR^1b of the group A10) is selected from —C(O)—CH₂—, —C(O)—(CH₂)₂—, —C(O)—(CH₂)₄—;R^3a is H or a (C₁-C₅) alkyl;

R^4a is H or —O(O)CH₃;

T is —O—, —S—, —NR′— or —O—CH(R′)—O—C(O)— wherein R′ is H or —CH₃, preferably T is —O—;T′ is —C(O)— or —O(O)—X″ wherein X″ is —S— or —O—, preferably T′ is —C(O)—;Y and Y′ are as below defined; or R_x is

(a8) —C(O)—CH(R^1a-T″-Y′-ONO₂)—NH-(T′-Y-ONO₂)

wherein

R^1a of the group A5) is selected from —CH₂—O—, —CH(CH₃)—O— or —CH₂—[(C₆H₄)-(4-O—)—], or

R^1a of the group A6) is selected from —CH₂—NH—, —(CH₂)₂—NH—, (CH₂)₃—NH—, —(CH₂)₄—NH—, orR^1a of the group A7) is selected from —CH₂—C(O)—, —(CH₂)₂—C(O)—, —(CH₂)₄—C(O)—;T″ is —C(O)— or —O(O)—X″ wherein X″ is —S— or —O—, when R^1a is selected from the group A5) or A6), preferably T″is —O(O)—;T″ is —O—, —S—, —NR′— or —O—CH(R′)—O—C(O)— wherein R′ is H or —CH₃, when R^1a is selected from the group A7);T′ is —C(O)— or —C(O)—X″ wherein X″ is —S— or —O—, preferably T′ is —C(O)—;Y and Y′ are as below defined;

or R_x is

(b2) —C(O)—CH₂—CH(R²)—NH-(T′-Y-ONO₂)

whereinR² of the group B1) is selected from H, CH₃, isobutyl, isopropyl, benzyl;T′ is —C(O)—, —C(O)—X″ wherein X″ is —S— or —O—, preferably T′ is —O(O)—;Y and Y′ are each independently selected froma)

a straight or branched C₁-C₁₀ alkylene,

a straight or branched C₁-C₁₀ alkylene substituted with a —ONO₂ group;

wherein:n² is an integer from 0 to 2, R¹³ is H or CH₃, T₁ is —O—C(O)— or to —C(O)O—;

n¹ is 1 and U is a linear C₁-C₁₀ alkylene or U is a linear or branched C₁-C₁₀ alkylene substituted with a —ONO₂ group;

n² is 1, R¹³ is CH₃, Y¹ is —CH═CH—(CH₂)_n^2′— and n^2′ is 0, T₁ is —C(O)O— and U is a linear C₁-C₁₀ alkylene;

wherein:n² is 1, R¹³ is CH₃;Y¹ is —(CH₂)_n^2′—CH═CH— and n^2′ is 0;

(T₁)′=—O—C(O)—;

n¹ is 1 and U is a linear C₁-C₁₀ alkylene or U is a linear or branched C₁-C₁₀ alkylene substituted with a —ONO₂ group;when Y and Y′ are selected from d), e) or e′), the —ONO₂ group of -(T-Y—ONO₂), -(T′-Y-ONO₂), (T″-Y′-ONO₂) (T′-Y′-ONO₂), —(T′″-Y-ONO₂) and -(T″-Y′-ONO₂) is linked to the —(CH₂)— group;

wherein T₂ is —O— or —S—, —NH—, preferably T₂ is —O—, n³ is 1 or 2;

Another embodiment of the invention relates to compounds of formula (I) wherein in the corticosteroid R of formula (II) R₁, R₂, R₃ and R₄ have the following meanings:

R₁ is OH in position α, R₂—CH₃ in position p, R₃ is Cl in position α and R₄ is H; orR₁ is OH in position α, R₂—CH₃ in position p, R₃ is F in position α and R₄ is H; orR₁ and R₂ are taken together to form a group of formula (III)

R₃ is F and R₄ is H, R₁, R₂ and R₃ are in position α; orR₁ and R₂ are taken together to form a group of formula (III)

R₃ and R₄ are F, R₁, R₂, R₃ and R₄ are in position α;in formula (I)

a is 1 and Z is —C(O)—;

R_x is

(a1) —HN—CH(R¹)—C(O)-(T-Y—ONO₂)

whereinR¹ of the group A1) is selected from H, isobutyl, benzyl, C₆H₅—CH₂—CH₂—, 2-monosubstituted benzyl, or 3-monosubstituted benzyl or 4-monosubstituted benzyl wherein the substituent of the benzyl is selected from —F, —Cl, I, —NO₂, —CF₃, —CH₃, CN, C₆H₅CO—;orR¹ of A2) is selected from —CH₂—OH, —CH(CH₃) —OH— or —CH₂[(C₆H₄)— (4-OH)], orR¹ of the group A3) is selected from —CH₂—NHR″, —(CH₂)₂—NHR″, —(CH₂)₃—NHR″, —(CH₂)₄—NHR″, wherein R″ is H, or —C(O)CH₃,R¹ of the group A4) is —CH₂—C(O)R′″, —(CH₂)₂—C(O) R′″, —(CH₂)₄—C(O)R′″ wherein R′″ is OR^5a wherein R^5a is H or a linear (C₁-C₅) alkyl;T is —O—, —S—, —NR′-O—CH(R′)—O—C(O)— wherein R′ is H or a straight or branched C₁-C₄ alkyl, preferably T is —O—;Y is as below defined;

or R_x is

(a3) —HN—CH(R^1a-T″-Y′-ONO₂)—COOR^3a wherein

R^1a of the group A5) is selected from —CH₂—O—, —CH(CH₃) O— or —CH₂[(C₆H₄) O_p—], orR^1a of the group A6) is selected from —CH₂—NH—, —(CH₂)₂—NH—, (CH₂)₃—NH—, —(CH₂)₄—NH—, orR^1a of the group A7) is —CH₂—C(O)—(CH₂)₂—C(O)—(CH₂)₄—C(O)—;R^3a is H or a (C₁-C₅) alkyl;T″ is —C(O)— or —C(O)—X″ wherein X″ is —S— or —O—, when R^1a is selected from the group A5) or A6), preferably T″ is —O(O)—;T″ is —O—, —S—, —NR′-O—CH(R′)—O—C(O)— wherein R′ is H or a straight or branched C₁-C₄ alkyl, when R^1a is selected from the group A7);Y′ is as below defined;

or R_x is

(a5) —R^1b—CH(NHR^4a)—C(O)-(T-Y—ONO₂)

(a6) —R^1b—CH(COOR^3a)NH-(T′-Y-ONO₂)

(a9) —R^1b—CH(NH-T′-Y′-ONO₂)—C(O)-(T-Y—ONO₂) or

(a10) —R^1b—CH(C(O)-T-Y′-ONO₂)—NH-(T′-Y—ONO₂)

whereinR^1b of the group A8) is selected from —O—CH(CH₃)—, —O—CH₂—, [-4-O)—(C₆H₄)]—CH₂—, orR^1b of the group A9) is selected from —HN—CH₂—, —HN—(CH₂)₂—, —HN—(CH₂)₃—, —HN—(CH₂)₄—;R^3a is H or a (C₁-C₅) alkyl;

R^4a is H or —C(O)CH₃;

T is —O—, —S—, —NR′—, —O—CH(R′)—O—C(O)— wherein R′ is H or a straight or branched C₁-C₄ alkyl, preferably T is —O—;T′ is —C(O)— or —C(O)—X″ wherein X″ is —S— or —O—, preferably T′ is —C(O)—;Y and Y′ are as below defined;

or R_x is

(a7) —HN—CH—ONO₂)—O(O)-(T-Y—ONO₂)

whereinR^1a of the group A5) is selected from —OH₂—O—, —CH(CH₃)—O— or —CH₂—[(C₆H₄)-(4-O)—], orR^1a of the group A6) is selected from —CH₂—NH—, —(CH₂)₂—NH—, —(CH₂)₃—NH—, —(CH₂)₄—NH—, orR^1a of the group A7) is —CH₂—C(O)—, —(CH₂)₂—C(O)—, —(CH₂)₄—C(O)—;T″ is —C(O)— or —C(O)—X″ wherein X″ is —S— or —O—, preferably T″ is —C(O)— when R^1a is selected from A5) or A6);T″ is —O—, —S—, —NR′—, —O—CH(R′)—O—C(O)— wherein R′ is H or a straight or branched C₁-C₄ alkyl, preferably T″ is —O—, when R^1a is selected from A7);T is —O—, —S—, —NR′—, —O—CH(R′)—O—C(O)— wherein R′ is H or a straight or branched C₁-C₄ alkyl, preferably T is —O—;Y and Y′ are as below defined;

or R_x is

(b1) —HN—OH(R²)—CH₂C(O)-(T-Y—ONO₂)

whereinR² of the group 131) is selected from H, CH₃, isobutyl, isopropyl, benzyl;R² of the group B2) is selected from —CH₂—OH, —CH(CH₃)—OH— or —CH₂[(C₆H₄) (4-OH)], orR² of the group B3) is selected from —CH₂—NHR″, —(CH₂)₂—NHR″, —(CH₂)₃—NHR″, —(CH₂)₄—NHR″, wherein R″ is H, or —C(O)CH₃,R² of the group B4) is —CH₂—C(O)R′″, —(CH₂)₂—C(O)R′″, —(CH₂)₄—C(O)R′″ wherein R′″ is OR^5a wherein R^5a is H or a linear (C₁-C₅) alkyl;T is —O—, —S—, —NR′—, —O—CH)(R′)—O—C(O)— wherein R′ is H or a straight or branched C₁-C₄ alkyl, preferably T is —O—;Y is as below defined;or R_x is selected from

(d1) —HN—CH(R¹²)—CH₂—O-(T″-Y-ONO₂)

(d2) —O—CH₂—CH(R¹²)—NH-(T′-Y-ONO₂)

wherein

R¹² of the group D1) is selected from H, CH₃, isobutyl, isopropyl, benzyl, orR¹² of the group D2) is selected from —CH₂—OH, —CH(CH₃) OH— or —CH₂[(C₆H₄)—(4-OH)], orR¹² of the group D3) is selected from —CH₂—NHR″, —(CH₂)₂—NHR″, (CH₂)₃—NHR″, —(CH₂)₄—NHR″ wherein R″ is H, orR¹² of the group D4) is —CH₂—C(O)R″, —(CH₂)₂—C(O)R′″, —(CH₂)₄—C(O)R′″ wherein R′″ is OR^5a wherein R^5a is H or a linear (C₁-C₅) alkyl;T′ and T″ are each independently selected from —C(O)— or —C(O)—X″ wherein X″ is —S— or —O—, preferably T′ and T″ are —C(O)—;Y is as below defined;or R_x is selected from

(d3) —HN—CH(R^12a-T″-Y-ONO₂)—CH₂OH

(d4) —O—CH₂—CH(R^12a-T″-Y′-ONO₂)—NHR^4a

(d7) —HN—CH(R^12a-T″-Y′-ONO₂)—CH₂—O-(T″-Y-ONO₂) or

(d8) —O—CH₂—CH(R^12a-T″-Y′-ONO₂)—NH-(T′-Y-ONO₂)

whereinR^12a of the group D5) is selected from —CH₂—O—, —CH(CH₃)—O— or —CH₂[(C₆H₄)-(4-O)—], orR^12a of the group D6) is selected from —CH₂—NH—, —(CH₂)₂—NH—, (CH₂)₃—NH—, —(CH₂)₄—NH—, orR^12a of the group D7) is —CH₂—C(O)—, —(CH₂)₂—C(O)—, —(CH₂)₄—C(O)—;

R^4a is H or —C(O)CH₃;

T″ is selected from —C(O)— or —C(O)—X″ wherein X″ is —S— or —O—, preferably T′ and T″ are —C(O)—, when R^12a is selected from D5) or D6);T″ is —O—, —S—, —NR′—, —O—CH(R′)—O—C(O)— wherein R′ is H or a straight or branched C₁-C₄ alkyl, preferably T is —O—, when R^12a is selected from D7);T″ is selected from —C(O)— or —C(O)—X″ wherein X″ is —S— or —O—, preferably T″ is —C(O)—,

Y and Y′ are as below defined;

or R_x is selected from

(d5) —R^12b—CH(NHR^4a)—CH₂—O-(T″-Y-ONO₂)

(d6) —R^12b—CH(CH₂OH)—NH-(T′-Y-ONO₂)

(d9) —R^12b—CH(NH-T′-Y′-ONO₂)—CH₂—O-(T″-Y-ONO₂) or

(d10) —R^12b—CH(CH₂—O-T″-Y′-ONO₂)—NH-(T′-Y-ONO₂)

whereinR^12b of the group D8) is selected from —O—CH(CH₃)—, —O—CH₂—, O_p (C₆H₄)—CH₂—, orR^12b of the group D9) is selected from —HN—CH₂—, —HN—(CH₂)₂—,

HN—(CH₂)₃—, —HN—(CH₂)₄—;

R^4a is H or —C(O)—CH₃,

T′ and T″ are each independently selected from —C(O)—, —C(O)—X″, wherein X″ is —S— or —O—, preferably T′ and T″ are —C(O)—;Y and Y′ are each independently selected froma)

a straight or branched C₁-C₁₀ alkylene,

a straight or branched C₁-C₁₀ alkylene substituted with a —ONO₂ group;

wherein:

n² is an integer from 0 to 2, R¹³ is H or CH₃, T₁ is —O—C(O)— or —C(O)O—;

n¹ is 1 and U is a linear C₁-C₁₀ alkylene or U is a linear or branched C₁-C₁₀ alkylene substituted with a —ONO₂ group;

n² is 1, R¹³ is CH₃, Y is —CH═CH—(CH₂)_n^2′— and n^2′ is 0, T₁ is —C(O)O— and U is a linear C₁-C₁₀ alkylene;

wherein:n² is 1, R¹³ is CH₃;Y¹ is —(CH₂)_n^2′—CH═CH— and n^2′ is 0;

(T₁)′=—O—C(O)—;

n¹ is 1 and U is a linear C₁-C₁₀ alkylene or U is a linear or branched C₁-C₁₀ alkylene substituted with a —ONO₂ group;when Y and Y′ are selected from d), e) or e′), the —ONO₂ group of -(T-Y—ONO₂), -(T′-Y—ONO₂), -(T″-Y′-ONO₂)-(T′-Y′-ONO₂) (T′″-Y-ONO₂) and -(T″-Y′-ONO₂) is linked to the —(CH₂) — group;

wherein T₂ is —O— or —S—, —NH—, preferably T₂ is —O—, n³ is 1 or 2;

Another embodiment of the present invention relates to compounds of formula (I) wherein

R is the corticosteroid of formula (II) as above defined;

a is 0,

R_x is

(a2) —C(O)—CH(R¹)—NH-(T′-Y—ONO₂)

whereinto R¹ of A1) is selected from H

T′ is —C(O)—;

Y is selected froma)

a straight or branched C₁-C₁₀ alkylene,

a straight or branched C₁-C₁₀ alkylene substituted with a —ONO₂ group;

wherein:n² is an integer from 0 to 2, R¹³ is H or CH₃, T₁ is —O—C(O)— or —C(O)O—;n¹ is 1 and U is a linear C₁-C₁₀ alkylene or U is a linear or branched C₁-C₁₀ alkylene substituted with a —ONO₂ group;

n² is 1, R¹³ is CH₃, Y¹ is —CH═CH—(CH₂)_n^2′ and n^2′ is 0, T_I is —C(O)O— and U is a linear C₁-C₁₀alkylene;

wherein:n² is 1, R¹³ is CH₃;Y¹ is —(CH₂)_n^2′—CH═CH— and n^2′ is 0;

(T₁)′=—O—C(O)—;

n is 1 and U is a linear C₁-C₁₀ alkylene or U is a linear or branched C₁-C₁₀ alkylene substituted with a —ONO₂ group; when Y and Y′ are selected from d), e) or e∝0), the —ONO₂ group of -(T′-Y—ONO₂) is linked to the —(CH₂)— group;

wherein T₂ is —O— or —S—, —NH—, preferably T₂ is —O—, n³ is 1 or is 2;

Another embodiment relates to compounds of formula (I) wherein R is the corticosteroid of formula (II) as above defined;

a is 0, R_x is

(a5) —R^1b—CH(NHR^4a)—C(O)-(T-Y—ONO₂) or

(a9) —R^1b—CH(NH-T′-Y′-ONO₂)—C(O)-(T-Y—ONO₂)

wherein

R^1b of A10) is —C(O)—CH₂—,

R^4d is H or —C(O)CH₃;

T is selected from —O—, —S—, —NR′— wherein R′ is as above defined,

T′ is —C(O)— and

Y and Y′ are each independently selected froma)

a straight or branched C₁-C₁₀ alkylene,

a straight or branched C₁-C₁₀ alkylene substituted with a —ONO₂ group;

wherein:n² is an integer from 0 to 2, R¹³ is H or CH₃, T₁ is —O—C(O)— or —C(O)O—;n is 1 and U is a linear C₁-C₁₀ alkylene or U is a linear or branched C₁-C₁₀ alkylene substituted with a —ONO₂ group;

n² is 1, R¹³ is CH₃, T¹ is —CH═CH—(CH₂)_n^2′— and n^2′ is 0, T₁ is —C(O)O— and U is a linear C₁-C₁₀ alkylene;

wherein:n² is 1, R¹³ is CH₃;Y is —(CH₂)_n^2′—CH═CH— and n^2′ is 0;

(T₁)¹=—O—C(O)—;

n is 1 and U is a linear C₁-C₁₀ alkylene or U is a linear or branched C₁-C₁₀ alkylene substituted with a —ONO₂ group;when Y and Y′ are selected from d), e) or e∝0), the —ONO₂ group of -(T-Y—ONO₂), -(T′-Y-ONO₂), -(T″-Y′-ONO₂), -(T″-Y′-ONO₂), (T″-Y-ONO₂) and -(T″-Y′-ONO₂) is linked to the —(CH₂)— group;

wherein T₂ is —O— or —S—, —NH—, preferably T₂ is —O—, n³ is 1 or 2;

Another embodiment relates to compounds of formula (I) wherein R is the corticosteroid of formula (II) as above defined;

a is 1 and Z is —C(O)—, R_x is

(a5) —R^1b—(NHR^4a)—C(O)-(T-Y—ONO₂) or

(a9) —R^1b—CH(NH-T′-Y′-ONO₂)—C(O) (T-Y—ONO₂)

wherein R^1b of A10) is —O—CH₂— or [—O_p—(C₆H₄)]—CH₂—,

R^4a is H or —C(O)CH₃,

T is selected from —O—, —S—, —NR′— wherein R′ is as above defined,

T′ is —C(O)— and

Y and Y′ are each independently selected froma)

a straight or branched C₁-C₁₀ alkylene,

a straight or branched C₁-C₁₀ alkylene substituted with a —ONO₂ group;

wherein:n² is an integer from 0 to 2, R¹³ is H or CH₃, T₁ is —O—0(O)— or —C(O)O—;n¹ is 1 and U is a linear C₁-C₁₀ alkylene or U is a linear or branched C₁-C₁₀ alkylene substituted with a —ONO₂ group;

n² is 1, R¹³ is CH₃, Y¹ is —CH═CH—(CH₂)_n^2′— and n^2′ is 0, T₁ is —C(O)O— and U is a linear C₁-C₁₀alkylene;

wherein:n², is 1, R¹³ is CH₃;Y¹ is —(CH₂)_n^2′—CH═CH— and n^2′ is 0;

(T₁)′=—O—C(O)—;

n¹ is 1 and U is a linear C₁-C₁₀ alkylene or U is a linear or branched C₁-C₁₀ alkylene substituted with a —ONO₂ group;when Y and Y′ are selected from d), e) or e′), the —ONO₂ group of -(T-Y—ONO₂), -(T′-Y—ONO₂), -(T″-Y′-ONO₂), -(T′-Y′-ONO₂)—(T″-Y-ONO₂) and -(T″-Y′-ONO₂) is linked to the —(CH₂)— group;

wherein T₂ is —O— or —S—, —NH—, preferably T₂ is —O—, n³ is 1 or 2;

Another embodiment of the present invention relates to compounds of formula (I) wherein

R is the corticosteroid of formula (II) as above defined;a is 0,

R_x is

(b2) —C(O)—CH₂—CH(R²)—NH-(T′-Y—ONO₂)

wherein

R² of 31) is H,

T′ is —C(O)—;

Y and Y′ are each independently selected froma)

a straight or branched C₁-C₁₀ alkylene,

a straight or branched O₁—C₁₀ alkylene substituted with a —ONO₂ group;

n² is an integer from 0 to 2, R¹³ is H or CH₃, T₁ is —O—C(O)— or —C(O)O—;n¹ is 1 and U is a linear C₁-C₁₀ alkylene or U is a linear or branched C₁-C₁₀ alkylene substituted with a —ONO₂ group;

n² is 1, R¹³ is CH₃, Y¹ is —CH═CH—(CH₂)_n^2′ and n^2′ is 0, T₁ is —C(O)O— and U is a linear C₁-C₁₀alkylene;

wherein:n² is 1, R¹³ is CH₃;Y¹ is —(CH₂)_n^2′—CH═CH— and n^2′ is 0;

(T₁)′=—O—C(O)—;

n¹ is 1 and U is a linear C₁-C₁₀ alkylene or U is a linear or branched C₁-C₁₀alkylene substituted with a —ONO₂ group;when Y and Y′ are selected from d), e) or e′), the —ONO₂ group of -(T-Y—ONO₂)-(T′-Y-ONO₂), -(T″-Y′-ONO₂), -(T′-Y′-ONO₂)(T′″-Y-ONO₂) and -(T″-Y′-ONO₂) is linked to the —(CH₂)— group;

wherein T₂ is —O— or —S—, —NH—, preferably T₂ is —O—, n³ is 1 or 2;

Preferred specific embodiments of the present invention are the selected compounds of formula below reported:

As stated above, the invention includes also the pharmaceutically acceptable salts of the compounds of formula (I) and stereoisomers thereof.

Examples of pharmaceutically acceptable salts are either those with inorganic bases, such as sodium, potassium, calcium and aluminium hydroxides, or with organic bases, such as lysine, arginine, triethylamine, dibenzylamine, piperidine and to other acceptable organic amines.

The compounds according to the present invention, when they contain in the molecule one salifiable nitrogen atom, can be transformed into the corresponding salts by reaction in an organic solvent such as acetonitrile, tetrahydrofuran with the corresponding organic or inorganic acids.

Examples of organic acids are: oxalic, tartaric, maleic, succinic, citric acids. Examples of inorganic acids are: nitric, hydrochloric, sulphuric, phosphoric acids. Salts with nitric acid are preferred.

The compounds of the invention which have one or more asymmetric carbon atoms can exist as optically pure enantiomers, pure diastereomers, enantiomers mixtures, diastereomers mixtures, enantiomer racemic mixtures, racemates or racemate mixtures. Within the object of the invention are also all the possible isomers, stereoisomers and their mixtures of the compounds of formula (I).

The compounds object of the present invention are formulated in the corresponding pharmaceutical compositions, also with belated release, for parenteral, oral and topic use, such as for example sublingual, inhalatory, suppository, transdermal, enema, according to the well known techniques in the art, together with the usual excipients; see for example the publication “Remington's Pharmaceutical Sciences” 15^th Ed.

The amount on a molar basis of the active principle in said compositions is generally the same, or lower than that of the corresponding precursor drug.

The daily administrable doses are those of the precursor drugs, or optionally lower. The precursor daily doses can be found in the publications of the field, such for example in the “Physician's Desk reference”.

The present invention compounds are used in particular for the treatment of ocular disease therapies such as ocular hypertension, age-related macular degeneration, diabetic macular edema, diabetic retinopathy, hypertensive retinopathy and retinal vasculopathies.

Synthesis Procedure

1) The compound of general formula (I) as above defined wherein a is equal to 0, the radical R_x is selected from (a2), (a4), (a8), (b2), (b4), (b8), (c2), (e2), (f1), (g2), (h1), (ii), (l2), (m2), (n2), (o2), (p2), (q2), (r2), (s2), (t2), (u2), (v2), can be obtained:1-i) by reacting a compound of (IIa)

wherein R₁, R₂, R₃, R₄, are as above defined, with a compound of formula (Ia)

W—X₁  (Ia)

wherein W is —OH, Cl, O—R_a, wherein R_a is pentafluorophenyl, 4-nitrophenyl or —(N-succimidyl), X₁ is as below defined, to obtain the compound of formula (IIa′)

wherein R_I, R₂, R₃, R₄, are as above defined and X₁ is as below defined,is X₁ is a radical having the following meaning:

• • (a2′) —C(O)—CH(R^1′)—NH-(T′-Y-Q)wherein R^1′ is selected fromA1) as defined above orA2′)—CH₂—SP¹, —CH₂—OP¹, —CH(CH₃) —OP¹, —CH₂[(C₆H₄)-4-OP¹]—CH₂—[(C₆H₃)-(3,5-diiodo)-4-OP¹], —(CH₂—[(C₆H₃)-3-nitro-4-OP¹] or

A3′) —CH₂—NHR″″, —(CH₂)₂—NHR″″, —(CH₂)₃—NHR″″, —(CH₂)₄—NHR″″,

wherein R″″ is P³ or —C(O)CH₃ or

wherein R^5a is as defined above;

A4′)—CH₂—C(O)R′″″, —(CH₂)₂—C(O)R′″″, —(CH₂)₄—C(O)R′″″

wherein R′″″ is P², —OR^5a or

wherein R^5a is as above defined;

• • (a4′) —C(O)—CH(R^1a-T″-Y′-Q)-NHR^4a′
  • (a8′) —C(O)—OH(R^1a-T″-Y′-Q)-NH-(T′-Y-Q)wherein R^1a is as defined above;
  • (b2′) —C(O)—CH₂—CH(R^2′)—NH-(T′-Y-Q)wherein R^2′ is selected fromB1) as defined above or

B2′) —CH(CH₃)—OP¹, —CH₂—[(C₆H₄)₄—OP¹];

B3′) —CH₂—NHR″″, —(CH₂)₂—NHR″″—(CH₂)₃—NHR″″, —(CH₂)₄—NHR″″,

wherein R″″ is as above defined;B4′) —CH₂—C(O)—R″″, —(CH₂)₂—C(O)—R′″″, —(CH₂)₄—C(O)—R′″″ whereinR′″″ is as above defined;

R^4a′ is P³ or —C(O)—CH₃ or

(b4′) —C(O)—CH₂—CH(R^2a-T″-Y′-Q)-NHR^4a′

(b8′) —C(O)—CH₂—CH(R^2a-T″-Y′-Q)-NH-(T′-Y-Q)

wherein R^2a and R^4a′ are as defined above;

(c2′) —C(O)—(CH₂)_b—NH-(T′-Y-Q);

wherein R³, R⁴, R⁵, R⁶, R⁷, R⁸, R⁹, Rⁿ, Rⁿ, b, c, d, e and f are as above defined;wherein P¹ is a hydroxyl or thiol protecting group such as silyl ethers, such as trimethylsilyl, tert-butyl-dimethylsilyl or trityl and those described in T. W. Greene “Protective groups in organic synthesis”, Harvard University Press, 1980, P² is a carboxylic protecting group such as tert-butyl ester and those described in T. W. Greene “Protective groups in organic synthesis”, Harvard University Press, 1980, P³ is a amino protecting group such as Boc, Fmoc or those described in T. W. Greene “Protective groups in organic synthesis”, Harvard University Press, 1980,T, T′, T″, Y and Y′ are as above defined,Q is independently —ONO₂ or Z₂ wherein Z₂ is selected from the group consisting of: a chlorine atom, a bromine atom, a iodine atom, a mesyl group or a tosyl group, and1-ii) when Q is Z_2r by converting the compound obtained in the step 1-i) into nitro derivative by reaction with a nitrate source such as silver nitrate, lithium nitrate, sodium nitrate, potassium nitrate, magnesium nitrate, calcium nitrate, iron nitrate, zinc nitrate or tetraalkylammonium nitrate (wherein alkyl is C₁-C₁₀alkyl) in a suitable organic solvent such as acetonitrile, tetrahydrofurane, methyl ethyl ketone, ethyl acetate, DMF, the reaction is carried out, in the dark, at a temperature from room temperature to the boiling temperature of the solvent. Preferred nitrate source is silver nitrate and1-iii) optionally deprotecting the compounds obtained in step 1-i) or 1-ii) as described in T. W. Greene “Protective groups in organic synthesis”, Harvard University Press, 1980, 2^nd edition. Fluoride ion is the preferred method for removing silyl ether protecting group. Trifluoroacetic acid or anhydrous inorganic acid are the preferred method for removing Boc protecting group, anhydrous organic or inorganic acid is the preferred method for removing trityl protecting group. Organic base such as piperidine is the preferred method for removing Fmoc protecting group. Aqueous or anhydrous organic or inorganic acid is the preferred method for removing t-butyl ester protecting group.1-i-1) The reaction of a compound of formula (Ia) wherein W=—OH and X₁ is as above defined, with a compound of formula (IIa) may be carried out in presence of a condensing agent as n dicyclohexylcarbodiimide (DCC), N′-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDAC) N,N′-carbonyldiimidazole (CDI), in the presence or not of a base as for example as N,N-dimethylamino pyridine (DMAP).

The reaction is carried out in an inert organic dry solvent such as N,N′-dimethylformamide, tetrahydrofuran, benzene, toluene, dioxane, a polyhalogenated aliphatic hydrocarbon at a temperature from −20° C. and 50° C. The reaction is completed within a time range from 30 minutes to 36 hours.

1-i-2) The reaction of a compound of formula (Ia) wherein W=—O—R, wherein R_a and X₁ are as above defined, with a compound of formula (IIa) may be carried out in presence of a catalyst, such as N,N-dimethylamino pyridine (DMAP) or in the presence of DMAP and a Lewis acid such as Sc(OTf)₃ or Bi(OTf)₃. The reaction is carried out in an inert organic solvent such as N,N′-dimethylformamide, tetrahydrofuran, benzene, toluene, dioxane, a polyhalogenated aliphatic hydrocarbon at a temperature from −20° C. and 40° C. The reaction is completed within a time range from 30 minutes to 36 hours.1-i-3) The reaction of a compound of formula (Ia) wherein W=—Cl, and X₁ is are as above defined, with a compound of formula (IIa) may be carried out in presence of an organic base such as N,N-dimethylamino pyridine (DMAP), triethylamine, pyridine. The reaction is carried out in an inert organic solvent such as N,N′-dimethylformamide, tetrahydrofuran, benzene, toluene, dioxane, a polyhalogenated aliphatic hydrocarbon at a temperature from −20° C. and 40° C. The reaction is completed within a time range from 30 minutes to 36 hours.

The compounds of formula (IIa) are commercially available.

1a) The compounds of formula (Ia) wherein W is —OH, T′ and T″ are C(O), and X₁ is the radical selected from (a2′), (a4′), (b2′), (b4′), (c2′), (e2′), (f1′), (g2′), (h1′), (i1′), (l2′), (m2′), (n2′), (o2′), (p2′), (q2′), (r2′), (s2′), (t2′), (u2′), (v2′), wherein R^1′ is selected from A1), A2′), A3′), A4′), R^1a is selected from A5) or A6), R^2a is selected from B5) or B6) and R^2′ is selected from B1), B2′), B3′), B4′) and Y, Y′ and R^4a′ are as above defined, can be obtained1a-i) by reacting a compound of formula (IIIa)

P²—X₂  (IIIa)

wherein P² is as above defined, X₂ is a radical having the following meaning

(a2″) —C(O)—CH(R^1′)—NH₂

(a4″) —C(O)—CH(R^1a—H)—NHR^4a′

wherein R^1′ is selected from A1), A2′), A3′), A4′), R^1a is selected from A5) or A6) and R^4a′ is as defined above

(b2″) —C(O)—CH₂—CH(R^2′)—NH₂,

(b4″) —C(O)—CH₂—CH(R^2a—H)—NHR^4a′

wherein R^2′ is selected from B1), B2′), B3′), B4′), R^2a is selected from B5) or B6) and R^4a′ is as defined above,

(c2″) —C(O)—(CH₂)_b—NH₂,

wherein R³, R⁴, R⁵, R⁶, R⁷, R⁸, R⁹, R¹⁰, R¹¹, b, c, d, e and f are as above defined;with a compound of formula (IVa)

W₁—(O)C-y-Q  (IVa)

wherein W₁ is OH or O—R_a, and R_a and Q are as above defined, y is the radical Y when X₂ is selected from (a2′), (b2′), (c2′), (e2′), (f1′), (g2′), (h1′), (i1′), (l2′), (m2′), (n2′), (o2′), (p2′), (q2′), (r2′), (s2′), (t2′), (u2′), (v2′), and y is the radical Y′ when X₂ is selected from (a4′) or (b4′), wherein Y and Y′ are as defined above, and1a-ii) when Q is Z₂, by converting the compound obtained in the step 1a-i) into nitro derivative by reaction with a nitrate source as above described and1a-iii) optionally deprotecting the compounds obtained in step 1a-i) or 1a-ii) as above described.

The reaction of a compound of formula (IIIa) wherein P² and X₂ are as above defined, with a compound of formula (IVa) wherein W₁ is OH, y, Q are as above defined, may be carried out as described in 1-i-1) or in presence of other known condensing reagents such as O-(7-azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate (HATU).

The reaction of a compound of formula (IIIa) wherein P² and X₂ are as above defined, with a compound of formula (IVa) wherein W₁ is O—R_a, y, Q are as above defined, may be carried as described in 1-i-2).

The compounds of formula (IIIa) are commercially available or can be obtained as known in the literature.

The compounds of formula (IVa) wherein W₁ is OH, y and Q are as above defined, can be obtained from the corresponding alcohols of formula HOOC-y-OH (IVb) by reaction with nitric acid and acetic anhydride in a temperature range from −50° C. to 0° C. or from the corresponding derivatives of formula HOOC-y-Z₂ (IVc) wherein Z₂ is as above defined, by reaction with a nitrate source as above described. Alternatively the reaction with AgNO₃ can be performed under microwave irradiation in solvents such acetonitrile or THF at temperatures in the range between about 100-180° C. for time range about 1-60 min.

The compounds of formula (IVb) are commercially available.

The compounds of formula (IVc) are commercially available or can be obtained as known in the literature.

The compounds of formula (IVa) wherein W₁ is O—R_a, y, Q are as above defined, can be obtained from the corresponding acids of formula (IVa) wherein W₁ is OH as known in the literature.

The compounds of formula (Ia) wherein W═Cl or O—R_a, X₁ is selected from (a2′), (a4′), (b2′), (b4′), (c2′), (e2′), (f1′), (g2′), (h1′), (i1′), (l2′), (m2′), (n2′), (o2′), (p2′), (q2′), (r2′), (s2′), (t2′), (u2′), (v2′), wherein R¹ is selected from A1), A2′), A3′), A4′), R^1a is selected from A5) or A6), R^ea is selected from B5) or B6) and R^2′ is selected from B1), B2′), B3′), B4′), and wherein Y, Y′ and Q are as above defined and T′ and T″ are C(O), can be obtained from the corresponding acids (Ia) wherein W is —OH as known in the literature.

1b) The compounds of formula (Ia) wherein W is —OH, X₁ is the radical selected from (a2′), (a4′), (b2′), (b4′) (c2′), (e2′), (f1′), (g2′), (h1′), (i1′), (l2′), (m2′), (n2′), (o2′), (p2′), (q2′), (r2′), (s2′), (t2′), (u2′), (v2′), wherein R^1′ is selected from A1), A2′), A3′), A4′), R^1a is selected from A5) or A6), R^2a is selected from B5) or B6) and R^2′ is selected from B1), B2′), B3′), B4′), Y and Y′ are as above defined, T′ and T″ are C(O)—X″, wherein X″ is —O— or —S— can be obtained1b-i) by reacting a compound of formula (IIIa)

P²—X₂  (IIIa)

wherein P² and X₂ are as defined above, with a compound of formula (IVd)

R_a—O—C(O)—X″-y-Q  (IVd)

wherein R, X″ and Q are as above defined, y is the radical Y when X₂ is selected from (a2′), (b2′), (c2′), (e2^f), (f1′), (g2′), (h1′), (i1′), (l2′), (m2′), (n2′), (o2′), (p2′), (q2′), (r2′), (s2′), (t2′), (u2′), (v2′), and y is the radical Y′ when X₂ is selected from (a4′) or (b4′), wherein Y and Y′ are as above defined, and1b-ii) when Q is Z₂, by converting the compound obtained in the step 1b-i) into nitro derivative by reaction with a nitrate source as above described and1b-iii) optionally deprotecting the compounds obtained in step 1b-i) or 1b-ii) as above described.

The reaction of a compound of formula (IIIc) wherein P² and X₂ are as above defined, with a compound of formula (IVd) wherein R_a, X″, y and Q are as above defined, may be carried out as described in 1-i-2)

The compounds of formula (IVd) wherein R_a, X″, y, Q are as above defined, can be obtained from the compounds of formula HX″-y-Q (IVe) wherein X″, y, Q are as above defined, as known in literature.

The compound of formula (IVe) are commercially available or are known in literature.

The compounds of formula (Ia) wherein W is —Cl or O—R, X₁ is selected from (a2′), (a4′), (b2′), (b4′), (c2′), (e2′), (f1′), (g2′), (h1′), (i1′), (l2′), (m2′), (n2′), (o2′), (p2′), (q2′), (r2′), (s2′), (t2′), (u2′), (v2′), wherein R^1′ is selected from A1), A2′), A3′), A4′), R^1a is selected from A5) or A6), R^ea is selected from B5) or B6) and R^2′ is selected from B1), B2′), B3′), B4′), Y, Y′ and Q are as above defined, T′ and T″ are C(O)—X″ wherein X″ is O or S, can be obtained from the corresponding acids (Ia) wherein W is —OH as known in the literature.

1c) The compounds of formula (Ia) wherein W is —OH and X₁ is a radical selected from (a8′) or (b8′), wherein R^1a is selected from A5) or A6), R^2a is selected from B5) or B6), Q is as above defined, T′ and T″ are C(O), Y and Y′ are the same and are as above defined, can be obtained1c-i) by reacting a compound of formula (IIIb),

P²—X₃  (IIIb)

wherein P² is as above defined, X₃ is the radical of formula

(a8″) —C(O)—CH(R^1a—H)—NH₂

(b8″) —C(O)—CH₂—CH(R^2a—H)—NH₂

wherein R^1a is selected from A5) or A6), R^2a is selected from B5) or B6), with a compound of formula (IVa)

W₁—(O)C-y-Q  (IVa)

wherein W₁ and Q are as above defined, wherein y is the radical Y or Y′, wherein Y and Y′ are as above defined, and1c-ii) when Q is Z₂, by converting the compound obtained in the step 1c-i) into nitro derivative by reaction with a nitrate source as above described and1c-iii) optionally deprotecting the compounds obtained in step 1c-i) or 1c-ii) as above described.

The reaction of a compound of formula (IIIb) wherein P² and X₃ are as above defined, with a compound of formula (IVa) wherein W₁ is OH, y and Q are as above defined, may be carried out as described in 1a-i) using a ratio (IIIb)/(IVa) 1:2.

The reaction of a compound of formula (IIIb) wherein P² and X₃ are as above defined, with a compound of formula (IVa) wherein W₁ is OR_a, y and Q are as above defined, may be carried out as described in 1-i-2) using a ratio (IIIb)/(IVa) 1:2.

The compounds of formula (IIIb) are commercially available or can be obtained as known in the literature.

The compounds of formula (Ia) wherein W is —Cl or O—R_a, X₁ is the radical selected from (a8′) or (b8′) wherein R^1a is selected from A5) or A6), R^2a is selected from 35) or 36) and wherein Y, Y′ and Q are as above defined and T′ and T″ are C(O), can be obtained from the corresponding acids (Ia) wherein W is —OH as known in the literature.

1d) The compounds of formula (Ia) wherein W is —OH, X₁ is the radical selected from (a8′) or (b8′), wherein R^1a is selected from A5) or A6), R^2a is selected from B5) or B6), Q, Y and Y′ are as above defined, T′ is C(O) or C(O)—X″ wherein X″ is as above defined, T″ is C(O), can be obtained1d-i) by reacting a compound of formula (Ib)

P²—X_3′  (Ib)

wherein P² is as above defined, X_3′, is the radical of formula

(a8″) —C(O)—CH(R^1a—H)—NH-(T′-Y-Q))

(b8′″) —C(O)—CH₂—CH(R^2a—H)—NH-(T′-Y-Q)

wherein R^1a is selected from A5) or A6), R^2a is selected from 35) or B6), with a compound of formula (IVa)

W₁—(O)C-y-Q  (IVa)

wherein W₁ and Q are as above defined, wherein y is the radical Y′, wherein Y′ is as above defined, and1d-ii) when Q is Z₂, by converting the compound obtained in the step 1d-i) into nitro derivative by reaction with a nitrate source as above described and1d-iii) optionally deprotecting the compounds obtained in step 1d-i) or 1d-ii) as above described.

The reaction of a compound of formula (Ib) wherein P² and X_3′, are as above defined, with a compound of formula (IVa) wherein W₁ is OH, y and Q are as above defined, may be carried out as described in 1a-i).

The reaction of a compound of formula (Ib) wherein P² and X_3′, are as above defined, with a compound of formula (IVa) wherein W₁ is OR_a, y and Q are as above defined may be carried out as described in 1-i-2).

The compounds of formula (Ib) wherein T′ is C(O), P² and X_3′, are as above defined, are obtained as described in 1a).

The compounds of formula (Ib) wherein T′ is C(O)—X″, P² and X_3′, are as above defined, are obtained as described in 1b).

The compounds of formula (Ia) wherein W is —Cl or O—R_a′, X₁ is the radical selected from (a8′) or (b8′) wherein R^1a is selected from A5) or A6), R^2a is selected from B5) or B6) and wherein Q, Y and Y′ are as above defined, T′ is C(O) or C(O)—X″ wherein X″ is as above defined, T″ is C(O), can be obtained from the corresponding acids (Ia) wherein W is —OH as known in literature.

1e) The compounds of formula (Ia) wherein W is —OH, X₁ is the radical selected from (a8′) or (b8′), wherein R^1a is selected from A5) or A6), R^2a is selected from B5) or B6), Q is as above defined, Y and Y′ are the same and are as above defined, T′ and T″ are C(O)—X″— wherein X″ is as above defined, can be obtained1e-i) by reacting a compound of formula (IIIb)

P²—X₃  (IIIb)

wherein P² and X₃ are as above defined, with a compound of formula (IVd)

R_a—O—C(O)—X″-y-Q  (IVd)

wherein R_a and Q are as above defined, wherein y is the radical Y′, wherein Y′ is as above defined, and1e-ii) when Q is Z₂, by converting the compound obtained in the step 1e-i) into nitro derivative by reaction with a nitrate source as above described and1e-iii) optionally deprotecting the compounds obtained in step 1e-i) or 1e-ii) as above described.

The reaction of a compound of formula (IIIb) wherein P² and X₃ are as above defined, with a compound of formula (IVd) wherein R_a, y and Q are as above defined, may be carried out as described in 1-i-2) using a ratio (IIIb)/(IVd) 1:2.

The compounds of formula (Ia) wherein W is —Cl or O—R, X₁ is the radical selected from (a8′) or (b8′) wherein R^1a is selected from A5) or A6), R^2a is selected from B5) or B6) and wherein Y and Y′, Q is as above defined and T′ and T″ are C(O)—X″— wherein X″ is as above defined, can be obtained from the corresponding acids (Ia) wherein W is —OH as known in literature.

1f) The compounds of formula (Ia) wherein W is —OH, X₁ is selected from (a8′) or (b8′), wherein R^1a is selected from A5) or A6), R^2a is selected from B5) or B6), Q, Y and Y′ are as above defined, T′ is C(O) or C(O)—X″ wherein X″ is as above defined, T″ is C(O)—X″, can be obtained1f-i) by reacting a compound of formula (Ib)

P²—X_3′  (Ib)

wherein X_3′ and P² are as above defined, with a compound of to formula (IVd)

W₁—O—C(O)—X″-y-Q  (IVd)

wherein W₁ and Q are as above defined, y is the radical Y′,wherein Y′ is as above defined, and1f-ii) when Q is Z₂, by converting the compound obtained in the step 1f-i) into nitro derivative by reaction with a nitrate source as above described and1f-iii) optionally deprotecting the compounds obtained in step 1f-i) or 1f-ii) as above described.

The reaction of a compound of formula (Ib) wherein P² and X_3′ are as above defined, with a compound of formula (IVd) wherein W₁ is OH, y and Q are as above defined, may be carried out as described in 1a-i).

The reaction of a compound of formula (Ib) wherein P² and X_3′ are as above defined, with a compound of formula (IVd) wherein W₁ is OR_a, y and Q are as above defined may be carried out as described in 1-i-2).

The compounds of formula (Ib) wherein T′ is C(O), P² and X_3′ are as above defined, are obtained as described in 1a).

The compounds of formula (Ib) wherein T′ is C(O)—X″, P² and X_3′ are as above defined, are obtained as described in 1b).

The compounds of formula (Ia) wherein W is —Cl or O—R_a′, X₁ is a radical selected from (a8′) or (b8′) wherein R^1a is A5) or A6), R^2a is B5) or B6) and wherein Q, Y and Y′ are as above defined, T′ is C(O) or C(O)—X″ and T″ is C(O)—X, wherein X″ is as above defined, can be obtained from the corresponding acids (Ia) wherein W is —OH as known in literature.

1g) The compounds of formula (Ia) wherein W is —OH, X₁ is a radical is selected from (a8′) or (b8′), wherein R^1a is selected from A5), A6), R^2a is selected from B5), B6), Q, Y and Y′ are as above defined, T′ is C(O) or C(O)—X″ wherein X″ is as above defined, T″ is C(O)—NR′ wherein R′ is above defined, can be obtained1g-i) by reacting a compound of formula (Ib)

P²—X_3′  (Ib)

wherein P² and X_3′ are as above defined, with a compound of formula

R_a—O—(O)C—NR′-y-Q  (IVf)

wherein R_a, R′ and Q are as above defined, y is the radical Y′, wherein Y′ is as above defined, and1g-ii) when Q is Z₂, by converting the compound obtained in the step 1g-i) into nitro derivative by reaction with a nitrate source as above described and1g-iii) optionally deprotecting the compounds obtained in step 1g-i) or 1g-ii) as above described.

The reaction of a compound of formula (Ib) wherein P² and X_3′ are as above defined, with a compound of formula (IVf) wherein R_a, R′, y, Q are as above defined, may be carried out as described in 1-i-2).

The compounds of formula (Ib) wherein T′ is C(O), wherein P² and X_3′ are as above defined, are obtained as described in 1a-i), 1a-ii).

The compounds of formula (Ib) wherein T′ is C(O)—X″, wherein P² and X₃′ are as above defined, are obtained as described in 1b-i), 1b-ii).

The compounds of formula (IVf) wherein R′, y and Q are as above defined, can be obtained from the compounds of formula HR′N-y-Q (IVg) by reaction with a chloroformate as known in the literature.

The compounds of formula (IVg) wherein y is as above defined and Q is Z₂ is commercially available, the compounds of formula (IVg) wherein y is as above defined and Q is —ONO₂ may be obtained from the compound of formula

P³—R′N-y-ONO₂  (IVh)

wherein P³ is as above defined by deprotection of amino group as known in literature. The compounds of formula (IVh) wherein P³, y are as above defined may be obtained from the alcohol

P³—R′N-y-OH  IVi)

by reacting with tetraalkylammonium nitrate as already described for analogous compounds. The compounds of formula (IVi) are commercially available or known in literature. Alternatively the compounds of formula (IVh) wherein P³, y are as above defined may be obtained from the corresponding compounds of formula

P³—R′N-y-Z₂  (IVl)

wherein P3, y, Z₂ are as above defined, by reaction with a nitrate source as above described.

The compounds of formula (Ia) wherein W is —Cl or O—R_a, X₁ is a radical selected from (a8′) or (b8′) wherein R selected from A5) or A6), R^2a is selected from B5) or B6) and wherein Y Y′ and Q are as above defined and T′ is C(O) or C(O)—X″, T″ is C(O)—NR′—, wherein X″ and R′ are as above defined, can be obtained from the corresponding acids (Ia) wherein W is —OH as m known in literature.

1h) The compounds of formula (Ia) wherein W is —OH, X₁ is a radical selected from (a8′) or (b8′), wherein R^1a is selected from A7), R^2a is selected from B7), Q, Y and Y′ are as above is defined, T′ is C(O) or C(O)—X″, T″ is X″ wherein X″ is above defined, can be obtained1 h-i) by reacting a compound of formula (Ie),

P²—X₅  (Ie)

wherein P² is defined above, X₅ is the radical of formula

(a8″) —C(O)—CH(R^1a—OH)—NH-(T′-Y-Q)

(b8″) —C(O)—CH₂—CH(R^2a—OH)—NH-(T′-Y-Q)

wherein R^1a is selected from A7), R^2a is selected from B7), with a compound of formula (IVe)

HX″-y-Q  (IVe)

wherein X″ and Q are as above defined, y is the radical Y′,wherein Y′ is as above defined, and1 h-ii) when Q is Z₂, by converting the compound obtained in the step 1h-i) into nitro derivative by reaction with a nitrate source as above described and1h-iii) optionally deprotecting the compounds obtained in step 1h-i) or 1 h-ii) as above described.

The reaction of a compound of formula (Ie) wherein P² and X₅ are as above defined, with a compound of formula (IVe) wherein y, X″ and Q are as above defined, may be carried out as described in 1-i-1).

The compounds of formula (Ie) wherein T′ is C(O), wherein P² and X₅ are as above defined, are obtained as described in 1a-i), 1a-ii).

The compounds of formula (Ie) wherein T′ is C(O)—X″, wherein P² and X₅ are as above defined, are obtained as described in 1b-i), 1b-ii).

The compounds of formula (Ia) wherein W is —Cl or O—R_a, X₁ is a radical selected from (a8′) or (b8′) wherein R^1a is selected from A7), R^2a is selected from B7) and wherein Y, Y′ and Q are as above defined, T′ is C(O) or C(O)—X″, and T″ is X″ wherein X″ is as above defined, can be obtained from the corresponding acids (Ia) wherein W is —OH as known in literature.

1i) The compounds of formula (Ia) wherein W is —OH, X₁ is a radical selected from (a8′) or (b8′), wherein R^1a is selected from A7), R^2a is selected from B7), Q, Y and Y′ are as above defined, T′ is C(O) or C(O)—X″ wherein X″ is as above defined, T″ is —NR′ wherein R′ is above defined, can be obtained1i-i) by reacting a compound of formula (Ie),

P²—X₅  (Ie)

wherein is P² and X₅ are defined above, with a compound of formula (IVg)

HR′N-y-Q  (IVg)

wherein R′ and Q are as above defined, y is the radical Y′,wherein Y′ is as above defined, and1i-ii) when Q is Z₂, by converting the compound obtained in the step 11-i) into nitro derivative by reaction with a nitrate source such above described and1i-iii) optionally deprotecting the compounds obtained in step 1i-i) or 1i-ii) as above described.

The reaction of a compound of formula (Ie) wherein P² and X₅ are as above defined, with a compound of formula (IVg) wherein R′, y and Q are as above defined, may be carried out as described u in 1a-i).

The compounds of formula (Ia) wherein W is —Cl or O—R_a, X₁ is the radical selected from (a8′) or (b8′) wherein R selected from A7), R^2a is selected from B7) and wherein Y, Y′ and Q are as above defined, T′ is C(O) or C(O)—X″ wherein X″ is as above defined, and T″ is —NR′ wherein R′ is as above defined can be obtained from the corresponding acids (Ia) wherein W is —OH as known in literature

1l) The compounds of formula (Ia) wherein W is —OH, X₁ is a radical selected from (a8′) or (b8′), wherein R^1a is selected from A7), R^2a is selected from B7), Q, Y and Y′ are as above defined, T′ is C(O) or C(O)—X″ wherein X″ is as above defined, T″ is —O—CH(R′)—O—C(O)—, wherein R′ is as above defined, can be obtained1l-i) by reacting a compound of formula (Ie),

P²—X₅  (Ie)

wherein is P² and X₅ are defined above, with a compound of formula (IVm)

Hal-CH(R′)—O—(O)C-y-Q  (IVm)

wherein R′ and Q are as above defined, Hal is an halogen atom, y is the radical Y′, wherein Y′ is as above defined, and1l-ii) when Q is Z₂, by converting the compound obtained in the m step 11-i) into nitro derivative by reaction with a nitrate source such above described and1l-iii) optionally deprotecting the compounds obtained in step 11-i) or 11-ii) as above described.

The reaction of a compound of formula (Ie) wherein P⁵ and X₅ are as above defined, with a compound of formula (IVm) wherein y, Q, R′ are as above defined may be carried out in the presence of a inorganic or organic base in an aprotic polar/non-polar solvent such as DMF, THF or CH₂Cl₂ at temperatures range between 0° to 100° C. or in a double phase system H₂O/Et₂O at temperatures range between 20° to 40° C.

The compounds of formula (IVm) wherein y, Q, R′ are as above defined, Hal is an halogen atom may be obtained by reacting a compound R′—CH₂—CHO, commercially available, with a compound of formula

Hal-(O)C-y-Q  (IVn),

wherein y and Q are as above defined, Hal is a chlorine atom and ZnCl₂ as known in literature.

The compounds of formula (IVn) may be obtained as known in literature.

The compounds of formula (Ia) wherein W is —Cl or O—R_a, X₁, is a radical selected from (a8′) or (b8′) wherein R^1a is selected from A7), R^2a is selected from B7) and wherein Y, Y′, and Q are as above defined, T′ is C(O) or C(O)—X″ wherein X″ is as above defined, and T″ is —O—CH(R′)—O—C(O)— wherein R′ is as above defined can be obtained from the corresponding acids (Ia) wherein W is —OH as known in literature.

1m) The compounds of formula (Ia) wherein W is —OH, X₁ is a radical selected from (a8′) or (b8′), wherein R^1a is selected from A7), R^2a is B7), Q, Y and Y′ are as above defined, T′ is C(O) or C(O)—X″ wherein X″ is as above defined, T″ is —O—CH(R′)—O—C(O)O—, wherein R′ is as above defined, can be obtained1m-i) by reacting a compound of formula (Ie),

P²—X₅  (Ie)

wherein is P² and X₅ are defined above, with a compound of formula (IVo)

Hal-OH(R′)—O—(O)C—O-y-Q  (IVo)

wherein R′ and Q are as above defined, y is the radical Y′, wherein Y′ is as above defined, Hal is an halogen atom, and1l-ii) when Q is Z₂, by converting the compound obtained in the step 11-i) into nitro derivative by reaction with a nitrate source such above described and1l-iii) optionally deprotecting the compounds obtained in step 1l-i) or 1l-ii) as above described.

The reaction of a compound of formula (Ie) wherein P² and X₅ are as above defined, with a compound of formula (IVo) wherein y, R′, Q, Hal are as above defined may be carried out as described in 1l-i).

The compounds of formula (IVo) wherein y, R′, Q are as above defined, may be obtained by reacting the compounds of formula Hal-(R′)CH—OC(O)Hal, wherein Hal is as above defined, commercially available, with a compound of formula

HO-y-Q  (IVe)

wherein y, Q are as above defined, in the presence of a inorganic or organic base in an aprotic polar or in an aprotic non-polar solvent such as DMF, THF or CH₂Cl₂ at temperatures range between 0° to 65° C.

The compounds of formula (Ia) wherein W is —Cl or O—R_a, X₁ is a radical selected from (a8′) or (b8′) wherein R^1a selected from A7), R^2a selected from B7) and wherein Y, Y′ and Q are as above defined, T′ is C(O) or C(O)—X″ wherein X″ is as above defined, and T″ is —O—CH(R′)—O—C(O)O—, may be obtained from the corresponding acids (Ia) wherein W is —OH as known in literature.

1n) The compounds of formula (Ia) wherein W is —OH, X₂ is a radical selected from (a4′) or (b4′), wherein R^1a is selected from A7), R^2a is selected from B7), Y′, Q and R^4a′ are as above defined and T″ is X″ wherein X″ is as above defined, can be obtained1n-i) by reacting a compound of formula (IIIc)

P²—X_5′  (IIIc)

wherein P² is defined above, X_5′ is

(a4″) —C(O)—CH(R^1a—OH)—NHR^4a′

(b4″) —C(O)—CH₂—CH(R^2a—OH)—NHR^4a′

wherein R^1a is selected from A7), R^2a is selected from B7) and P³ is as above defined,with a compound of formula (IVe)

HX″-y-Q  (IVe)

wherein X″ and Q are as above defined, y is the radical Y′, wherein Y′ is as above defined, and1n-ii) when Q is Z₂, by converting the compound obtained in the step 1n-i) into nitro derivative by reaction with a nitrate source as above described and1n-iii) optionally deprotecting the compounds obtained in step is 1n-i) or 1n-ii) as above described.

The reaction of a compound of formula (IIIc) wherein X_y and P² are as above defined, with a compound of formula (IVe) wherein X″, y, Q are as above defined may be carried out as described in 1-i-1).

The compounds of formula (IIIc) wherein X_5′ and P² are as above defined, are commercially available or can be obtained as known in the literature.

The compounds of formula (Ia) wherein W is —Cl or O—R_a, X₁ is a radical selected from (a4′) or (b4′), wherein R^1a is selected from A7), R^2a is selected from B7), Y′ and Q are as above defined, T″ is X″, wherein X″ is as above defined, can be obtained from the corresponding acids (Ia) wherein W is —OH as known in literature.

The compounds of formula (Ia) wherein W is —OH, X₁ is a radical selected from (a4′) or (b4′), wherein R^1a is selected from A7), R^2a is selected from B7), Y′, Q and R^4a′ are as above defined and T″ is —NR′ wherein R′ is as above defined, can be obtained

1o-i) by reacting a compound of formula (IIIc)

P²—X_5′  (IIIc)

wherein P² and X_y are as above defined, with a compound of formula (IVg)

HR′N-y-Q  (IVg)

wherein R′ and Q are as above defined, y is the radical Y′, and1o-ii) when Q is Z₂, by converting the compound obtained in the is step 1o-i) into nitro derivative by reaction with a nitrate source as above described and1o-iii) optionally deprotecting the compounds obtained in step 1o-i) or 1o-ii) as above described.

The reaction of a compound of formula (IIIc) wherein X_y and P² are as above defined, with a compound of formula (IVg) wherein R′, y and Q are as above defined may be carried out as described in 1a-i).

The compounds of formula (Ia) wherein W is —Cl or —OR_a, X₁ is a radical selected from (a4′) or (b4′), wherein R^1a is selected from A7), R^2a is selected from B7) and wherein Y′, Q are as above defined and T″ is —NR′ wherein R′ is as above defined, can be obtained may be obtained from the corresponding acids (Ia) wherein W=—OH as known in literature.

1p) The compounds of formula (Ia) wherein W is —OH, X₁ is a radical selected from (a4′) or)(b4′), wherein R^1a is selected from A7), R^2a is selected from B7), Y′, Q and R^4a′ are as above defined and T″ is —O—CH(R′)—O—C(O), wherein R′ is as above defined, can be obtained1p-i) by reacting a compound of formula (IIIc)

P²—X_5′  (IIIc)

wherein P² and X_y are as above defined, with a compound of formula (IVm)

Hal-CR(R′)—O—(O)C-y-Q  (IVm)

wherein R′ and Q are as above defined, y is the radical Y′, wherein Y′ is as above defined, Hal is an halogen atom and1p-ii) when Q is Z₂, by converting the compound obtained in the step 1p-i) into nitro derivative by reaction with a nitrate source as above described and1p-iii) optionally deprotecting the compounds obtained in step 1p-i) or 1p-ii) as above described.

The reaction of a compound of formula (IIIc) wherein P² and X_y are as above defined, with a compound of formula (IVm) wherein R′, y, Q, Hal are as above defined, may be carried out as described in 1l-1).

The compounds of formula (Ia) wherein W is —C₁ or OR_a, X₁ is a radical selected from (a4′) or (b4′), wherein R^1a is selected from A7), R^2a is selected from B7) and wherein Y and Q are as above defined and T″ is the group —O—CH(R′)—O—C(O), wherein R′ is as above defined, can be obtained from the corresponding acids (Ia) wherein W=—OH as known in literature.

The compounds of formula (Ia) wherein W is —OH, X₁ is a radical selected from (a4′) or (b4′), wherein R^1a is selected from A7), R^2a is selected from B7), Y′, Q and R^4a′ are as above defined and T″ is —O—CH(R¹)—O—C(O)—O—, wherein R′ is as above defined, can be obtained

1q-i) by reacting a compound of formula (IIIc)

P²—X_5′  (IIIc)

wherein P² and X_y are as above defined, with a compound of formula (IVo)

Hal-CR(R′)—O—(O)C—O-y-Q  (IVo)

wherein R′ and Q are as above defined, y is the radical Y′, wherein Y′ is as above defined, Hal is an halogen atom and is 1q-ii) when Q is Z₂, by converting the compound obtained in the step 1q-i) into nitro derivative by reaction with a nitrate source as above described and1q-iii) optionally deprotecting the compounds obtained in step 1q-i) or 1q-ii) as above described.

The reaction of a compound of formula (IIIc) wherein P² and X_y are as above defined, with a compound of formula (IVo) wherein R′, y, Q, Hal are as above defined, may be carried out as described in 1l-1).

The compounds of formula (Ia) wherein W is —Cl or OR_a, X₁ is a radical selected from (a4′) or (b4′), wherein R^1a is selected from A7), R^2a is selected from B7) and wherein Y, Q, are as above defined and T″ is the group —O—CH(R′)—O—C(O)—O—, wherein R′ is as above defined, can be obtained may be obtained from the corresponding acids (Ia) wherein W=—OH as known in literature.

2) The compound of general formula (I) as above defined wherein a is equal to 1, the radical R_x is the radical selected from (a2), (a4), (a8), (b2), (b4), (b8), (c2), (e2), (f1), (g2), (h1), (i1), (12), (m2), (n2), (o2), (p2), (q2), (r2), (s2), (t2), (u2), (v2), Z is —CH(R′)—O— wherein R′ is selected from H or straight or branched C₁-C₄ alkyl, can be obtained:2-i) by reacting a compound of formula (IIa)

R—OH  (IIa)

wherein R is as above defined with a compound of formula (If)

Hal-CH(R′)—O—X₁  (If)

wherein Hal is an halogen atom, R′ and X₁ are as above defined and2-ii) when Q is Z₂, by converting the compound obtained in the step 2-i) into nitro derivative by reaction with a nitrate source as above described and2-iii) optionally deprotecting the compounds obtained in step 2-i) or 2-ii) as above described.

The reaction of a compound of formula (If) wherein) X₁ and R′ are as above defined, with a compound of formula (IIa) wherein R is as above defined, may be carried out as described in 11-i).

The compounds of formula (If) are obtained by reacting a compound R′—CHO, wherein R′ is as above defined with compounds of formula (Ia)

W—X₁  (Ia)

wherein W is a chlorine atom, X₁ is as above defined, and ZnCl₂ as known in literature.3) The compound of general formula (I) as above defined wherein a is equal to 1, the radical R_x is selected from (a1), (a3), (a7), (b1), (b3), (b7), (c1), (e1), (f2), (g1), (h2), (i2), (l1), (m1), (n1), (o1), (p1), (q1), (r1), (s1), (t1), (u1), (v1), Z is C(O), can be obtained3-i) by reacting a compound of formula

R—C(O)—O—R_a  (IIb)

wherein R and R_a are as above defined, with a compound of formula (Ig)

H—X₂  (Ig)

wherein X₂ is a radical having the following meanings:

(a1′) —HN—CH(R^1′)—C(O)-(T-Y-Q)

• • (a3′) —HN—CH(R^1a-T″-Y′-Q)-COOR^3a′

(a7′) —HN—OH(R^1a-T″-Y′-Q)-C(O)-(T-Y-Q)

(b1′) —HN—CH(R^2′)—CH₂C(O)-(T-Y-Q)

(b3′)—HN—CH(R^2a-T″-Y′-Q)-CH₂COOR^3a′

(b7′) —HN—CH(R^2a-T″-Y′-Q)-CH₂—C(O)-(T-Y-Q)

wherein R^1′, R^1a, R^2′, R^2a are as above definedR^3a′ is selected from P², —OR^5a or

wherein R^5a is as above defined;

wherein T, T″, Y and Y′ are as above defined,3-ii) when Q is Z₂, by converting the compound obtained in the step 3-i) into nitro derivative by reaction with a nitrate source such above described and3-iii) optionally deprotecting the compounds obtained in step 3-i) or 3-ii) as above described.

The reaction of a compound of formula (IIb) wherein R and R_a are as above defined, with a compound of formula (Ig) wherein X, is to as above defined, may be carried out as described in 1-i-2).

The compounds of formula R—C(O)—O—R_a (IIb) wherein R and R_a are as above defined, are obtained from the compounds R—H (IIa) by reaction with the compounds of formula C1-C(O)—O—R_a wherein R_a is as above defined, as known in literature.

3a) The compounds of formula (Ig) wherein X₂ is selected from (a1′), (a3′), (b1′), (b3′), (c1′), (e1′), (f2′), (g1′), (h2′), (i2′), (l1′), (m1′), (n1′), (o1′), (p1′), (q1′), (r1′), (s1′), (t1′), (u1′), (v1′), wherein R^1′ is selected from A1), A2′), A3′), A4′), R^1a is selected from A7), R^2a is selected from B7) and R^2′ is selected from B1), B2′), B3′), B4′), Y and Y′ are as above defined, T and T″ are X″ wherein X″ is as above defined may be obtained3a-i) by reacting a compound of formula (IIIe),

P³—X₆  (IIIe)

wherein P³ is as above defined, X₆ is a radical having the following meanings:

(a1″) —HN—CH(R^1′)—C(O)—OH

(a3″) —HN—CH(R^1a—OH)—COOR^1a′

(b1″) —HN—CH(R^2′)—OH₂O(O)—OH

(b3″) —HN—OH(R^2a—OH)—CH₂COOR^3a′

wherein R^1′ is selected from A1), A2′), A3′), A4′), R^1a is selected from A7), R^2a is selected from B7) and R^2′ is selected from B1), B2′), B3′), B4′), and R^3′ is defined above

(c1″) —HN—(CH₂)_b—C(O)—OH;

with a compound of formula (IVe)

HX″-y-Q  (IVe)

wherein Q and X″ are as above defined y is the radical Y when X₆ is selected from (a1′), (b1′), (c1′), (e1′), (f2′), (g1′), (h2′), (i2′), (l1′), (m1′), (n1′), (o1′), (p1′), (q1′), (r1′), (s1′), (t1′), (u1′) and (v1′), y is the radical Y′ when X₆ is selected from (a3′) and (b3′), wherein Y and Y′ are as defined above, and3a-ii) when Q is Z₂, by converting the compound obtained in the step 3a-i) into nitro derivative by reaction with a nitrate source as above described and3a-iii) optionally deprotecting the compounds obtained in step 3a-i) or 3a-ii) as above described.

The reaction of a compound of formula (IIIe) wherein P³ and X₆ are as above defined, with a compound of formula (IVe), wherein y, Q and X″ are as above defined, may be carried out as described in 1-i-1).

The compounds of formula (IIIe) are commercially available or can be obtained as known in the literature.

3b) The compounds of formula (Ig) wherein X₂ is selected from (a1′), (a3′), (b1′), (b3′), (c1′), (e1′), (f2′), (g1′), (h2′), (i2′), (l1′), (m1′), (n1′), (o1′), (p1′), (q1′), (r1′), (S1′), (t1′), (u1′), (v1′), wherein is selected from A1), A2′), A3′), A4′), R^1a is selected from A7), R^2a is selected from B7) and R^2′ is selected from B1), B2′), B3′), B4′), and R^3a′, Y and Y′ are as above defined, T and T″ are —NR′ wherein R′ is as above defined may be obtained3b-i) by reacting a compound of formula (IIIe),

P³—X₆  (IIIe)

wherein P³ and X₆ are as above defined, with a compound of formula

HR′N-y-Q  (IVg)

wherein R′ and Q are as above defined, y is the radical Y when X₆ is selected from (a1′), (b1′), (c1′), (e1′), (f2′), (g1′), (h2′), (i2′), (l1′), (m1′), (n1′), (o1′), (p1′), (q1′), (r1′), (s1′), (t1′), (u1′) and (v1′), y is the radical Y′ when X₆ is selected from (a3′) and (b3′), wherein Y and Y′ are as defined above, and3b-ii) when Q is Z₂, by converting the compound obtained in the step 3b-i) into nitro derivative by reaction with a nitrate source as above described and3b-iii) optionally deprotecting the compounds obtained in step 3b-i) or 3b-ii) as above described.

The reaction of a compound of formula (IIIe) wherein P³ and X₆ are as above defined, with a compound of formula (IVg) wherein R′, y, Q are as above defined, may be carried out 1a-i).

3c) The compounds of formula (Ig) wherein X₂ is selected from is (a1′), (a3′), (b1′), (b3′), (c1′), (e1′), (f2′), (g1′), (h2′), (i2′), (l1′), (m1′), (n1′), (o1′), (p1′), (q1′), (r1′), (s1′), (t1′), (u1′), (v1′), wherein R^1′ is selected from A1), A2′), A3′), A4′), R^1a is selected from A7), R^2a is selected from B7) and R^2′ is selected from B1), B2′), B3′), B4′), and R^3a′, Y and Y′ are as above defined, T and T″ are —O—CH(R′)—O—C(O)—, wherein R′ is as above defined, may be obtained3c-i) by reacting a compound of formula (IIIe)

P³—X₆  (IIIe)

wherein P³, X₆ are as above defined with compounds of formula (IVm)

Hal-CH(R′)—O—(O)C-y-Q  (IVm)

wherein R′ and Q are as above defined, Hal is an halogen atom, y is the radical Y when X₆ is selected from (a1′), (b1′), (c1′), (e1′), (f2′), (g1′), (h2′), (i2′), (l1′), (m1′), (n1′), (o1′), (p1′), (q1′), (r1′), (s1′), (t1′), (u1′) and (v1′), y is the radical Y′ when X₆ is selected from (a3′) and (b3′), wherein Y and Y′ are as defined above, and3c-ii) when Q is Z₂, by converting the compound obtained in the step 3c-i) into nitro derivative by reaction with a nitrate source as above described and3c-iii) optionally deprotecting the compounds obtained in step 3c-i) or 3c-ii) as above described.

The reaction of a compound of formula (IIIe) wherein P³ and X₆ are as above defined, with a compound of formula (IVm) wherein y, Q, R′ are as above defined, may be carried out as described in 1l-i)

3d) The compounds of formula (Ig) wherein X₂ is selected from (a1′), (a3′), (b1′), (b3′), (c1′), (e1′), (f2′), (g1′), (h2′), (i2′), (l1′), (m1′), (n1′), (o1′), (p1′), (q1′), (r1″), (s1′), (t1′), (u1′), (v1′), wherein is selected from A1), A2′), A3′), A4′), R^1a is selected from A7), R^ea is selected from B7) and R^2′ is selected from B1), B2′), B3′), B4′), and R^3a′, Y and Y′ are as above defined, T and T″ are —O—CH(R′)—O—C(O)O— wherein R′ is as above defined may be obtained3d-i) by reacting a compound of formula (IIIe)

P³—X₆  (IIIe)

wherein P³ and X₆ are as above defined, with compounds of formula (IVo)

Hal-CH(R′)—O—(O)C—O-y-Q  (IVo)

wherein R′ and Q are as above defined, Hal is an halogen atom y is the radical Y when X₆ is selected from (a1′), (b1′), (c1′), (e1′), (f2′), (g1′), (h2′), (i2′), (l1′), (m1′), (n1′), (o1′), (p1′), (q1′), (r1′), (s1′), (t1′), (u1′) and (v1′), y is the radical Y′ when X₆ is selected from (a3′) and (b3′), wherein Y and Y′ are as defined above, and3d-ii) when Q is Z₂, by converting the compound obtained in the step 3d-i) into nitro derivative by reaction with a nitrate source as above described and3d-iii) optionally deprotecting the compounds obtained in step 3d-i) or 3d-ii) as above described.

The reaction of a compound of formula (IIIe) wherein P³ and X₆ are as above defined, with a compound of formula (IVo) wherein y, Q, R′ are as above defined, may be carried out as described in 1l-i).

3e) The compounds of formula (Ig) wherein X₂ is selected from (a7′) or (b7′) wherein R^1a is selected from A5) or A6), R^1b is selected from B5) or B6) T″ is —C(O)—, T is —X″, —NR′, —O—CH(R′)—O—C(O)— or —O—CH(R′)—O—C(O)O— wherein X″ and R′, Y and Y′ are as above defined, may be obtained3e-i) by reacting a compound of formula (Ih)

P³—X₇  (Ih)

wherein P³ is as above defined and X₇ is the radical having the following meaning

(a7″) —HN—CH(R^1a—H)—C(O)-(T-Y-Q)

(b7″) —HN—CH(R^2a—H)—CH₂—C(O)-(T-Y-Q)

wherein R^1a is selected from A5) or A6), R^2a is selected from B5) or B6), with compounds of formula (IVa)

W₁—C(O)-y-Q  (IVa)

wherein W₁ and Q are as above defined, y is the radical Y′, wherein Y′ is as above defined, and3e-ii) when Q is Z_2f by converting the compound obtained in the step 3e-i) into nitro derivative by reaction with a nitrate source as above described and3e-iii) optionally deprotecting the compounds obtained in step 3e-i) or 3e-ii) as above described.

The reaction of a compound of formula (Ih) wherein P³ and X₇ are to as above defined, with a compound of formula (IVa) wherein y, Q, W₁ are as above defined may be carried out as described in 1-1-i), 1-i-2), 1-i-3) and 1a-i).

The compounds of formula (Ih) wherein P³ and X₇ are as above defined, T is —X″ are obtained as described in 3a).

The compounds of formula (Ih) wherein P³ and X₇ are as above defined, T is —NR′ are obtained as described in 3b).

The compounds of formula (Ih) wherein P³ and X₇ are as above defined, T is —O—CH(R′)—O—C(O)— are obtained as described in 3c).

The compounds of formula (Ih) wherein P³ and X₇ are as above defined, T is —O—CH(R′)—O—C(O)O— are obtained as described in 3d).

3f) The compounds of formula (Ig) wherein X₂ is selected from (a7′) or (b7′) wherein R^1a is selected from A5) or A6), R^1b is selected from B5) or B6) T″ is —C(O)—X″, T is —X″, —NR′, —O—CH(R′)—O—C(O)— or —O—CH(R′)—O—C(O)O— wherein X″ and R′, Y and Y′ are as above defined, may be obtained3f-i) by reacting a compound of formula (Ih)

P³—X₇  (Ih)

wherein P³ and X₇ are as above defined with compounds of formula (IVd)

R_a—O—C(O)—X″-y-Q  (IVd)

wherein R_a, X″ and Q are as above defined, y is the radical Y′, wherein Y′ is as above defined, and3f-ii) when Q is Z_2f by converting the compound obtained in the step 3f-i) into nitro derivative by reaction with a nitrate source as above described and3f-iii) optionally deprotecting the compounds obtained in step 3e-i) or 3f-ii) as above described.

The reaction of a compound of formula (Ih) wherein P³ and X₇ are as above defined, with a compound of formula (IVd) wherein y, Q, R_a are as above defined, may be carried out as described in 1-i-2).

3g) The compounds of formula (Ig) wherein X₂ is selected from (a7′) or (b7′) wherein R^1a is selected from A5), A6), R^1b is selected from B5), B6), T″ is —C(O)—NR′, T is X″, NR′, —O—CH(R′)—O—C(O)— or —O—CH(R′)—O—C(O)O— wherein X″ and R′, Y and Y′ are as above defined, may be obtained3g-i) by reacting a compound of formula (Ih)

P³—X₇  (Ih)

wherein P³ and X₇ are as above defined, with compounds of formula (IVf)

R_a—O—C(O)—NR′-y-Q  (IVf)

wherein R_a and Q are as above defined, y is the radical Y′, wherein Y′ is as above defined, and3g-ii) when Q is Z_2f by converting the compound obtained in the step 3g-i) into nitro derivative by reaction with a nitrate source as above described and3g-iii) optionally deprotecting the compounds obtained in step 3g-i) or 3g-ii) as above described.

The reaction of a compound of formula (Ih) wherein P³ and X₇ are as above defined, with a compound of formula (IVf) wherein y, Q, R_a and R′ are as above defined may be carried out as described in 1-i-2).

The compounds of formula (Ih) wherein P³ and X₇ are as above defined, T is —X″ are obtained as described in 3a).

The compounds of formula (Ih) wherein P³ and X₇ are as above defined, T is —NR′ are obtained as described in 3b).

The compounds of formula (Ih) wherein P³ and X₇ are as above defined, T is —O—CH(R′)—O—C(O)— are obtained as described in 3c).

The compounds of formula (II) wherein P³ and X₇ are as above defined, T is —O—CH(R′)—O—C(O)O— are obtained as described in 3d).

3h) The compounds of formula (Ig) wherein X₂ is selected from (a7′) or (b7′) wherein R^1a is selected from A7), R^1b is selected from B7), T″ is —X″, T is —X″, —NR′, —O—CH(R′)—O—C(O)— or —O CH(R′)—O—C(O)O— wherein X″ and R′, Y and Y′ are as above defined, may be obtained3h-i) by reacting a compound of formula (Iv)

P³—X₈  (IV)

wherein P³ is as above defined and X₈ is the radical having the following meaning

(a7″) —HN—CH(R^u—H)—C(O)-(T-Y-Q)

(b7″) —HN—CH(R^2a—H)—CH₂—C(O)-(T-Y-Q)

wherein R^1a is selected from A7), R^1b is selected from B7), with compounds of formula (IVe)

H—X″-y-Q (IVe)

wherein X″ and Q are as above defined, y is the radical Y′, wherein Y′ is as above defined, and3h-ii) when Q is Z₂, by converting the compound obtained in the step 3h-i) into nitro derivative by reaction with a nitrate source as above described and3h-iii) optionally deprotecting the compounds obtained in step 3h-i) or 3h-ii) as above described.

The reaction of a compound of formula (Iv) wherein P³ and X₈ are as above defined, with a compound of formula (IVe) wherein y, Q, X″ are as above defined, may be carried out as described in 1-i-1), 1-i-2) and 1a-1).

The compounds of formula (Iv) wherein P³ and X₈ are as above defined, T is —X″ are obtained as described in 3a).

The compounds of formula (Iv) wherein P³ and X₈ are as above defined, T is —NR′ are obtained as described in 3b).

The compounds of formula (Iv) wherein P³ and X₈ are as above defined, T is —O—CH(R′)—O—C(O)— are obtained as described in 3c).

The compounds of formula (Iv) wherein P³ and X₈ are as above defined, T is —O—CH(R′)—O—C(O)O— are obtained as described in 3d).

3i) The compounds of formula (Ig) wherein X₂ is selected from (a7′) or (b7′) wherein R^1a is selected from A7), R^1b is selected from B7), T″ is NR′, T is —X″, —NR′, —O—CH(R′)—O—C(O)— or —O—CH(R′)—O—C(O)O— wherein X″ and R′, Y and Y′ are as above defined, may be obtained3i-i) by reacting a compound of formula (Iv)

P³—X₈  (Iv)

wherein P³ and X₈ are as above defined, with compounds of formula (IVg)

H—NR′-y-Q  (IVg)

wherein R′ and Q are as above defined, y is the radical Y′, wherein Y′ is as above defined, and3i-ii) when Q is Z₂, by converting the compound obtained in the step 3i-i) into nitro derivative by reaction with a nitrate source as above described and3i-iii) optionally deprotecting the compounds obtained in step 31-i) or 31-ii) as above described.

The reaction of a compound of formula (Iv) wherein P³ and X₈ are as above defined, with a compound of formula (IVg) wherein y, Q, R′ are as above defined, may be carried out as described in 1a-i).

3l) The compounds of formula (Ig) wherein X₂ is selected from (a7′) or (b7′) wherein R selected from A7), R^1b is selected from B7), T″ is —O—CH(R′)—O—C(O)—, T is X″, NR′, —O—CH(R′)—O—C(O)— or —O—CH(R′)—O—C(O)O— wherein X″ and R′, Y and Y′ are as above defined, may be obtained3l-i) by reacting a compound of formula (Iv)

P³—X₈  (Iv)

wherein P³ and X₈ are as above defined with compounds of formula (IVm)

Hal-OH(R′)—O—(O)C-y-Q  (IVm)

wherein R′ and Q are as above defined, y is the radical Y′, wherein Y′ is as above defined, Hal is an halogen atom and3l-ii) when Q is Z₂, by converting the compound obtained in the step 31-i) into nitro derivative by reaction with a nitrate source as above described and3l-iii) optionally deprotecting the compounds obtained in step 3l-i) or 3l-ii) as above described.

The reaction of a compound of formula (Iv) wherein P³ and X₈ are as above defined, with a compound of formula (IVm) wherein y, Q, R′ are as above defined, may be carried out as described in 1l-i).

3m) The compounds of formula (Ig) wherein X₂ is selected from (a7′) or (b7′) wherein R^1a is selected from A7), R^1b is selected from B7), T″ is —O—CH(R′)—O—C(O)O—, T is X″, NR′, —O—CH(R′)—O—C(O)— or —O—CH(R′)—O—C(O)O— wherein X″ and R′, Y and Y′ are as above defined, may be obtained3m-i) by reacting a compound of formula (Iv)

P³—X₈  (Iv)

wherein P³ and X₈ are as above defined with compounds of formula (IVo)

Hal-CH(R′)—O—(O)C—O-y-Q  (IVo)

wherein R′ and Q are as above defined, y is the radical Y′, wherein Y′ is as above defined, Hal is an halogen atom and3m-ii) when Q is Z₂, by converting the compound obtained in the step 3m-i) into nitro derivative by reaction with a nitrate is source as above described and3m-iii) optionally deprotecting the compounds obtained in step 31-i) or 3m-ii) as above described.

The reaction of a compound of formula (Iv) wherein P³ and X₈ are as above defined, with a compound of formula (IVo) wherein y, Q, R′ are as above defined, may be carried out as described in 1l-i).

3n) The compounds of formula (Ig) wherein X₂ is selected from (a3′) or (b3′), wherein R^1a is selected from A5) or A6), R^2a is selected from B5) or B6), Y′ is as above defined, T″ is C(O) may be obtained3n-i) by reacting a compound of formula (IIIf),

P³—X₉  (IIIf)

wherein P³ is as above defined, X₉ is a radical having the following meaning

(a3″) —HN—CH(R^1a—H)—COOR^3a′

(b3″) —HN—CH(R^2a—H)—CH₂COOR^3a′

wherein R selected from A5 or A6) and R^2a is selected from B5) or B6), wherein R^3a′ is as above defined, with compounds of formula (IVa)

W₁—C(O)-y-Q  (IVa)

wherein W₁ and Q are as above defined, y is the radical Y′, wherein Y′ is as above defined, and3n-ii) when Q is Z₂, by converting the compound obtained in the step 3n-i) into nitro derivative by reaction with a nitrate source as above described and3n-iii) optionally deprotecting the compounds obtained in step 3n-i) or 3n-ii) as above described.

The reaction of a compound of formula (IIIf) wherein P³ and X₉ are as above defined, with a compound of formula (IVa) wherein W₁, y, Q are as above defined, may be carried out as described in 1-i-1), 1-i-2), 1a-1).

The compounds of formula (IIIf) wherein P³ and X₉ are as above defined, is commercially available or obtained as known in literature.

3o) The compounds of formula (Ig) wherein X₂ is selected from (a3′) or (b3′), wherein R^1a is selected from A5) or A6), R^2a is selected from B5) or B6), Y′ is as above defined, T″ is C(O)—X″ wherein X″ is as above defined, can be obtained

3o-i) by reacting a compound of formula (IIIf)

P³—X₉  (IIIf)

wherein P³ and X₉ are as above defined with compounds of formula (IVd)

R_a—O—C(O)—X″-y-Q  (IVd)

wherein R_a, X″, Q are as above defined, y is the radical Y′, wherein Y′ is as above defined, and3o-ii) when Q is Z₂, by converting the compound obtained in the step 3o-i) into nitro derivative by reaction with a nitrate source as above described and3o-iii) optionally deprotecting the compounds obtained in step 3o-i) or 3o-ii) as above described.

The reaction of a compound of formula (IIIf) wherein P³ and X₉ are as above defined, with a compound of formula (IVd) wherein R_a, X″, y, Q are as above defined, may be carried out as described in 1-i-2).

3p) The compounds of formula (Ig) wherein X₂ is selected from (a3′) or (b3′), wherein R^1a is selected from A5) or A6), R^2a is selected from B5) or B6), Y′ is as above defined, T″ is C(O)—NR′ wherein R′ is as above defined, can be obtained3p-i) by reacting a compound of formula (IIIg),

P³—X₉  (IIIf)

wherein P³ and X₉ are as above defined, with compounds of formula (IVf)

R_a—O—(O)C—NR′-y-Q  (IVf)

wherein R_a, R′ and Q are as above defined, y is the radical Y′, wherein Y′ is as above defined, and3p-ii) when Q is Z₂, by converting the compound obtained in the step 3p-i) into nitro derivative by reaction with a nitrate source as above described and3p-iii) optionally deprotecting the compounds obtained in step 3p-i) or 3p-ii) as above described.

The reaction of a compound of formula (IIIf) wherein P³ and X₉ are as above defined, with a compound of formula (IVf) wherein R_a, R′, y, Q are as above defined, may be carried out as described in 1-i-2).

4) The compound of general formula (I) as above defined wherein a is equal to 1, the radical R_x is selected from (d1), (d2), (d3), (d4), (d7), (d8), Z is C(O), can be obtained4-i) by reacting a compound of formula (IIb)

R—C(O)—O—R_{a (IIb)}

wherein R and R_a are as above defined, with a compound of formula (Im)

H—X₁₂  (Im)

wherein X₁₂ is the radical R_x having the following meaning

(d1′) —HN—CH(R^12′)—CH₂—O-(T″-Y-Q)

(d2′) —O—OH₂—CH(R^12′)—NH-(T′-Y-Q)

(d3′) —HN—CH(R^12a-T″-Y′-Q)-CH₂OH

(d4′) —O—CH₂—CH(R^12a-T″-Y′-Q)-NHR^4a

(d7′) —HN—CH(R^12a-T″-Y′-Q)-CH₂—O-(T″-Y-Q)

(d8′) —O—OH₂—CH(R^12a-T″-Y′-Q)-NH-(T′-Y-Q) wherein R^12′ is

D1),

D2′) —CH₂—OP¹, —CH(CH₃)—OP¹, —CH₂—[(C₆H₄)-4-OP¹], —CH₂—[(C₆H₃)-(3,5-diiodo)-4-OP¹], —CH₂—[(C₆H₃)-3-nitro-4-OP¹];

D3′) —CH₂—NHR″″, —(CH₂—NHR″″, —(CH₂)₃—NHR″″, —(CH₂)₄—NHR″″, wherein R″″ is as above defined;

D4′) —CH₂—C(O)R′″″, —(CH₂)₂—C(O)R′″″, —(CH₂)₄—C(O)R″″, wherein R′″″ is as above defined;

wherein R^12a is as above defined; and4-i) when Q is Z₂, by converting the compound obtained in the step 4-i) into nitro derivative by reaction with a nitrate source as above described and4-iii) optionally deprotecting the compounds obtained in step 4-i) or 4-ii) as above described.

The reaction of a compound of formula (IIb) wherein R and R_a are as above defined, with a compound of formula (Im) wherein X₁₂ is as above defined, may be carried out as described in 1-i-2).

4a) The compound of formula (Im) wherein X₁₂ is selected from (d1′), (d2′), (d3′) or (d4′) wherein R^12′ is selected from D1), D2′), D3′) or D4′) and R^12a is selected from D5) or D6), Y and Y′ are as above defined, T′ and T″ and T′″ are C(O) can be obtained4a-i) by reacting a compound of formula (IIIi),

P⁴X₁₃  (IIIi)

wherein P⁴ is P³ or P¹ as above defined and X₁₃ is a radical having the following meaning

(d1″) —HN—CH(R^12′)—CH₂—OH

(d2″) —O—CH₂—CH(R^12′)—NH₂

(d3″) —HN—CH(R^12a—H)—CH₂OP¹

(d4″) —O—CH₂—CH(R^12a—H)—NHR^4a′

wherein R^12′ is D1), D2′), D3′) or D4′), R^12a is D5) or D6), R^4a′ and P¹ are as above defined, with a compound of formula (IVa)

W₁—(O)C-y-Q  (IVa)

wherein Q and W₁ are as above defined, y is the radical Y when X₁₃ is selected from (d1′) or (d2′), y is the radical Y′ when X_E is selected from (d3′) or (d4′), wherein Y and Y′ are as above defined, and4a-ii) when Q is Z₂, by converting the compound obtained in the step 4a-i) into nitro derivative by reaction with a nitrate source as above described and4a-iii) optionally deprotecting the compounds obtained in step 4a-i) or 4a-ii) as above described.

The reaction of a compound of formula (IIIi) wherein X₁₃ and P⁴ are as above defined, with a compound of formula (IVa) wherein W₁, y and Q are as above defined, may be carried out as described in 1-i-1) and 1-i-2).

The compounds of formula (IIIi) wherein X₂₃ and P⁴ are as above described, are commercially available or known in literature.

4b) The compound of formula (Im) wherein X₁₂ is selected from (d1′), (d2′), (d3′) or (d4′) wherein R^12′ is selected from D1), D2′), D3′) or D4′) and R^12a is selected from D5) or D6), Y and Y′ are as above defined, T′ and T″ and T′″ are C(O)—X″, wherein X″ is as above defined, can be obtained4b-i) by reacting a compound of formula (IIIi),

P⁴—X₁₃  (IIIi)

wherein P⁴ and X₁₃ are defined above, with a compound of formula (IVd)

R_a—O—(O)C—X″-y-Q  (IVd)

wherein Q, R_a and X″ are as above defined, y is the radical Y when X₁₃ is selected from (d1′) or (d2′), y is the radical Y′ when X₁₃ is selected from (d3′) or (d4′), wherein Y and Y′ are as above defined, and4b-ii) when Q is Z₂, by converting the compound obtained in the step 4b-i) into nitro derivative by reaction with a nitrate source as above described and4b-iii) optionally deprotecting the compounds obtained in step 4b-i) or 4b-ii) as above described.

The reaction of a compound of formula (IIIi) wherein X₁₃ and P⁴ are as above defined, with a compound of formula (IVd) wherein y, Q, R_a and X″ are as above defined, may be carried out as described in 1-i-2).

4c) The compound of formula (Im) wherein X₁₂ is selected from (d7′) or (d8′) wherein R^12a is selected from D5) or D6), Y′ and Y are as above defined, T′ and T″ and T″ are C(O), can be obtained4c-i) by reacting a compound of formula (IIIl),

P⁴—X₁₄  (IIIl)

wherein P⁴ is P¹ or P³, X₁₄ is the radical having the following meaning

(d7″) —HN—CH(R^12a—H)—CH₂—OH

(d8″) —O—CH₂—CH(R^12a—H)—NH₂

wherein R^12a is selected from D5) or D6), with a compound of formula (IVa)

W₁—(O)C-y-Q  (IVa)

wherein W₁ and Q are as above defined, y is the radical Y′, wherein Y′ is as above defined, and4c-ii) when Q is Z₂, by converting the compound obtained in the step 4c-i) into nitro derivative by reaction with a nitrate source as above described and4c-iii) optionally deprotecting the compounds obtained in step 4c-i) or 4c-ii) as above described.

The reaction of a compound of formula (IIIl) wherein P⁴ and X₁₄ are as above defined, with a compound of formula (IVa) wherein W₁ is OH, y and Q are as above defined, may be carried out as described in 1-i-1) using a ratio (IIIl)/(IVa) 1:2.

The reaction of a compound of formula (IIIl) wherein P⁴ and X₁₄ are as above defined, with a compound of formula (IVa) wherein W₁ is OR_a, y and Q are as above defined, may be carried out as described in 1-i-2) using a ratio (IIIl)/(IVa) 1:2.

The compounds of formula (IIIl) wherein P⁴ and X₁₄ are as above described, are commercially available or known in literature.

4d) The compound of formula (Im) wherein X₁₂ is selected from (d7′) or (d8′) wherein R^12a is selected from D5) or D6), Q, Y and Y′ are as above defined, T′, T″ and T″ are C(O), can be obtained4d-i) by reacting a compound of formula (In)

P⁴—X₁₅  (In)

wherein P⁴ is defined above and X_L5 is the radical having the following meaning

(d7″) —HN—CH(R^12a—H)—CH₂—O-(T″-Y-Q)

(d8″) —O—OH₂—CH(R^12a—H)—NH-(T′-Y-4)

wherein R^12a is selected from D5) or D6), Y, Q, T′ and T″ are as above defined, with a compound of formula (IVa)

W₁—(O)C-y-Q  (IVa)

wherein W₁, y and Q′ are as above defined, y is the radical Y′, wherein Y′ is as above defined, and4d-ii) when Q is Z₂, by converting the compound obtained in the step 4d-i) into nitro derivative by reaction with a nitrate source as above described and4d-iii) optionally deprotecting the compounds obtained in step 4d-i) or 4d-ii) as above described.

The reaction of a compound of formula (In) wherein P⁴ and X₁₅ it) are as above defined, with a compound of formula (IVa) wherein W₁ is OH, y and Q are as above defined, may be carried out as described in 1-i-1).

The reaction of a compound of formula (In) wherein P⁴ and X₁₅ are as above defined, with a compound of formula (IVa) wherein W₁ is OR_a, y and Q are as above defined, may be carried out as described in 1-i-2).

The compounds of formula (In) wherein P⁴ and X_n are as above defined, T′ and T′″ are —C(O)— can by obtained as described in 4a).

4e) The compound of formula (Im) wherein X₁₂ is selected from (d7′) or (d8′) wherein R^12a is selected from D5) or D6), Q, Y and Y′ are as above defined, T″ is C(O)—X″ wherein X″ is as above defined, T′ and T′″ are C(O), can be obtained4e-i) by reacting a compound of formula (In)

P⁴—X₁₅  (In)

wherein P⁴ and X₁₅ are defined above, with a compound of formula (IVa)

W₁—(O)C-y-Q  (IVa)

wherein W₁, y and Q are as above defined, y is the radical Y′, wherein Y′ is as above defined, and4e-ii) when Q is Z₂, by converting the compound obtained in the step 1e-i) into nitro derivative by reaction with a nitrate source as above described and4e-iii) optionally deprotecting the compounds obtained in step 4e-i) or 4e-ii) as above described.

The reaction of a compound of formula (In) wherein P⁴ and X₁₅ are as above defined, with a compound of formula (IVa) wherein W₁ is OH, y and Q are as above defined, can by carried out as described in 1-i-1).

The reaction of a compound of formula (In) wherein P⁴ and X₁₅ are as above defined, with a compound of formula (IVa) wherein W₁ is OR_a, y and Q are as above defined, can by carried out as described in 1-i-2).

The compounds of formula (In) wherein P⁴ and X₁₅ are as above defined can by obtained as described in 4b).

4f) The compound of formula (Im) wherein X₁₂ is selected from (d7′) or (d8′) wherein R^12a is selected from D5) or D6), Y and Y′ are the same and are as above defined, T′, T″ and T′″ are C(O)—X″ wherein X″ is as above defined, can be obtained4f-i) by reacting a compound of formula (IIIl),

P⁴—X₁₄  (IIIl)

wherein P⁴ and X₁₉ are as above defined, with a compound of formula (IVd)

R_a—O—C(O)—X″-y-Q  (IVd)

wherein R_a, X″ and Q are as above defined, y is the radical Y′, wherein Y′ is as above defined, and4f-ii) when Q is Z_2r by converting the compound obtained in the step 4f-i) into nitro derivative by reaction with a nitrate source as above described and4f-iii) optionally deprotecting the compounds obtained in step 4f-i) or 4f-ii) as above described.

The reaction of a compound of formula (IIIl) wherein P⁴ and X₁₄ are as above defined, with a compound of formula (IVd) wherein R_a, X″, y and Q are as above defined, may be carried out as described in 1-i-2) using a ratio (IIIl)/(IVd) 1:2.

4g) The compound of formula (Im) wherein X₁₂ is selected from (d7′) or (d8′) wherein R^12a is selected from D5) or D6), Q, Y and Y′ are as above defined, T″ is C(O)—X″, T′ and T″ are C(O) or C(O)—X″, wherein X″ is as above defined, can be obtained4g-i) by reacting a compound of formula (In)

P⁴—X₁₅  (In)

wherein P⁴ and X₁₅ are as above defined, with a compound of formula (IVd)

R_a—O—C(O)—X″-y-Q  (IVd)

wherein R_a, X″ and Q are as above defined, y is the radical Y′, wherein Y′ is as above defined, and

4g-ii) when Q is Z₂, by converting the compound obtained in the step 4g-i) into nitro derivative by reaction with a nitrate source as above described and

4g-iii) optionally deprotecting the compounds obtained in step 4g-i) or 4g-ii) as above described.

The reaction of a compound of formula (In) wherein P⁴ and X₁₅ are as above defined, with a compound of formula (IVd) wherein R_a, X″, y and Q are as above defined, may be carried out as described in 1-i-2).

The compounds of formula (In) wherein T′ or T″ are C(O), P⁴ and X₁₅ are as above defined are obtained as described in 4a-i), 4a-ii).

The compounds of formula (In) wherein T′ or T″ are C(O)—X″, wherein P⁴ and X₁₅ are as above defined are obtained as described in 4b-i), 4b-ii).

4h) The compound of formula (Im) wherein X₁₂ is selected from (d7′) or (d8′) wherein R^12a is selected from D5) or D6), Q, Y and Y′ are as above defined, T″ is C(O)—NR′—, T′ and T″ are C(O) or C(O)—X″, wherein X″ is as above defined, can be obtained4h-i) by reacting a compound of formula (In)

P⁴—X₁₅  (In)

wherein P⁴ and X₁₅ are as above defined, with a compound of formula

R_a—O—(O)C—NR′-y-Q  (IVf)

wherein R_a, R′ and Q are as above defined, y is the radical Y′, wherein Y′ is as above defined, and4h-ii) when Q is Z₂, by converting the compound obtained in the step 4h-i) into nitro derivative by reaction with a nitrate source as above described and4h-iii) optionally deprotecting the compounds obtained in step 4h-i) or 4h-ii) as above described.

The reaction of a compound of formula (In) P⁴ and X₁₅ are as above defined, with a compound of formula (IVf) wherein R_a, R′, y, Q are as above defined, may be carried out as described in 1-i-2).

The compounds of formula (In) wherein T′ or T″ are C(O), wherein P⁴ and X₁₅ are as above defined, are obtained as described in 4a-i), 4a-ii).

The compounds of formula (In) wherein T′ or T″ are C(O)—X″, wherein P⁴ and X₁₅ are as above defined, are obtained as described in 4b-i), 4b-ii).

41) The compound of formula (Im) wherein X₁₂ is selected from (d7′) or (d8′) wherein R^12a is selected from D7), Q, Y and Y′ are as above defined, T″ is X″, wherein X″ is as above defined, T′ and T″ are C(O) or C(O)—X″, wherein X″ is as above defined, can be obtained4i-i) by reacting a compound of formula (Ir),

P⁴X₁₆  (Ir)

(d7″) —HN—CH(R^12a—OH)—CH₂—O-(T′″-Y-Q)

(d8″) —O—CH₂—CH(R^12a—OH)—NH-(T′-Y-Q)

wherein P⁴ is as above defined, R^12a is selected from D7), with a compound of formula (IVe)

HX″-y-Q  (IVe)

wherein Y′, X″ and Q are as above defined, y is the radical Y′, wherein Y′ is as above defined, and4i-ii) when Q is Z₂, by converting the compound obtained in the step 41-i) into nitro derivative by reaction with a nitrate source as above described and4i-iii) optionally deprotecting the compounds obtained in step 4i-i) or 41-ii) as above described.

The reaction of a compound of formula (Ir) wherein P⁴ and X₁₆ are as above defined with a compound of formula (IVe) wherein y, X″ and Q are as above defined, may be carried out as described in 1-i-1).

The compounds of formula (Ir) wherein T′ or T″ are C(O), and X₁₆ are as above defined are obtained as described in 4a-i), 4a-ii).

The compounds of formula (Ir) wherein T′ or T″ are C(O)—X″, P⁴ and X₁₆ are as above defined, are obtained as described in 4b-i), 4b-ii).

4l) The compound of formula (Im) wherein X₁₂ is selected from (d7′) or (d8′) wherein R^12a is selected from D7), Q, Y and Y′ are as above defined, T″ is —NR′ wherein R′ is as above defined, T′ and T″ are C(O) or C(O)—X″, wherein X″ is as above defined, can be obtained4l-i) by reacting a compound of formula (Ir),

P⁴—X₁₆  (Ir)

wherein P⁴ and X₁₆ are as above defined and R^12a is selected from D7), with a compound of formula

HR′N-y-Q  (IVg)

wherein R′ and Q are as above defined, y is the radical Y′, wherein Y′ is as above defined, and4i-ii) when Q is Z_2f by converting the compound obtained in the step 41-i) into nitro derivative by reaction with a nitrate source such above described and4i-iii) optionally deprotecting the compounds obtained in step 41-i) or 41-ii) as above described.

The reaction of a compound of formula (Ir) P⁴ and X₁₆ are as above defined, with a compound of formula (IVg) wherein R′, y, Q are as above defined, may be carried out as described in 1-i-1).

4m) The compound of formula (Im) wherein X₁₂ is selected from (d7′) or (d8′) wherein R^12′ is selected from D7), Q, Y and Y′ are is as above defined, T″ is —O—CH(R′)—O—C(O)—, wherein R′ is as above defined, T′ and T″ are C(O) or C(O)—X″, wherein X″ is as above defined, can be obtained4m-i) by reacting a compound of formula (Ir),

P⁴—X₁₆  (Ir)

wherein P⁴ and X₁₆ are as above defined and R^12′ is selected from D7), with a compound of formula (IVm)

Hal-OH(R′)—O—(O)C-y-Q  (IVm)

wherein R′ and Q are as above defined, Hal is an halogen atom, y is the radical Y′, wherein Y′ is as above defined, and4m-ii) when Q is Z₂, by converting the compound obtained in the step 4m-i) into nitro derivative by reaction with a nitrate source such above described and4m-iii) optionally deprotecting the compounds obtained in step 4m-i) or 1m-ii) as above described.

The reaction of a compound of formula (Ir) wherein P⁴ and X₁₆ are as above defined, with a compound of formula (IVm) wherein y, Q, R′ are as above defined, may be carried out as described in 1l-i).

4n) The compound of formula (Im) wherein X₁₂ is selected from (d7′) or (d8′) wherein R^12a is selected from D7), Q, Y and Y′ are as above defined, T″ is —O—CH(R′)—O—C(O)—O—, wherein R′ is as above defined, T′ and T′″ are C(O) or C(O)—X″, wherein X″ is as above defined, can be obtained4n-i) by reacting a compound of formula (Ir),

P⁴—X₁₆  (Ir)

wherein P⁴ and X₁₆ are as above defined and R^12′ is selected from is D7), with a compounds of formula (IVo)

Hal-CH(R′)—O—(O)C—O-y-Q  (IVo)

wherein R and Q′ are as above defined, Hal is an halogen atom, y is the radical Y′, wherein Y′ is as above defined, and4n-ii) when Q is Z₂, by converting the compound obtained in the step 4n-i) into nitro derivative by reaction with a nitrate source as above described and4n-iii) optionally deprotecting the compounds obtained in step 4n-i) or 4n-ii) as above described.

The reaction of a compound of formula (Ir) wherein P⁴ and X₁₆ are as above defined, with a compound of formula (IVo) wherein y, R′, Q, Hal are as above defined, may be carried out as described in 1l-i).

4o) The compound of formula (Im) wherein X₁₂ is (selected from d3′) or (d4′) wherein R^12a is selected from D7), Y′ is as above defined, T″ is X″, wherein X″ is defined above, can be obtained4o-i) by reacting a compound of formula (IIIm),

P⁴—X₁₇  (IIIm)

wherein P⁴ is defined above and X₁₇ is the radical

(d3″) —HN—CH(R^12a—H)—CH₂OP¹

(d4″) —O—CH₂—CH(R^12a—H)—NHR^4a′

wherein R^12a is selected from D7), wherein P¹ and R^4a′ are as above defined, with a compound of formula (IVe)

HX″-y-Q  (IVe)

wherein X″ and Q are as above defined, y is the radical Y′, wherein Y′ is as above defined, and4o-ii) when Q is Z_2f by converting the compound obtained in the step 4o-i) into nitro derivative by reaction with a nitrate source as above described and4o-iii) optionally deprotecting the compounds obtained in step 4o-i) or 4o-ii) as above described.

The reaction of a compound of formula (IIIm) wherein P⁴ and X₁₇ are as above defined with a compound of formula (IVe) wherein y, X″ and Q are as above defined, may be carried out as described in 1-i-1).

The compounds of formula (IIIm), wherein P⁴ and X₁₇ are as above defined, are commercially available or obtained as known in literature.

4p) The compound of formula (Im) wherein X₁₂ is selected from (d3′) or (d4′) wherein R^12a is selected from D7), Y′ is as above defined, T″ is —NR′ wherein R′ is as above defined, can be obtained4p-i) by reacting a compound of formula (IIIm),

P⁴—X₁₇  (IIIm)

wherein P⁴ and X₁₇ are as defined above, wherein R^12a is selected from D7), with a compound of formula

HR′N-y-Q  (IVg)

wherein R′ and Q are as above defined, y is the radical Y′, wherein Y′ is as above defined, and4p-ii) when Q is Z₂, by converting the compound obtained in the step 4p-i) into nitro derivative by reaction with a nitrate source such above described and4p-iii) optionally deprotecting the compounds obtained in step 4p-i) or 4p-ii) as above described.

The reaction of a compound of formula (IIIm) wherein P⁴ and X₁₇ are as above defined, with a compound of formula (IVg) wherein R′, y, Q are as above defined, may be carried out as described in 1a-i).

4q) The compound of formula (Im) wherein X₁₂ is selected from (d3′) or (d4′) wherein R^12a is selected from D7), Y′ is as above defined, T″ is —O—CH(R′)—O—C(O)— wherein R′ is as above defined, can be obtained4q-i) by reacting a compound of formula (IIIm),

P⁴—X₁₇  (IIIm)

wherein P⁴ and X₁₇ are as defined above, wherein R^12a is selected from D7), with a compound of formula (IVm)

Hal-CH(R′)—O—(O)C-y-Q  (IVm)

wherein R′ and Q are as above defined, Hal is an halogen atom, y is the radical Y′, wherein Y′ is as above defined, and4q-ii) when Q is Z₂, by converting the compound obtained in the step 4q-i) into nitro derivative by reaction with a nitrate source such above described and4q-iii) optionally deprotecting the compounds obtained in step 4q-i) or 4q-ii) as above described.

The reaction of a compound of formula (IIIm) wherein P⁴ and X₁₇ are as above defined, with a compound of formula (IVm) wherein R′, y, Q are as above defined, may be carried out as described in 1l-i).

4r) The compound of formula (Im) wherein X₁₂ is selected from (d3′) or (d4′) wherein R^12a is selected from D7), Y′ is as above defined, T″ is —O—CH(R′)—O—C(O)—O— wherein R′ is as above defined, can be obtained4r-i) by reacting a compound of formula (IIIm),

P⁴—X₁₇  (IIIm)

wherein P⁴ and X₁₇ are as defined above, wherein R^12a is selected from D7), with a compound of formula (IVo)

Hal-CH(R′)—O—(O)C—O-y-Q  (IVo)

wherein R′ and Q are as above defined, Hal is an halogen atom, y is the radical Y′, wherein Y′ is as above defined, and4r-ii) when Q is Z_2r by converting the compound obtained in the step 4r-i) into nitro derivative by reaction with a nitrate source as above described and4r-iii) optionally deprotecting the compounds obtained in step 4r-i) or 4r-ii) as above described.

The reaction of a compound of formula (IIIm) wherein P⁴ and X₁₇ are as above defined, with a compound of formula (IVo) wherein y, R′, Q, Hal are as above defined, may be carried out as described in 1l-i).

5) The compound of general formula (I) as above defined wherein a is equal to 0, R_x is a radical selected from (d5), (d6), (d9) or (d10), wherein R^12b is selected from D10) can be obtained5-i) by reacting a compound of formula (IIa)

R—H  (IIa)

wherein R is as above defined, with a compound of formula (Is)

W—X₁₈  (Is)

wherein W is as above defined, X₁₈ is the radical having the following meanings

(d5′) —R^12b—CH(NHR^4a)—CH₂—O-(T′″-Y-Q)

(d6′) —R^12b—CH(CH₂OH)—NH-(T′-Y-Q)

(d9′) —R^12b—CH(NH-T′″-Y′-Q)-CH₂—O-(T′-Y-Q)

(d10′) —R^12b—CH(CH₂—O-T″-Q)-NH-(T′-Y-Q)

wherein R^12b is selected from D10), T′, T′″, Y, Y′ and Q are as above defined and5-ii) when Q is Z₂, by converting the compound obtained in the step 5-i) into nitro derivative by reaction with a nitrate source as above described and5-iii) optionally deprotecting the compounds obtained in step 5-i) or 5-ii) as above described.

The reaction of a compound of formula (IIa) wherein R is as above defined, with a compound of formula (Is) wherein W and X₁₈ are as above defined may be carried out as described in 1).

5a) The compounds of formula (Is) wherein X₁₈ is a radical of formula (d5′) or (d6′), wherein R^12b is selected from D10), T′ and T″ are C(O) can be obtained5a-i) by reacting a compound of formula (IIIn),

P²—X₁₉  (IIIn)

wherein P² is as above defined, X₁₉ is the radical having the following meanings

(d5″) —R^12b—CH(NHP³)—CH₂—OH

(d6″) —R^12b—CH(CH₂OP¹)—NH₂

wherein P¹ and P³ are as above defined and R^12b is selected from D10), with a compound of formula (IVa)

W₁—C(O)-y-Q  (IVa)

wherein W₁, y, Q are as above defined, y is the radical Y, wherein Y is as above defined, and5a-ii) when Q is Z₂, by converting the compound obtained in the step 5a-i) into nitro derivative by reaction with a nitrate source as above described and5a-i) optionally deprotecting the compounds obtained in step 5a-i) or 5a-ii) as above described.

The reaction of a compound of formula (IIIn) wherein P² and X₁₉ are as above defined, with a compound of formula (IVa) W₁, y, and Q are as above defined may be carried out as described in 1-i-1), 1-i-2), 1-i-3) and 1a-1).

The compounds of formula (IIIn), wherein P² and X₁₉ are as above defined, are commercially available or obtained as known in literature.

5b) The compounds of formula (Is) wherein X₁₈ is a radical of formula (d5′) or (d6′), wherein R^12b is selected from D10), T′ and T′″ are C(O)—X″, wherein X″ is defined above, can be obtained5b-i) by reacting a compound of formula (IIIn),

P²—X₁₉  (IIIn)

wherein P² and X₁₉ are as above defined, with a compound of formula (IVd)

R_a—O—C(O)—X″-y-Q  (IVd)

wherein R_a and Q, X″ are as above defined, y is the radical Y, wherein Y is as above defined, and5b-ii) when Q is Z_2f by converting the compound obtained in the step 5b-i) into nitro derivative by reaction with a nitrate source as above described and5b-iii) optionally deprotecting the compounds obtained in step 5b-i) or 5b-ii) as above described.

The reaction of a compound of formula (IIIn) wherein P² and X₁₉ are as above defined, with a compound of formula (IVd) R_a, y, Q, X″ are as above defined may be carried out as described in 1-i-2).

5c) The compounds of formula (Is) wherein X₁₈ is a radical of formula (d9′), wherein R^12b is selected from D10), Y and Y′ are as defined above, T′ is C(O)— and T′″ is C(O) or C(O)—X″, wherein X″ is defined above, can be obtained5c-i) by reacting a compound of formula (It),

P²—X₂₀  (It)

wherein P² is as above defined and X₂₀ is the radical having the following meanings

(d9″) —R^12b—CH(NH₂)—CH₂—O-(T″-Y-Q)

wherein R^12b is selected from D10), T″, Y and Q are as above defined, with a compound of formula (IVa)

W₁—C(O)-y-Q  (IVa)

wherein W₁ and Q are as above defined, y is the radical Y′, wherein Y′ is as above defined, and5c-ii) when Q is Z₂, by converting the compound obtained in the step 5c-i) into nitro derivative by reaction with a nitrate is source as above described and5c-iii) optionally deprotecting the compounds obtained in step 5c-i) or 5c-ii) as above described.

The reaction of a compound of formula (It) wherein P² and X₂₀ are as above defined, with a compound of formula (IVa) wherein W₁, y, 4 are as above defined, may be carried out as described in 1-i-1), 1-i-2), 1-i-3) and 1a-1).

5d) The compounds of formula (Is) wherein X₁₈ is a radical of formula (d9′), wherein R^12b is selected from D10), T′ is C(O)—X″ and T″ is C(O)— or C(O)—X″, wherein X″ is defined above, can be obtained

5d-i) by reacting a compound of formula (It′),

P²—X_20′  (It′)

wherein P² and X_20′ are as above defined, with a compound of formula (IVd)

R_a—O—C(O)—X″-y-Q  (IVd)

wherein R_a and Q, X″ are as above defined, y is the radical Y′, wherein Y′ is as above defined, and5d-ii) when Q is Z₂, by converting the compound obtained in the step 5d-i) into nitro derivative by reaction with a nitrate source as above described and5d-iii) optionally deprotecting the compounds obtained in step 5d-i) or 5d-ii) as above described.

The reaction of a compound of formula (It′) wherein P² and X_20′ are as above defined, with a compound of formula (IVd) R_a, y, X″ are as above defined may be carried out as described in 1-i-2).

5e) The compounds of formula (Is) wherein X₁₈ is the radical of formula (d10′), wherein R^12b is selected from D10), Y and Y′ are as defined above, T″ is C(O)— and T′ is C(O) or C(O)—X″, wherein X″ is defined above, can be obtained5e-i) by reacting a compound of formula (It),

P²—X₂₀  (It)

wherein P² is as above defined and X₂₀ is the radical having the following meaning

(d10″) —R^12b—CH(CH₂—OH)—NH-(T′-Y-Q) wherein R^12b is selected from D10), T′, Y and Q are as above defined, with a compound of formula (IVa)

W₁—C(O)-y-Q  (IVa)

wherein W₁ and Q are as above defined, y is the radical Y′, wherein Y′ is as above defined, and5e-ii) when Q is Z₂, by converting the compound obtained in the step 5e-i) into nitro derivative by reaction with a nitrate source as above described and5e-iii) optionally deprotecting the compounds obtained in step 5e-i) or 5e-ii) as above described.

The reaction of a compound of formula (It) wherein P² and X₂₀ are as above defined, with a compound of formula (IVa) wherein W₁, y, Q are as above defined, may be carried out as described in 1-i-1), 1-i-2), 1-i-3) and 1a-1).

5f) The compounds of formula (Is) wherein X₁₈ is the radical of formula (d10′), wherein R^12b is selected from D10), T″ is C(O)—X″ and T′ is C(O)— or C(O)—X″, wherein X″ is defined above, can be obtained5f-i) by reacting a compound of formula (It′),

P²—X_20′  (It′)

wherein P² and X_20′ are as above defined, with a compound of formula (IVd)

R_a—O—C(O)—X″-y-Q  (IVd)

wherein R_a and Q, X″ are as above defined, y is the radical Y′, wherein Y′ is as above defined, and5f-ii) when Q is Z₂, by converting the compound obtained in the step 5f-i) into nitro derivative by reaction with a nitrate source as above described and5f-iii) optionally deprotecting the compounds obtained in step 5f-i) or 5f-ii) as above described.

The reaction of a compound of formula (It′) wherein P² and X_20′ are as above defined, with a compound of formula (IVd) R_a, y, Q, X″ are as above defined may be carried out as described in 1-i-2).

6) The compounds of general formula (I) as above defined wherein a is equal to 1, R_x is a radical selected from (d5), (d6), (d9) or (d10), wherein R^12b is selected from D10), Z is —CH(R′)—O—, wherein R′ is defined above, can be obtained6-i) by reacting a compound of formula (IIa)

R—OH  (IIa)

wherein R is as above defined with a compound of formula (Iu)

Hal-CH(R′)—O—X₂₁  (Iu)

wherein Hal is an halogen atom, R′ is as above defined and X₂₁ is a radical selected from (d5′), (d6′), (d9′) or (d10′),wherein R^12b is selected from D10), and6-ii) when Q is Z_2f by converting the compound obtained in the step 6-i) into nitro derivative by reaction with a nitrate source as above described and6-iii) optionally deprotecting the compounds obtained in step 6-i) or 6-ii) as above described.

The reaction of a compound of formula (Iu) wherein Hal, X_n and R′ are as above defined, with a compound of formula (IIa) wherein R is as above defined, may be carried out as described in 1l-i).

The compounds of formula (Iu) are obtained by reacting a compound R′—CHO, wherein R′ is as above defined with compounds of formula (IIIo)

W—X₂₂  (IIIo)

wherein W is a chlorine atom, X₂₂ is the radical having the following meanings

(d5′″) —R^12b—CH(NHP³)—CH₂—O-(T′″-Y-Q)

(d6″) —R^12b—CH(CH₂OP¹)—NH-(T′-Y-Q)

(d9′″) —R^12b—CH(NH-T′-Y′-Q)-CH₂—O-(T′″-Y-Q)

(d10″) —R^12b—CH(CH₂—O-T″-Y′-Q)-NH-(T′-Y-Q)

wherein R^12b, P³, P¹, T′, T″, Y′, Y and Q are as above defined, and ZnCl₂ as known in literature.

The compounds of formula (IIIo), wherein W and X₂₂ are as above defined, may be carried out as described in 5).

7) The compounds of general formula (I) as above defined wherein a is equal to 1, R_x is a radical selected from (d5), (d6), (d9) or (d10), wherein R^12b is selected from D8) or D9), Z is —C(O)—, can be obtained7-i) by reacting a compound of formula (IIb)

R—C(O)—O—R_a, (IIb)

wherein R and R_a are as above defined with a compound of formula (Iv)

H—X₂₃  (Iv)

wherein X₂₃ is a radical selected from (d5′), (d6′), (d9′) or (d10′), wherein R^12b is selected from D8) or D9), and7-ii) when Q is Z₂, by converting the compound obtained in the step 7-i) into nitro derivative by reaction with a nitrate source as above described and7-iii) optionally deprotecting the compounds obtained in step 7-i) or 7-ii) as above described.

The reaction of a compound of formula (Iv) wherein X₂₃ and is as above defined, with a compound of formula (IIb) wherein R is as above defined, may be carried out as described in 1l-i).

8) The compound of general formula (I) as above defined wherein a is equal to 0, R_x is a radical selected from (a5), (a6), (a9) or (a10), (b5), (b6), (b9) or (MO) wherein R^1b is selected from A10) and R^2b is selected from B10), can be obtained8-i) by reacting a compound of formula (IIa)

R—H  (IIa)

wherein R is as above defined, with a compound of formula (Iz)

W—X₂₄  (Iz)

wherein W is as above defined, X₂₄ is the radical R_x having the following meanings

(a5′) —R^1b—CH(NHR^4a)—C(O)-(T-Y-Q)

(a6′) —R^1b—CH(COOR^3a)NH-(T′-Y-Q)

(a9′) —R^1b—CH(NH-T′-Y′-Q)-C(O)-(T-Y-Q)

(a10′) —R^1b—CH(C(O)-T′-Q)-NH-(T-Y-Q)

(b5′) —R^2b—CH(NHR^4a)—CH₂C(O)-(T-Y-Q)

(b6′) —R^2b—CH(CH₂COOR^3a)NH-(T′-Y-Q)

(b9′) —R^2b—CH(NH-T′-Y′-Q)-CH₂C(O)-(T-Y-Q)

(b10′) —R^2b—CH(CH₂C(O)-T′-Y′-Q)-NH-(T-Y-Q)

wherein R^1b is selected from A10), R^2b is selected from B10), T,

T′, Y and Q are as above defined and

8-ii) when Q is Z₂, by converting the compound obtained in the step 8-i) into nitro derivative by reaction with a nitrate source as above described and8-iii) optionally deprotecting the compounds obtained in step 8-i) or 8-ii) as above described.

The reaction of a compound of formula (IIa) wherein R is as above defined, with a compound of formula (Iv) wherein W and X₂₄ are as above defined may be carried out as described in 1).

8a) The compounds of formula (Iz) wherein X₂₄ is a radical of formula (a5′), (a6′), (b5′) or (b6′), wherein R^1b is selected from A10) and R^2b is selected from B10), T and T′ are C(O) can be obtained8a-i) by reacting a compound of formula (IIIq),

P²—X₂₅  (IIIq)

wherein P² is as above defined, X₂₅ is the radical having the following meanings

(a5″) —R^1b—CH(NHP³)—C(O)—OH

(a6″) —R^1b—CH(COO P²)—NH₂

• • (b5″) —R^2b—CH(NH P³)—CH₂C(O)—OH
  • (b6″) —R^2b—CH(CH₂COO P²)NH₂ wherein P² and P³ are as above defined and R^1b is selected from A10), R^2b is selected from B10), with a compound of formula III (IVa)

W₁—C(O)-y-Q  (IVa)

wherein W_I, and Q are as above defined, y is the radical Y, wherein Y is as above defined, and8a-ii) when Q is Z₂, by converting the compound obtained in the step 8a-i) into nitro derivative by reaction with a nitrate source as above described and8a-iii) optionally deprotecting the compounds obtained in step 8a-i) or 8a-ii) as above described.

The reaction of a compound of formula (IIIq) wherein P² and X₂₅ are as above defined, with a compound of formula (IVa) W₁, Y, and Q are as above defined may be carried out as described in 1-i-1), 1-i-2), 1-i-3) and 1a-1).

The compounds of formula (IIIq), wherein P² and X₂₅ are as above defined, are commercially available or obtained as known in literature.

8b) The compounds of formula (Iz) wherein X₂₄ is the radical of formula (a5′), (a6′), (b5′) or (b6′), wherein R^1b is selected from A10) and R^2b is selected from B10), T and T′ are C(O)—X″, wherein X″ is defined above, can be obtained8b-i) by reacting a compound of formula (IIIq),

P²—X₂₅  (IIIq)

wherein P² and X₂₅ are as above defined, with a compound of formula (IVd)

R_a—O—C(O)—X″-y-Q  (IVd)

wherein R_a, Q and X″ are as above defined, y is the radical Y, wherein Y is as above defined, and8b-ii) when Q is Z₂, by converting the compound obtained in the step 8b-i) into nitro derivative by reaction with a nitrate source as above described and8b-iii) optionally deprotecting the compounds obtained in step 8b-i) or 8b-ii) as above described.

The reaction of a compound of formula (IIIq) wherein P² and X₂₅ are as above defined, with a compound of formula (IVd) R_a, y, Q, X″ are as above defined may be carried out as described in 1-i-2).

8c) The compounds of formula (Iz) wherein X₂₄ is the radical of formula (a9′) or (b9′) wherein R^1b is selected from A10), and R^2b is selected from B10) Y and Y′ are as defined above, T is C(O)— or C(O)—X″, wherein X″ is defined above and T′ is C(O) can be obtained8c-i) by reacting a compound of formula (Iy),

P²—X₂₆  (Iy)

wherein P² is as above defined and X₂₆ is the radical having the following meanings

(a9″) —R^1b—CH(NH₂) —C(O)-(T-Y-Q)

(b9″) —R^2b—CH(NH₂) —CH₂C(O)-(T-Y-Q)

wherein R^1b is selected from A10) and R^2b is selected from B10), with a compound of formula (IVa)

W₁—C(O)-y-Q  (IVa)

wherein W₁ and Q are as above defined, y is the radical Y′, wherein Y′ is as above defined, and8c-ii) when Q is Z₂, by converting the compound obtained in the step 8c-i) into nitro derivative by reaction with a nitrate source as above described and8c-iii) optionally deprotecting the compounds obtained in step 8c-i) or 8c-ii) as above described.

The reaction of a compound of formula (Iy) wherein P² and X₂₆ are as above defined, with a compound of formula (IVa) wherein W₁, y, Q are as above defined, may be carried out as described in 1-i-1), 1-i-2), 1-i-3) and 1a-1).

8d) The compounds of formula (Iz) wherein X₂₄ is the radical of formula (a9′) or (b9′) wherein R^1b is selected from A10), R^2b is selected from B10), Y and Y′ are as defined above, T is C(O)— or C(O)—X″, wherein X″ is defined above and T′ is C(O)—X″ can be obtained8d-i) by reacting a compound of formula (Iy),

P²—X₂₆  (Iy)

wherein P² and X₂₆ are as above defined, with a compound of formula (IVd)

R_a—O—C(O)—X″-y-Q  (IVd)

wherein R_a and X″ are as above defined, y is the radical Y′, wherein Y′ is as above defined, and8d-ii) when Q is Z₂, by converting the compound obtained in the step 8d-i) into nitro derivative by reaction with a nitrate source as above described and8d-iii) optionally deprotecting the compounds obtained in step 8d-i) or 8d-ii) as above described.

The reaction of a compound of formula (Iy) wherein P² and X₂₀ are as above defined, with a compound of formula (IVd) R_a, y, Q, X″ are as above defined may be carried out as described in 1-i-2).

8e) The compounds of formula (Iz) wherein X₂₄ is the radical of formula (a10′) or (b10′) wherein R^1b is selected from A10), and R^2b is selected from in B10) Y and Y′ are as defined above, T is C(O)— or C(O)—X″, wherein X″ is defined above and T′ is C(O) can be obtained8e-i) by reacting a compound of formula)(Iy′),

P²—X_26′  (Iy′)

wherein P² is as above defined and X_26′ is the radical having the following meanings

• • (a10″) —R^1b—CH(C(O)—OH)—NH-(T-Y-Q)
  • (b10″) —R^2b—CH(CH₂C(O)—OH)—NH-(T-Y-Q)wherein R^1b is selected from selected from A10) and R^2b is B10), with a compound of formula (IVa)

W₁—C(O)-y-Q  (IVa)

wherein W₁ and Q are as above defined, y is the radical Y′, wherein Y′ is as above defined, and8e-ii) when Q is Z₂, by converting the compound obtained in the step 8e-i) into nitro derivative by reaction with a nitrate source as above described and8e-iii) optionally deprotecting the compounds obtained in step 8e-i) or 8e-ii) as above described.

The reaction of a compound of formula (Iy′) wherein P² and X_26′ are as above defined, with a compound of formula (IVa) wherein W₁, y, Q are as above defined, may be carried out as described in 1-i-1), 1-i-2), 1-i-3) and 1a-1).

8f) The compounds of formula (Iz) wherein X₂₄ is the radical of formula (a10′) or (b10′) wherein R^1b is selected from A10), and R^2b is selected from B10), Y and Y′ are as defined above, T is C(O)— or C(O)—X″, wherein X″ is defined above and T′ is C(O)—X″ can be obtained8f-i) by reacting a compound of formula (Iy′),

P²—X_26′  (Iy′)

wherein P² and X_26′ are as above defined, with a compound of formula (IVd)

R_a—O—C(O)—X″-y-Q  (IVd)

wherein R_a and X″ are as above defined, y is the radical Y′, wherein Y′ is as above defined, and8f-ii) when Q is Z_2f by converting the compound obtained in the step 8f-i) into nitro derivative by reaction with a nitrate source as above described and8f-iii) optionally deprotecting the compounds obtained in step 8f-i) or 8f-ii) as above described.

The reaction of a compound of formula (Iy′) wherein P² and X_26′ are as above defined, with a compound of formula (IVd) R_a, y, Q, X″ are as above defined may be carried out as described in 1-i-2).

9) The compounds of general formula (I) as above defined wherein a is equal to 1, R_x is a radical selected from (a5)_f (a6), (a9) or (a10), (b5), (b6), (b9) or (b10) wherein R^1b is selected from A8) or A9), R^2b is selected from B8) or B9), Z is —C(O)—, can be obtained9-i) by reacting a compound of formula (IIb)

R—C(O)—O—R_a  (IIb)

wherein R and R_a are as above defined with a compound of formula (Ix)

H—X₂₇  (Ix)

wherein X₂₇ is the radical selected from (a5′), (a6′), (a9′), (a10′), (b5′), (b6′), (b9′) or (b10′), wherein R^2b is selected from A8) or A9), R^2b is selected from B8) or B9), and9-ii) when Q is Z₂, by converting the compound obtained in the step 9-i) into nitro derivative by reaction with a nitrate source as above described and9-iii) optionally deprotecting the compounds obtained in step 9-i) or 9-ii) as above described.

The reaction of a compound of formula (Ix) wherein X₂₇ and is as above defined, with a compound of formula (IIb) wherein R is as above defined, may be carried out as described in 1l-i).

Example 1

Synthesis of (11β,16β)-9-Chloro-11,17-dihydroxy-16-methyl-21-[1-oxo-((2-(4-(nitrooxy)butyloxy-carbonylamino)acetyl)]-pregna-1,4-diene-3,20-dione

(11β,16β)-9-Chloro-11,17-dihydroxy-16-methyl-21-[1-oxo-2-((tert-butylcarbonylamino)acetyl)]-pregna-1,4-diene-3,20-dione

To solution of beclomethasone (0.6 g, 1.46 mmol) in acetone (35 ml), N-Boc-glycine (0.334 g, 1.90 mmol) and DMAP (cat. amount) were added. The reaction was cooled at 0° C. and EDAC (0.365 g, 1.90 mmol) was added. The reaction was stirred at room temperature for 2 hours. The solvent was evaporated under vacuum. The residue was treated with water (50 ml) and methylene chloride (50×3 ml), the organic layers were dried over sodium sulfate and concentrated under reduced pressure. The residue was purified by flash chromatography, eluent n-hexane/ethyl acetate 6/4. The product (0.8 g) was obtained.

(11β,16β)-9-Chloro-11,17-dihydroxy-16-methyl-21-[1-oxo-2-((carbonylamino)acetyl)]-pregna-1,4-diene-3,20-dione Hydrochloride

A solution of compound A (0.8 g, 0.41 mmol) in methylene chloride (70 ml) was stirred at room temperature. HCl gas was buddle in the solution for 1 hour. The solvent was evaporated under reduced pressure. The product was used in the next step without any purification.

(11β,16β)-9-Chloro-11,17-dihydroxy-16-methyl-21-[1-oxo-(2-((4-(nitrooxy)butyoxy-carbonylamino)acetyl)]-pregna-1,4-diene-3,20-diene

To a solution of B) (0.75 g, 1.46 mmol) in methylene chloride (40 ml), 4-nitrooxybutyrric acid pentafluorophenyl ester (0.41 g, 1.46 mmol), DMAP (cat. amount) and triethylamine (0.3 ml, 2.19 mmol) were added. The reaction was stirred at room temperature for 24 hours. The solution was treated with a 5% solution of H₃PO₄ (50 ml). The organic layer was dried over sodium sulfate and concentrated under reduced pressure. The residue was purified by flash chromatography, (Biotage System, column FLASH 40+M™ KP-Sil) eluent:gradient n-hexane/ethyl acetate 1/1 (130 ml), to ethyl acetate 100% during 130 ml, ethyl acetate 100% (130 ml). The product (0.62 g) was to obtained as white powder.

¹H-NMR: (DMSO), δ: 8.42 (1H, t); 7.30 (1H, d); 6.22 (1H, dd); 5.98 (1H, s); 5.46 (1H, d); 5.42 (2H, s); 5.05 (1H, d); 4.84 (1H, d); 4.5 (2H, t); 4.34 (1H, sb); 3.97 (2H, d); 2.71-2.57 is (2H, m); 2.5-2.2 (6H, m); 2.0-1.7 (5H, m); 1.65-1.35 (5H, m); 1.25-0.97 (4H, m); 0.8 (3H, s).

Example 2

Synthesis of (11β,16β)-9-Fluoro-11,17-dihydroxy-16-methyl-21-[1-oxo-(2-((4-(nitrooxy)butyoxy-carbonylamino)acetyl)]-pregna-1,4-diene-3,20-dione

The compound was synthesized using the procedure described in example 1 starting from betamethasone, Boc-glycine and 4-nitrooxybutyric acid pentafluorophenol ester.

¹H-NMR: (DMSO), 6:8.4 (1H, t); 7.28 (1H, d); 6.22 (1H, dd); 6.0 (1H, s); 5.30 (1H, d); 5.08 (1H, d); 4.83 (1H, d); 4.53 (2H, t); 4.15 (1H, bp); 3.95 (2H, d); 2.71-2.52 (1H, m); 2.51-2.4 (6H, m); 2.38-2.07 (2H, m); 2.03-1.75 (6H, m); 1.58-1.45 (4H, m), 1.11-0.8 (6H, m).

Example 3

Synthesis of (11β,16β)-9-Fluoro-11-hydroxy-16,17-(1-methylethylidenebis(oxy))-21-[1-oxo-(2-(4-(nitrooxy)butyoxy-carbonylamino)acetyl)]-pregna-1,4-diene-3,20-dione

The compound was synthesized using the procedure described in example 1 starting from triamcinolone acetonide, Boc-glycine and 4-nitrooxybutyric acid pentafluorophenol ester.

¹H-NMR: (DMSO), : 8.43 (1H, t); 7.27 (1H, d); 6.21 (1H, dd); 6.0 (1H, s); 5.46 (1H, d); 5.18 (1H, d); 4.87-4.83 (1H, m); 4.74 (1H, d); 4.50 (1H, t); 4.18 (1H, sb); 3.98-3.96 (2H, m); 2.71-2.31 (5H, m); 2.30-2.2 (3H, m); 2.10-1.77 (6H, m); 1.75-1.42 (7H, m); 1.4-1.32 (4H, m); 1.12 (3H, s); 0.85 (3H, s).

Example 4

Synthesis of (6α,11β,16α)-6,9-difluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-21-[1-oxo-(2-((4-(nitrooxy)butyoxy-carbonylamino)acetyl)]-pregna-1,4-diene-3,20-dione

The compound was synthesized using the procedure described in example I starting from fluocinolone acetonide, Boc-glycine and 4-nitrooxybutyric acid pentafluorophenol ester.

¹H-NMR: (DMSO), : 8.43 (1H, t); 7.25 (1H, d); 6.28 (1H, dd); 6.09 (1H, s); 5.75-5.48 (2H, m); 5.18 (1H, d); 4.83 (1H, d); 4.78 (1H, d); 4.50 (2H, t); 4.18 (1H, sb); 3.9-3.8 (2H, m); 2.72-2.48 (4H, m); 2.25 (2H, t); 2.10-1.8 (3H, m); 1.78-1.65 (1H, m); 1.62-1.51 (2H, m); 1.48 (3H, s); 1.32 (3H, s); 1.10 is (3H, s); 0.8 (3H, s).

Example 5

Synthesis of 4-(nitrooxy)butyl 2-acetamido-3-(4-((2-((9R,10S,11S,13S,16R,17S)-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethoxy) carbonyloxy)phenyl)propanoate

D) 4-(nitrooxy)butyl 2-(tert-butoxycarbonylamino)-3-(4-hydroxyphenyl)propanoate

To a solution of Boc-(L)-tyrosine (5.0 g, 17.77 mmol) in N,N-dimethylformamide (40 ml) cesium carbonate (5.79 g, 17.77 mmol) was added. The reaction was cooled at 0° C. and a solution of 4-bromobutyl nitrate (17.77 mmol) in dichloromethane (20% w/w, 17.06 g) was added drop wise. The reaction was stirred at 0° C. w for 20 minutes and then at room temperature for 22 hours. The mixture was poured into a 5% aqueous NaH₂PO₄ solution and extracted with diethyl ether (40×4 ml), the organic layers were dried over sodium sulfate and concentrated under reduced pressure. The residue was purified by flash chromatography, (Biotage System, column FLASH 65+M™ KP-Sil, eluent: gradient n-hexane/ethyl acetate 9/1 (500 ml), to n-hexane/ethyl acetate 1/1 during 4000 ml, n-hexane/ethyl acetate 1/1 (1000 ml)). The product (3.91 g) was obtained.

E) 4-(nitrooxy)butyl 2-amino-3-(4-hydroxyphenyl)propanoate

A solution of compound D (0.96 g, 2.41 mmol) in dichloromethane (20 ml) was stirred at room temperature. HCl gas was buddle in the solution for 3 hours. The mixture was diluted with dichloromethane (25 ml), washed with saturated aqueous sodium carbonate. The organic layer was dried over sodium sulfate and concentrated under reduced pressure. The product (0.71 g) was used in the next step without any purification.

F) 4-(nitrooxy)butyl 2-acetamido-3-(4-hydroxyphenyl)propanoate

To a solution of compound E (0.63 g, 2.25 mmol) in dichloromethane (15 ml) triethylamine (0.31 ml, 2.25 mmol) was added. The reaction was cooled at 0° C. and acetyl chloride (0.17 ml, 2.48 mmol) was added drop wise. The reaction was stirred at 0° C. for 10 minutes and then at room temperature for 16 hours. The mixture was diluted with dichloromethane (25 ml), washed with water. The organic layer was dried over sodium sulfate and concentrated under reduced pressure. The residue was purified is by flash chromatography, (Biotage System, column FLASH 25+M™ KP-Sil, eluent: gradient n-hexane/ethyl acetate 9/1 (100 ml), to n-hexane/ethyl acetate 2/8 during 1200 ml). The product (0.54 g) was obtained.

G) 4-(nitrooxy)butyl 2-acetamido-3-(4-((4-nitrophenoxy)carbonyloxy)phenyl)propanoate

To a solution of compound F (0.54 g, 1.58 mmol) in dichloromethane (8 ml) pyridine (0.15 ml, 1.58 mmol) was added. The reaction was cooled at 0° C. and p-nitrophenylchloroformate (320 mg, 1.58 mmol) was added. The reaction was stirred at 0° C. for 15 minutes and then at room temperature for 48 hours. The mixture was diluted with dichloromethane (25 ml), washed with 1M aqueous HCl solution and then with saturated aqueous sodium carbonate. The organic layers was dried over sodium sulfate and concentrated under reduced pressure. The residue was purified by flash chromatography, (Biotage System, column FLASH 25+M™ KP-Sil, eluent: gradient n-hexane/ethyl acetate 9/1 (150 ml), to n-hexane/ethyl acetate 3/7 during 1200 ml, n-hexane/ethyl acetate 3/7 (600 ml)). The product (0.59 g) was obtained.

H) 4-(nitrooxy)butyl 2-acetamido-3-(4-((2-((9R,10S,11S,13S,16R,17S)-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethoxy)phenyl)propanoate

To a solution of compound G (0.55 g, 1.09 mmol) in dichloromethane (12 ml), scandium triflate (0.05 g, 0.11 mmol) and DMAP (0.26 g, 2.19 mmol) were added. The reaction was cooled at 0° C. and triamcinolone acetonide (0.47 g, 1.09 mmol) was added. The reaction was stirred at room temperature for 18 hours. The mixture was diluted with dichloromethane (24 ml), washed with 5% NaH₂PO₄ and then with saturated aqueous sodium carbonate. The organic layer was dried over sodium sulfate and concentrated under reduced pressure. The residue was purified by flash chromatography, (Biotage System, column FLASH 25+M™ KP-Sil, eluent: gradient n-hexane/ethyl acetate 9/1 (150 ml), to n-hexane/ethyl acetate 2/8 during 1200 ml, n-hexane/ethyl acetate 2/8 (800 ml)). The product (0.29 g) was obtained.

¹H-NMR: (DMSO), : 8.36 (1H, d); 7.37-7.32 (3H, m); 7.21-7.12 (2H, m); 6.23 (1H, dd); 6.02 (1H, s); 5.47 (1H, d); 5.31 (1H, d); 4.97-4.87 (2H, m); 4.59-4.48 (3H, m); 4.27-4.17 (1H, sb); 4.11-3.97 (2H, m); 3.10-2.90 (1H, m); 2.71-2.29 (4H, m); 2.10-1.75 (5H, m); 1.60-1.40 (7H, m); 1.38 (3H, s); 1.12 (3H, s); 0.80 (3H, s).

Example 6

Synthesis of (2S)-4-(nitrooxy)butyl 2-acetamido-3-(4-((2-((6S,9R,10S,11S,13S,16R,17S)-6,9-difluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethoxy)carbonyloxy)phenyl)propanoate

The compound was synthesized using the procedure described in example 5 starting from fluocinolone acetonide and compound G.

¹H-NMR: (DMSO), : 8.36 (1H, d); 7.28 (3H, m); 7.09 (2H, m); 6.30 (1H, dd); 6.11 (1H, d); 5.56 (1H, d); 5.31 (1H, d); 4.91 (2H, m); 4.50 (2H, t); 4.93 (1H, m); 4.25 (1H, m); 4.02 (3H, t); 2.96 (2H, m); 2.27 (1H, m); 2.01 (3H, m); 1.90-1.25 (17H, m); 1.15 (3H, s); 0.80 (3H, s).

Example 7

Synthesis of (2S)-4-(nitrooxy)butyl 2-amino-3-(4-((2-((9R,10S,11S,13S,16R,17S)-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta [a]phenanthren-17-yl)-2-oxoethoxy)carbonyloxy)phenyl)propanoate Hydrochloride

I) 4-hydroxybutyl 2-(tert-butoxycarbonylamino)-3-(4-((4-nitrophenoxy)carbonyloxy)phenyl)propanoate

To a solution of compound D (1.97 g, 4.86 mmol) in dichloromethane (24 ml) pyridine (0.48 ml, 4.86 mmol) was added. The reaction was cooled at 0° C. and p-nitrophenylchloroformate (980 mg, 4.86 mmol) was added. The reaction was stirred at 0° C. for 10 minutes and then at room temperature for 21 hours. The mixture was diluted with dichloromethane (25 ml), washed with 1M aqueous HCl solution and then with saturated aqueous sodium carbonate. The organic layers was dried over sodium sulfate and concentrated under reduced pressure. The residue was purified by flash chromatography, (Biotage System, column FLASH 40+M™ KP-Sil, eluent: gradient n-hexane/ethyl acetate 98/2 (200 ml), to n-hexane/ethyl acetate 6/4 during 1600 ml, n-hexane/ethyl acetate 6/4 (300 ml)). The product (2.19 g) was obtained.

J) (2S)-4-(nitrooxy)butyl 2-(tert-butoxycarbonylamino)-3-(4-((2-((9R,10S,11S,13S,16R,17S)-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethoxy)carbonyloxy)phenyl)propanoate

To a solution of compound I (1.35 g, 2.4 mmol) in dichloromethane (40 ml), scandium triflate (0.11 g, 0.24 mmol) and DMAP (0.57 g, 4.8 mmol) were added. The reaction was cooled at 0° C. and triamcinolone acetonide (1.25 g, 2.88 mmol) was added. The reaction was stirred at room temperature for 70 hours. The solvent was evaporated under reduced pressure. The residue was purified by flash chromatography, (Biotage System, column FLASH 40+M™ KP-Sil, eluent: gradient n-hexane/ethyl acetate 9/1 (200 ml), to n-hexane/ethyl acetate 3/7 during 1600 ml, n-hexane/ethyl acetate 3/7 (500 ml)). The product (0.98 g) was obtained.

K) (2S)-4-(nitrooxy)butyl-2-amino-3-(4-((2-((9R,10S,11S,13S, 16R,17S)-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis (oxy))-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethoxy) carbonyloxy)phenyl)propanoate Hydrochloride

A solution of compound J (1.42 g, 1.65 mmol) in dichloromethane (28 ml) was stirred at room temperature. HCl gas was buddle in the solution for 15 minutes. The mixture was diluted with dichloromethane (35 ml), washed with saturated aqueous sodium carbonate. The organic layer was dried over sodium sulfate and concentrated under reduced pressure. The residue was purified by reverse-phase flash chromatography, (Biotage System, column FLASH 40+M™ KP-Sil, eluent: gradient water/acetonitrile 9/1 (150 ml), to water/acetonitrile 2/8 during 1400 ml, water/acetonitrile 2/8 (200 ml)). The free base of product M (0.67 g) was treated with a solution of HCl in diethyl ether. The hydrochloride salt of compound M was filtered and dried under vacuum. The product (0.57 g) was obtained.

¹H-NMR: (DMSO), : 8.57 (2H, m); 7.38-7.29 (3H, m); 7.22-7.19 (2H, m); 6.22 (1H, dd); 6.00 (1H, s); 5.54 (1H, d); 5.31 (1H, d); 4.88-4.84 (2H, m); 4.52-4.40 (2H, m); 4.25-4.20 (1H, sb); 4.16-4.09 (3H, m); 3.22-3.04 (1H, m); 2.71-2.29 (4H, m); 2.10-1.75 (5H, m); 1.60-1.34 (7H, m); 1.13 (3H, s); 0.82 (3H, s).

Example 8

Synthesis of (2S)-4-(nitrooxy)butyl 2-amino-3-(4-((2-((6S,9R,10S,11S,13S,16R,17S)-6,9-difluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethoxy)carbonyloxy)phenyl)propanoate Hydrochloride

The compound was synthesized using the procedure described in example 7 starting from fluocinolone acetonide and compound

¹H-NMR: (DMSO), : 8.64 (2H, s); 7.41-7.35 (3H, m); 7.23 (2H, d); 6.30 (1H, dd); 6.11 (1H, s); 5.80-5.50 (2H, m); 5.40-5.27 (1H, m); 5.00-4.75 (2H, m); 4.53-4.45 (2H, m); 4.48-4.05 (4H, m); 3.31-3.03 (2H, m); 2.75-2.60 (1H, m); 2.27 (1H, sb); 2.11-1.98 (3H, m); 1.82-1.52 (5H, m); 1.50 (3H, s); 1.38 (3H, s); 1.10 (3H, s); 0.81 (3H, s).

Example 9

Synthesis of 2-((8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-16,17-(1-methyl ethylidenebis(oxy))-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta [a]phenanthren-17-yl)-2-oxoethyl-2-(5-(nitrooxy)pentanamido) Acetate

The compound was synthesized using the procedure described in example I starting from triamcinolone acetonide, Boc-glycine and 4-nitrooxybutyric acid pentafluorophenol ester.

¹H-NMR: (DMSO), : 7.29 (1H, d); 6.23 (1H, dd); 6.02 (1H, s); 5.48 (1H, d); 5.20 (1H, d); 4.86 (1H, m); 4.78 (1H, d); 4.50 (2H, t); 4.18 (1H, sb); 3.98-3.96 (2H, m); 2.71-2.25 (2H, m); 2.30 (5H, m); 1.75-1.42 (14H, m); 1.4-1.32 (4H, m); 1.12 (3H, s); 0.83 (3H, s).

Example 10

Synthesis of 2-((8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl 2-(5-(nitrooxy)hexanamidoamido) Acetate

The compound was synthesized using the procedure described in example I starting from betamethasone, Boc-glycine and 6-nitrooxyhexanoic acid pentafluorophenol ester.

¹H-NMR: (DMSO), : 8.28 (1H, t); 7.27 (1H, d); 6.15 (1H, dd); m 5.99 (1H, s); 5.35 (1H, s); 5.27 (1H, d); 4.99 (1H, d), 4.79 (1H, d); 4.48 (2H, t), 4.11 (1H, m); 3.91 (2H, d); 2.60 (1H, m); 2.50-2.30 (2H, m); 2.10 (4H, m); 2.00-1.80 (3H, m); 1.70-1.30 (11H, m); 1.00 (4H, d); 0.99 (3H, s).

Example 11

Synthesis of 2-((6S,8S,9R,10S,11S,13S,14S,16R,17S)-6,9-difluoro-11-hydroxy-16,17-dimethoxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl 2-(6-nitrooxy hexanamido) Acetate

The compound was synthesized using the procedure described in example I starting from fluocinolone acetonide, Boc-glycine and 6-nitrooxyhexanoic acid pentafluorophenol ester.

¹H-NMR: (DMSO), : 8.32 (1H, t); 7.25 (1H, d); 6.28 (1H, dd); 6.09 (1H, s); 5.74-5.50 (2H, m); 5.18 (1H, d); 4.85 (1H, w d); 4.78 (1H, d); 4.48 (2E, t); 4.19 (18, sb); 3.94 (2H, m); 2.63-2.48 (1H, m); 2.25 (1H, t); 2.13 (2H, t); 2.10-1.93 (2H, m); 1.73-1.40 (11H, m); 1.30 (5H, m); 1.10 (3H, s); 0.8 (3H, s).

Example 12

Synthesis of 1-(2-((8S,9R,10S,11S,13S,143,16R,17S)-9-fluoro-11-hydroxy-16,17-((1-methyl-ethylidene)bis(oxy))-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta m [a]phenanthren-17-yl)-2-oxoethyl)-1-(4-(nitrooxy)butyl) 2-acetamido Pentanedioate

L) 2-acetamido-4-(2-((8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta [a]phenanthren-17-yl)-2-oxoethoxy)-4-oxobutanoic Acid

To a solution of triamcinolone acetonide (3.1 g, 7.13 mmol) in acetone (100 ml), N-acetyl aspartic acid (2.0 g, 11.42 mmol) and DMAP (cat. amount) were added. The reaction was cooled at 0° C. and EDAC (2.18 g, 11.42 mmol) was added. The reaction was stirred at room temperature for 24 hours. The solvent was evaporated under vacuum. The residue was purified by flash chromatography (Biotage System, column FLASH 65+M™ KP-Sil, eluent: gradient dichloromethane/methanol 95/5 (675 ml), to dichloromethane/methanol 9/1 during 3600 ml, dichloromethane/methanol 9/1 (900 ml)). The product (2.67 g) was obtained.

M) 1-(4-chlorobutyl) 4-(2-((8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl)-2-acetamido succinate

To a solution of compound L (0.6 g, 1.31 mmol) in dichloromethane (30 ml), 4-chlorobutanol (0.13 ml, 1.31 mmol) and DMAP (cat. amount) were added. The reaction was cooled at 0° C. and EDAC (0.25 g, 1.31 mmol) was added. The reaction was stirred at room temperature for 24 hours. The solvent was evaporated under vacuum. The residue was purified by flash chromatography (Biotage System, column FLASH 25+M™ KP-Sil, eluent: gradient n-hexane/ethyl acetate 6/4 (60 ml), to n-hexane/ethyl acetate 2/8 during 600 ml, to ethyl acetate during 60 ml, ethyl acetate (180 ml)). The product (0.65 g) was obtained.

N) 1-(4-iodobutyl) 4-(2-((8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl)-2-acetamido succinate

To a solution of compound M (0.55 g, 0.76 mmol) in acetonitrile (18 ml), sodium iodide (0.45 g, 3.06 mmol) was added. The reaction was heated to 120° C. for 60 minutes under microwave irradiation. The resulting mixture was cooled, filtered and the solvent was removed under reduced pressure to give a solid product which was used without further purification.

O) 1-(2-((8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl)-1-(4-(nitrooxy)butyl)-2-acetamido Pentanedioate

To a solution of compound N (0.60 g, 0.76 mmol) in acetonitrile (20 ml), silver nitrate (0.51 g, 3.06 mmol) was added. The reaction was heated to 120° C. for 5 minutes under microwave irradiation. The resulting mixture was cooled, filtered and the solvent was removed under reduced pressure. The residue was purified by flash chromatography (Biotage System, column FLASH 25+M™ KP-Sil, eluent: gradient n-hexane/ethyl acetate 4/6 (60 ml), to ethyl acetate 100% during 480 ml, ethyl acetate (120 ml)). The product (0.40 g) was obtained.

¹H-NMR: (DMSO): 8.45 (1H, d); 7.26 (1H, d); 6.22 (1H, dd); 6.00 (1H, s); 5.48 (1H, m); 5.12 (1H, dd), 4.84-4.76 (3H, m); 4.52 (2H, t); 4.20 (1H, m), 4.06 (2H, m); 2.87 (1H, dm); 2.75-2.48 (3H, m); 2.10-1.75 (4H, m); 1.82 (3H, s); 1.50-1.70 (7H, m); 1.47(3H, s); 1.33 (4H, m); 1.15 (3H, s); 0.83 (3H, s).

Example 13

Synthesis of 2-((8S,9R,10S,11S, 3S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl 3-(6-(nitrooxy)hexanamido) propanoate

The compound was synthesized using the procedure described in example 1 starting from betamethasone, Boc-beta-alanine and 6-nitrooxyhexanoic acid pentafluorophenol ester.

¹H-NMR: (DMSO), δ: 7.88 (1H, t); 7.29 (1H, d); 6.22 (1H, dd); 6.01 (1H, s); 5.36 (1H, s); 5.31 (1H, d); 5.01 (1H, d); 4.84 (1H, d); 4.50 (2H, t); 4.15 (1H, sb); 3.48-3.25 (2H, m); 2.75-2.25 (7H, m); 2.20-2.00 (4H, m); 1.99-1.75 (4H, m); 1.71-1.61 (2H, m); 1.57-1.48 (5H, m); 1.42-1.27 (2H, m); 1.01 (3H, d); 0.90 (3H, s).

Example 14

Synthesis of 2-((8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-16,17-dimethoxy-10,13-((1-methyl ethylidene)bis(oxy))-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta [a]phenanthren-17-yl)-2-oxoethyl-3-(6-(nitrooxy)hexanamido) Propanoate

The compound was synthesized using the procedure described in example I starting from triamcinolone acetonide, Boc-beta- and 6-nitrooxyhexanoic acid pentafluorophenol ester.

¹H-NMR: (DMSO), : 8.31 (1H, t); 7.30 (1H, d); 6.24 (1H, dd); 6.01 (1H, s); 5.49 (1H, d); 5.25 (1H, d); 4.86 (1H, d); 4.75 (1H, d); 4.50 (2H, t); 4.19 (1H, sb); 3.93 (2H, m); 2.75-2.25 (2H, m); 2.15 (2H, t); 2.10-1.75 (3H, m); 1.75-1.45 (7H, m); 1.47 (3H, s); 1.40-1.20 (6H, m); 1.17 (5H, m); 0.80 (3H, s).

Example 15

Synthesis of 2-((6S,8S,9R,10S,11S,13S,14S,16R,17S)-6,9-difluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl-3-(6-(nitrooxy) hexanamido) Propanoate

The compound was synthesized using the procedure described in example I starting from fluocinolone acetonide, Boc-beta-alanine and 6-nitrooxyhexanoic acid pentafluorophenol ester.

¹H-NMR: (DMSO), : 7.91 (1H, t); 7.27 (1H, d); 6.30 (1H, dd); 6.11 (1H, s); 5.75-5.50 (2H, m); 5.16 (1H, d); 4.85-4.90 (1H, m); 4.76 (1H, d); 4.61-4.48 (2H, t); 4.22 (1H, sb); 3.40-3.25 (3H, m); 2.70-2.50 (4H, m); 2.40-2.30 (1H, m); 2.15-1.93 (2H, m); 1.80-1.45 (10H, m); 1.41-1.28 (5H, m); 1.21 (3H, s); 0.82 (3H, s).

Example 16

Synthesis of 4-(2-((8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta [a]phenanthren-17-yl)-2-oxoethyl)-1-(4-(nitrooxy)butyl)2-(6-(nitrooxy)hexanamido)succinate

P) 1-allyl 4-(2-((8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-m hydroxy-16,17-((1-methylethylidene)bis(oxy))-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl)-2-(tert-butoxycarbonyl amino)succinate

To a solution of triamcinolone acetonide (3.0 g, 6.9 mmol) in dichloromethane (100 ml), 4-(allyloxy)-3-(tert-butoxycarbonylamino)-4-oxobutanoic acid (1.88 g, 6.9 mmol) and DMAP (cat. amount) were added. The reaction was cooled at 0° C. and EDAC (1.7 g, 8.97 mmol) was added. The reaction was stirred at room temperature for 12 hours. The solvent was evaporated under vacuum. The residue was purified by flash chromatography (Biotage System, column FLASH 40+M™ KP-Sil, eluent: gradient n-hexane/ethyl acetate 8/2 (300 ml), to n-hexane/ethyl acetate 4/6 during 900 ml, n-hexane/ethyl acetate 4/6 (300 ml)). The product (4.16 g) was obtained.

Q) 1-allyl 4-(2-((8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl)-2-(amino)succinate Hydrochloride

A solution of compound P (1.0 g, 1.45 mmol) in dichloromethane (28 ml) was stirred at room temperature. HCl gas was buddle in the solution for 15 minutes. The solvent evaporated under vacuum to give a solid product which was used without further purification.

R) 1-allyl 4-(2-((8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta [a]phenanthren-17-yl)-2-oxoethyl)-2-(6-(nitrooxy)hexanamido) Succinate

To a solution of compound Q (0.91 g, 1.45 mmol) in dichloromethane (100 ml), DMAP (0.26 g, 2.17 mmol) and 6-nitrooxyhexanoic acid pentafluorophenol ester (0.49 g, 1.45 mmol) were added. The reaction was stirred at room temperature for 12 hours. The solvent was evaporated under reduced pressure. The residue was purified by flash chromatography, (Biotage System, column FLASH 40+M™ KP-Sil, eluent: gradient n-hexane/ethyl acetate 1/1 (150 ml), to ethyl acetate during 900 ml, ethyl acetate (450 ml)). The product (0.64 g) was obtained.

S) 4-(2-((8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-16,17-((1-methylethyl idene)bis(oxy))-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta [a]phenanthren-17-yl)-2-oxoethyl)-2-(6-(nitrooxy)hexanamido)-4-oxobutanoic Acid

To a solution of compound R (0.58 g, 0.77 mmol) in dichloromethane (20 ml), 5,5-cimethyl-1,3-cyclohexanedione (0.13 g, 0.97 mmol), triphenylphosphine (0.30 g, 1.16 mmol) and tetrakis(triphenylphosphine)palladium (0.045 g, 0.039 mmol) is were added. The reaction was stirred at room temperature for 12 hours. The solvent was evaporated under reduced pressure. The residue was purified by flash chromatography, (Biotage System, column FLASH 40+M™ KP-Sil, eluent: n-hexane/acetone/acetic acid 4/6/0.1%) The product (0.31 g) was obtained.

T) 4-(2-((8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta [a]phenanthren-17-yl)-2-oxoethyl)-1-(4-(chloro)butyl)2-(6-(nitrooxy)hexanamido)succinate

To a solution of compound S (0.33 g, 0.47 mmol) in dichloromethane (20 ml), 4-chlorobutanol (0.06 ml, 0.61 mmol) and DMAP (cat. amount) were added. The reaction was cooled at 0° C. and EDAC (0.12 g, 0.62 mmol) was added. The reaction was stirred at room temperature for 24 hours. The solvent was evaporated under vacuum. The residue was purified by flash chromatography (Biotage System, column FLASH 25+M™ KP-Sil, eluent: gradient n-hexane/ethyl acetate 6/4 (60 ml), to n-hexane/ethyl acetate 2/8 during 360 ml, n-hexane/ethyl acetate 2/8 (240 ml)). The product (0.25 g) was obtained.

U) 4-(2-((8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-10,13-dimethyl-3-oxo-1-(4-(iodo)butyl) 2-(6-(nitrooxy)hexanamido)succinate

To a solution of compound T (0.25 g, 0.31 mmol) in acetonitrile (10 ml), sodium iodide (0.18 g, 1.25 mmol) was added. The reaction was heated to 120° C. for 60 minutes under microwave irradiation. The resulting mixture was cooled, filtered and the solvent was removed under reduced pressure to give a solid product which was used without further purification.

V) 4-(2-((8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta [a]phenanthren-17-yl)-2-oxoethyl)-1-(4-(nitrooxy)butyl)2-(6-(nitrooxy)hexanamido)succinate

To a solution of compound U (0.27 g, 0.31 mmol) in acetonitrile (10 ml), silver nitrate (0.21 g, 1.24 mmol) was added. The reaction was heated to 120° C. for 5 minutes under microwave irradiation. The resulting mixture was cooled, filtered and the solvent was removed under reduced pressure. The residue was purified by flash chromatography (Biotage System, column FLASH 25+M™ KP-Sil, eluent: gradient n-hexane/acetone 8/2 (120 ml), to n-hexane/acetone 55/45 during 480 ml, n-hexane/acetone 55/45 (120 ml)). The product (0.13 g) was obtained.

¹H-NMR: (DMSO), δ: 7.18 (1H, d); 6.59 (1H, d); 6.32 (1H, dd); 6.13 (1H, s); 5.02-4.88 (4H, m); 4.51-4.40 (5H, m); 4.27-4.11 (2H, m); 3.05 (1H, dd); 2.90 (1H, dd); 2.68-2.30 (4H, m); 2.27 (2H, t); 2.27-2.00 (2H, m); 1.90-1.40 (18H, m); 1.21 (3H, s); 0.88 (3H, s).

Example 17

Synthesis of 1-(2,3-bis(nitrooxy)propyl)4-(2-((9R,10S,11S,13S,16R,17S)-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl)-2-aminosuccinate Hydrochloride

W) 1-allyl-4-(4-nitrophenyl)-2-(tert-butoxycarbonylamino) Succinate

To a solution of 4-(allyloxy)-3-(tert-butoxycarbonylamino)-4-oxobutanoic acid (3.0 g, 11.0 mmol) in dichloromethane (50 ml), 4-nitrophenol (1.4 g, 11.0 mmol) and DMAP (cat. amount) were added. The reaction was cooled at 0° C. and EDAC (2.85 g, 15.0 mmol) was added. The reaction was stirred at room temperature for 12 hours. The solvent was evaporated under vacuum. The residue was purified by flash chromatography (Biotage System, column FLASH 65+M™ KP-Sil, eluent: gradient n-hexane/ethyl acetate 95/5 (450 ml), to n-hexane/ethyl acetate 6/4 during 4500 ml, n-hexane/ethyl acetate 6/4 (900 ml)). The product (1.5 g) was obtained.

X) 1-(2,3-bis(nitrooxy)propyl)4-(4-nitrophenyl)2-(tert-butoxycarbonylamino)succinate

To a solution of compound W (1.5 g, 3.8 mmol) in acetonitrile (60 ml), silver nitrate (0.63 g, 3.8 mmol) was added. The reaction was cooled at −15° C. and iodine (0.96 g, 3.8 mmol) was added. The reaction was stirred at 0° C. for 1 hour. Silver nitrate (1.27 g, 7.6 mmol) was added and the mixture was stirred at 70° C. for 7 days adding silver nitrate (0.96 g, 3.8 mmol) every day. The solvent was evaporated under vacuum. The residue was purified by flash chromatography (Biotage System, column FLASH 65+M™ KP-Sil, eluent: gradient n-hexane/ethyl acetate 95/5 (450 ml), to n-hexane/ethyl acetate 6/4 during 4500 ml, n-hexane/ethyl acetate 6/4 (900 ml)). The product (0.54 g) was obtained.

Y) 1-(2,3-bis(nitrooxy)propyl)4-(2-((9R,10S,11S,13S,16R,17S)-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl)-2-(tert-butoxy carbonylamino)succinate

To a solution of triamcinolone acetonide (0.21 g, 0.5 mmol) in dichloromethane (13 ml), compound X (0.26 g, 0.5 mmol) and DMAP (0.06 g, 0.5 mmol)) were added. The reaction was stirred at room temperature for 12 hours. The solvent was evaporated under vacuum. The residue was purified by flash chromatography (Biotage System, SNAP Cartridge silica 100 g, eluent: gradient n-hexane/ethyl acetate 88/12 (150 ml), to ethyl acetate during 1500 ml, ethyl acetate (300 ml)). The product (0.4 g) was obtained.

Z) 1-(2,3-bis(nitrooxy)propyl)4-(2-((9R,10S,11S,13S,16R,17S)-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl)2-aminosuccinate Hydrochloride

A solution of compound Y (0.4 g, 0.49 mmol) in dichloromethane (8 ml) was stirred at room temperature. HCl gas was buddle in the solution for 15 minutes. The solvent evaporated under vacuum. The residue was purified by reverse phase flash chromatography (Biotage column FLASH 25+M™, eluent: water/acetonitrile 1/1. The product (0.13 g) was obtained

¹H-NMR: (DMSO), δ: 7.30 (1H, d); 6.23 (1H, dd); 6.02 (1H, s); 5.66 (1H, m); 5.49 (1H, m); 5.17 (1H, dd), 4.97 (1H, dd); 4.89-4.79 (3H, m); 4.48 (1H, dm); 4.38 (1H, dd), 4.20 (1H, m); 3.82 w (1H, m); 2.78 (1H, dm); 2.68-2.49 (7H, m); 2.10-1.75 (3H, m); 1.54 (1H, m); 1.49 (5H, m); 1.35 (4H, m); 1.15 (3H, s); 0.83 (3H, s).

Claims

1. A compound of general formula (I) and pharmaceutically acceptable salts or stereoisomers thereof R-(Z)a-Rx  (I)wherein R is a corticosteroid residue of formula (II):

2. A compound of formula (I) according to claim 1 wherein R, R1, R2, R3 and R4 are as defined in claim 1; a is 0 andRx is selected from:(a2) —C(O)—CH(R1)—NH-(T′Y—ONO2)whereinR1 of the group A1) is selected from H, isobutyl, benzyl, C6H5—CH2—CH2—, 2-monosubstituted benzyl, or 3-monosubstituted benzyl or 4-monosubstituted benzyl wherein the substituent of the benzyl is selected from F, —Cl, I, —NO2, —CF3, —CH3, CN, C6H5CO—;R1 of the group A2) is selected from —CH2—OH, —CH(CH3)OH— or CH2—[(C6H4)-(4-OH)], orR1 of the group A3) is selected from —CH2—NHR″, —(CH2)2—NHR″, —(CH2)3—NHR″, —(CH2)4—NHR″, wherein R″ is H, or —C(O)CH3;R1 of the group A4) is selected from —CH2—C(O)R′″, —(CH2)2—C(O)R′″, —(CH2)4—C(O)R′″ wherein R′″ is OR5a wherein Rya is H or a linear (C1-C5) alkyl;T′ is —C(O)—, —C(O)—X″ wherein X″ is —S— or O—;or Rx is(a4) —C(O)—CH(R1a-T″-Y′—ONO2)—NHR4a wherein R1a of the group A5) is selected from —CH2—O—, —CH(CH3)O— or —CH2[(C6H4)-(4-O)—], orR1a of the group A6) is selected from —CH2—NH—, —(CH2)2—NH—, —(CH2)3—NH—, —(CH2)4—NH—, orR1a of the group A7) is selected from —CH2—C(O)—, —(CH2)2—C(O)—, —(CH2)4—C(O)—;R4a is H or —C(O)CH3;T″ is —C(O)— or —C(O)—X″ wherein X″ is —S— or —O—, when R1a is selected from the group A5) or A6);T″ is —O—, —S—, —NR′— or —O—CH(R′)—O—C(O)— wherein R′ is H or —CH3, when R1a is selected from the group A7);or Rx is selected from(a5) —R1b—CH(NHR4a)—C(O)-(T-Y—ONO2)(a6) —R1b—CH(COOR3a)NH-(T′-Y—ONO2)(a9) —R1b—CH(NH-T′-Y′—ONO2)—C(O)-(T-Y—ONO2) or(a10) —R1b—CH(C(O)-T-Y′—ONO2)—NH-(T-Y—ONO2)whereinR1b of the group A10) is selected from —C(O)—CH2—, —C(O)—(CH2)2—, —C(O)—(CH2)4—;R1a is H or a (C1-C5) alkyl;R4a is H or —C(O)CH3;T is —O—, —S—, —NR′— or —O—CH(R′)—O—C(O)— wherein R′ is H or —CH3;T′ is —C(O)— or —C(O)—X″ wherein X″ is —S— or —O—;or Rx is(a8) —C(O)—CH(R1a-T″-Y′—ONO2)—NH-(T′-Y—ONO2)whereinR1a of the group A5) is selected from —CH2—O—, —CH(CH3)—O— or—CH2—[(C6H4)-(4-O)—], orR1a of the group A6) is selected from —CH2—NH—, —(CH2)2—NH—, —(CH2)3—NH—, —(CH2)4—NH—, orR1a of the group A7) is selected from —CH2—C(O)—, —(CH2)2—C(O)—, —(CH2)4—C(O)—;T″ is —O(O)— or —C(O)—X″ wherein X″ is —S— or —O—, when R1a is selected from the group A5) or A6), -;T″ is —O—, —S—, —NR′— or —O—CH(R′)—O—C(O)— wherein R′ is H or —CH3, when R1a is selected from the group A7);T′ is —C(O)— or —C(O)—X″ wherein X″ is —S— or —O—;or Rx is(b2) —C(O)—CH2—CH(R2)—NH-(T′-Y—ONO2)whereinR2 of the group B1) is selected from H, CH3, isobutyl, isopropyl, benzyl;T′ is —C(O)—, —C(O)—X″ wherein X″ is —S— or —O—;Y and Y′ are each independently selected from a) a straight or branched C1-C10 alkylene,a straight or branched C1-C10 alkylene substituted with a —ONO2 group;

3. A compound of formula (I) according to claim 1 wherein R, R1, R2, R3 and R4 are as defined in claim 1, A is 1 and Z is —C(O)—;Rx is(a1) —HN—CH(R1)—C(O)-(T-Y—ONO2)whereinR1 of the group A1) is selected from H, isobutyl, benzyl, C6H5—CH2—CH2—, 2-monosubstituted benzyl, or 3-monosubstituted benzyl or 4-monosubstituted benzyl wherein the substituent of the benzyl is selected from F, —Cl, I, —NO2, —CF3, —CH3, CN, C6H5CO—;orR1 of A2) is selected from —CH2—OH, —CH(CH3) —OH— or —CH2—[(C6H4)-(4-OH)], orR1 of the group A3) is selected from —CH2—NHR″, —(CH2)2—NHR″, —(CH2)3—NHR″, —(CH2)4—NHR″, wherein R″ is H, or —C(O)CH3, R1 of the group A4) is —CH2—C(O)R′″, —(CH2)2—C(O)R′″, —(CH2)4—C(O)R′″ wherein R′″ is OR5a wherein Rya is H or a linear (C1-C5) alkyl;T is —O—, —S—, —NR′—, —O—CH(R′)—O—C(O)— wherein R′ is H or a straight or branched C1-C4 alkyl;Y is as below defined;or Rx is(a3) —HN—CH(R1a-T″-Y′—ONO2)—COOR3a whereinR1a of the group A5) is selected from —CH2—O—, —CH(CH3)O— or —CH2—[(C6H4)Op—], orR1a of the group A6) is selected from —CH2—NH—, —(CH2)2—NH—, —(CH2)3—NH—, —(CH2)4—NH—, orR1a of the group A7) is —CH2—C(O)—, —(CH2)2—C(O)—, —(CH2)4—C(O)—;R1a is H or a (C1-C5) alkyl;T″ is —C(O)— or —C(O)—X″ wherein X″ is —S— or —O—, when R1a is selected from the group A5) or A6);T″ is —O—, —S—, —NR′—, —O—CH(R′)—O—C(O)— wherein R′ is H or a straight or branched C1-C4 alkyl, when R1a is selected from the group A7);Y′ is as below defined;or Rx is(a5) —R1b—CH(NHR4a)—C(O)-(T-Y—ONO2)(a6) —R1b—CH(COOR3a)NH-(T-Y—ONO2)(a9) —R1b—CH(NH-T′-Y′—ONO2)—C(O)-(T-Y—ONO2) or(a10) —R1b—CH(C(O)-T-Y′—ONO2)—NH-(T′-Y—ONO2)whereinR1b of the group A8) is selected from —O—CH(CH3)—, —O—CH2—, [-4-O)—(C6H4)]—CH2—, orR1b of the group A9) is selected from —HN—CH2—, —HN—(CH2)2—, —HN—(CH2)3—, —HN—(CH2)4—;R3a is H or a (C1-C5) alkyl;R4a is H or —C(O)CH3;T is —O—, —S—, —NR′—, —O—CH(R′)—O—C(O)— wherein R′ is H or a straight or branched C1-C4 alkyl;T′ is —C(O)— or —C(O)—X″ wherein X″ is —S— or —O—;Y and Y′ are as below defined;or Rx is(a7) —HN—CH(R1a-T″-Y′—ONO2)—C(O)-(T-Y—ONO2)whereinR1a of the group A5) is selected from —CH2—O—, —CH(CH3)—O— or —CH2—[(C6H4)-(4-O)—], orR1a of the group A6) is selected from —CH2—NH—, —(CH2)2—NH—, —(CH2)3—NH—, —(CH2)4—NH—, orR1a of the group A7) is —CH2—C(O)—, —(CH2)2—C(O)—, —(CH2)4—C(O)—;T″ is —C(O)— or —C(O)—X″ wherein X″ is —S— or —O—;T″ is —O—, —S—, —NR′—, —O—CH(R′)—O—C(O)— wherein R′ is H or a straight or branched C1-C4 alkyl, when R1a is selected from A7);T is —O—, —S—, —NR′—, —O—CH(R′)—O—C(O)— wherein R′ is H or a straight or branched C1-C4 alkyl;Y and Y′ are as below defined;or Rx is(b1) —HN—CH(R2)—CH2C(O)-(T-Y—ONO2)whereinR2 of the group B1) is selected from H, CH3, isobutyl, isopropyl, benzyl;R2 of the group B2) is selected from —CH2—OH, —CH(CH3)—OH— or —CH2—[(C6H4)(4-OH)], orR2 of the group B3) is selected from —CH2—NHR″, —(CH2)2—NHR″, —(CH2)3—NHR″, —(CH2)4—NHR″, wherein R″ is H, or —C(O)CH3,R2 of the group B4) is —CH2—C(O)R′″, —(CH2)2—C(O)R″, —(CH2)4—C(O)R″ wherein R″ is OR5a wherein R5a is H or a linear (C1-C5) alkyl;T is —O—, —S—, —NR′—, —O—CH(R′)—O—C(O)— wherein R′ is H or a straight or branched C1-C4 alkyl;Y is as below defined;or Rx is selected from(d1) —HN—CH(R12)—CH2—O-(T″-Y—ONO2)(d2) —O—CH2—CH(R12)—NH-(T′-Y′ONO2)whereinR12 of the group D1) is selected from H, CH3, isobutyl, isopropyl, benzyl, orR12 of the group D2) is selected from —CH2—OH, —CH(CH3)OH— or CH2—[(C6H4)-(4-OH)], orR12 of the group D3) is selected from —CH2—NHR″, —(CH2)2—NHR″, —(CH2)3—NHR″, —(CH2)4—NHR″ wherein R″ is H, orR12 of the group D4) is —CH2—C(O)R″, —(CH2)2—C(O)R″, —(CH2)4—C(O)R″ wherein R″ is OR5a wherein R5a is H or a linear (C1-C5) alkyl;T′ and T″ are each independently selected from —C(O)— or —C(O)—X″ wherein X″ is —S— or —O—;Y is as below defined;or Rx is selected from(d3) —HN—CH(R12a-T″-Y′—ONO2)—CH2OH(d4) —O—CH2—CH(R12a-T″-Y′—ONO2)—NHR4a (d7) —HN—CH(R12a-T″-Y′—ONO2)—CH2—O-(T′″-Y—ONO2) or(d8) —O—CH2—CH(R12a-T″-Y′—ONO2)—NH-(T-Y—ONO2)whereinR12a of the group D5) is selected from —CH2—O—, —CH(CH3)—O— or —CH2—[(C6H4)-(4-O)—], orR12a of the group D6) is selected from —CH2—NH—, —(CH2)2—NH—, —(CH2)3—NH—, —(CH2)4—NH—, orR12a of the group D7) is —CH2—C(O)—, —(CH2)2—C(O)—, —(CH2)4—C(O)—;R4a is H or —C(O)OH3;T″ is selected from —O(O)— or —C(O)—X″ wherein X″ is —S— or —O—;T″ is —O—, —S—, —NR′—, —O—CH(R′)—O—C(O)— wherein R′ is H or a straight or branched C1-C4 alkyl;T″ is selected from —C(O)— or —C(O)—X″ wherein X″ is —S— or —O—;Y and Y′ are as below defined;or Rx is selected from(d5) —R12b—C H(NHR4a)—CH2—O-(T′″-Y—ONO2)(d6) —R12b—CH(CH2OH)—NH-(T′-Y—ONO2)(d9) —R12b—CH(NH-T′-Y′—ONO2)—CH2—O-(T′-Y—ONO2) or(d10) —R12b—CH(CH2—O-T′″-Y′—ONO2)—NH-(T′-Y—ONO2)whereinR12b) of the group D8) is selected from —O—CH(CH3)—, —O—CH2—, [—Op(C6H4)]-CH2—, orR12b of the group D9) is selected from —HN—CH2—, —HN—(CH2)2—, —HN—(CH2)3—, —HN—(CH2)4—;R4a is H or —C(O)—CH3,T′ and T″ are each independently selected from —C(O)—, —C(O)—X″, wherein X″ is —S— or —O—;Y and Y′ are each independently selected froma) a straight or branched C1-C10 alkylene,a straight or branched C1-C10 alkylene substituted with a —ONO2 group;

4. A compound of formula (I) according to claim 1 wherein R, R1, R2, R3, R4, are as defined in claim 1; Rx is(a2) —C(O)—CH(R1)—NH-(T′-Y—ONO2)whereinR1 is HT′ is —C(O)—;Y is selected froma) a straight or branched C1-C10 alkylene,a straight or branched C10-C10 alkylene substituted with a —ONO2 group;

5. A compound of formula (I) according to claim 1 wherein R, R1, R2, R3, and R4 are as defined in claim 1; A is 0;Rx is (a5) —R1b—CH(NHR4a)—C(O)-(T-Y—ONO2) or(a9) —R1b—CH(NH-T′-Y′—ONO2)—C(O)-(T-Y—ONO2)whereinR1b is —C(O)—CH2—,R4a is H or —O(O)OH3;T is selected from —O—, —S—, —NR′— wherein R′ is as above defined,T′ is —C(O)— andY and Y′ are each independently selected froma) a straight or branched C1-C10 alkylene,a straight or branched C1-C10 alkylene substituted with a —ONO2 group;

6. A compound of formula (I) according to claim 1 wherein R, R1, R2, R3 and R4 are as defined in claim 1; A is 1 and Z is —C(O)—,Rx is (a5) —R1b—CH(NHR4a)—C(O)-(T-Y—ONO2) or(a9) —R1b—CH(NH-T′-Y′—ONO2)—C(O)-(T-Y—ONO2)wherein R1b of A10) is —O—CH2— or [—Op—(C6H4)]—CH2—,R4a is H or —C(O)CH3,T is selected from —O—, —S—, —NR′— wherein R′ is as above defined,T′ is —C(O)— andY and Y′ are each independently selected froma) a straight or branched C1-C10 alkylene,a straight or branched C1-C10 alkylene substituted with a —ONO2 group;

7. A compound of formula (I) according to claim 1 wherein R, R1, R2, R3 and R4 are as defined in claim 1; A is 0,Rx is(b2) —C(O)—CH2—CH(R2)—NH-(T-Y—ONO2)whereinR2 is H,T′ is —C(O)—;Y and Y′ are each independently selected froma) a straight or branched C1-C10 alkylene,a straight or branched C1-C10 alkylene substituted with a —ONO2 group;

8. A compound of formula (I) according to claim 1 and pharmaceutically acceptable salts or stereoisomers thereof selected from the group consisting of:

9. A compound of formula (I) according to claim 1 for use as a medicament.

10. A compound of formula (I) according to claim 1 for use in the treatment of ocular diseases.

11. A compound according to claim 10 for use in the treatment of ocular hypertension, age-related macular degeneration, diabetic macular edema, diabetic retinopathy, hypertensive retinopathy and retinal vasculopathies.

12. A compound of formula (I) according to claim 1 for use in the treatment of respiratory diseases.

13. A compound according to claim 12 for use in the treatment of asthma and COPD.

14. A compound of formula (I) according to claim 1 for use in the treatment of dermatological diseases.

15. A compound according to claim 14 for use in the treatment of dermatosis, atopic dermatitis, inflammation, eczema, erythema, papulation, scaling, erosion, oozing,

9. A compound of formula (I) according to claim 1 for use as a medicament.

10. A compound of formula (I) according to claim 1 for use in the treatment of ocular diseases.

11. A compound according to claim 10 for use in the treatment of ocular hypertension, age-related macular degeneration, diabetic macular edema, diabetic retinopathy, hypertensive retinopathy and retinal vasculopathies.

12. A compound of formula (I) according to claim 1 for use in the treatment of respiratory diseases.

13. A compound according to claim 12 for use in the treatment of asthma and COPD.

14. A compound of formula (I) according to claim 1 for use in the treatment of dermatological diseases.

15. A compound according to claim 14 for use in the treatment of dermatosis, atopic dermatitis, inflammation, eczema, erythema, papulation, scaling, erosion, oozing, crusting, pruritis, psoriasis, epidermalysis bullosa, erythema, hidradenitis suppurative, warts, diaper rash, jock itch.

16. A pharmaceutical formulation comprising at least a compound of formula (I) as described in claim 1 and one or more pharmaceutical acceptable excipients.